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A. ABSTRACT 
Pathogenic bacteria of the genus Yersinia have in common the capacity to overcome the 
defense mechanisms of their mammalian hosts and to survive and proliferate in lymphoid 
tissues. Yersiniae employ a type III secretion system to inject effector proteins (Yops) that 
modulate host cell signaling by unique biochemical activities. One of these effector proteins 
(YopO) is a 729 amino acid serine/threonine kinase activated by G-actin. Studies of YopO 
protein organization revealed the following functional domains: Amino acids 1-88 comprise a 
bacterial secretion/translocation domain also responsible for localization of YopO at the 
plasma membrane of target cells. The catalytic activity is encompassed by amino acids 89-
440 and the C-terminal amino acids 441-729 harbour a Rho GTPase-binding guanine 
nucleotide dissociation inhibitor (GDI) -like region and an actin binding region.  
Here, YopO constructs were established and biochemically characterized with the aim to 
separate the different YopO activities (kinase, Rho-binding, actin binding) and investigate 
their cellular effects. In the course of these experiments two separate G-actin binding sites 
(89-440 and 441-729) were identified and shown to be necessary for effective YopO 
autophosphorylation on amino acids serine-90 and serine-95. 
In infected cells YopO was shown earlier to disrupt F-actin structures and cause a specific 
phenotype referred to as rounding/arborization where cell retraction occurs without 
dissolution of focal adhesions. Here the biochemically characterized constructs were 
individually evaluated for their effects on cell morphology. A YopO construct comprising 
only the C-terminal Rho-binding GDI-like domain was capable of disrupting F-actin 
structures. Cell rounding/arborization, however, was specifically dependent on the kinase 
activity, because the kinase dead YopOD267A/K269A and truncations with reduced kinase 
activity showed significantly reduced rounding/arborization. Actin binding of YopO itself did 
not affect F-actin disruption or cell rounding. Using the established constructs we also found 
that kinase activity was essential for inhibition of YadA-mediated internalization. This 
internalization mechanism is Yersinia-specific and involves bridging of the Yersinia adhesin 
YadA with extracellular matrix to cellular integrin receptors. 
Thus, the different structural entities of YopO could be assigned to specific cellular effects 
and for the first time the kinase activity of YopO could be related to modulation of an 
immunologically relevant cell function. These results provide a novel piece of information as 
to the molecular mode of action of a Yersinia virulence factor and further our knowledge of 
the pathogenicity of yersiniae. 
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B. INTRODUCTION 
1. THE GENUS YERSINIA 
The genus Yersinia (named Pasteurella until 1964) is named after Alexandre Yersin, who 
isolated and identified Yersinia pestis as the causative agent of plague in the year 1894 
(Schleifstein and Coleman 1939; Frederiksen 1964). The genus Yersinia belongs to the family 
of Enterobacteriaceae and comprises gram negative, rod shaped, facultative anaerobe, 
katalase-positive, oxidase-negative, non spore forming bacteria (Brenner 1979; Miller, Finlay 
et al. 1988). 
There are 11 known Yersinia species, three of which, Yersinia pestis, Yersinia pseudotube-
rculosis and Yersinia enterocolitica are pathogenic to humans and rodents causing syndromes 
ranging from the deadly plague to gastroenteritis (Brenner 1979; Cornelis, Laroche et al. 
1987; Knapp 1988). Credible estimates of the number of people killed by Yersinia pestis 
during the course of history approach 200 million (Perry and Fetherston 1997). Y. pestis is 
known to be lethal to non-human primates and many rodents at infecting doses of 10 bacteria 
or less (Brubaker 1991). Yersinia has several chromosomal and plasmid-associated factors 
(overviewed in Table B1) that are essential to its virulence and survival in mammalian hosts 
and flea vectors (Brubaker 1991; Straley and Perry 1995). 
Y. pestis is an obligate pathogen dependent on an insect-mammal infection cycle. In contrast, 
Y. enterocolitica and Y. pseudotuberculosis are free living microorganisms and food-borne 
pathogens. Contaminated milk and pork products are the main source of Y. enterocolitica 
infections (Black, Jackson et al. 1978). Yersinia pseudotuberculosis causes mesenteric 
adenitis and septicemia, and Yersinia enterocolitica, the most prevalent in human infections, 
causes gastrointestinal syndromes ranging from an acute enteritis to mesenteric 
lymphadenitis. All three species are invasive lymphotrophic bacteria, which have a common 
capacity to resist non-specific immune response, in particular phagocytosis and killing by 
macrophages and polymorphonuclear leukocytes (PMNs) (Cornelis, Boland et al. 1998). The 
three pathogenic species however differ considerably in invasiveness; while Y .enterocolitica 
and Y. pseudotuberculosis can cross the gastro-intestinal mucosa to infect underlying tissue, 
Y. pestis is injected into the body by an insect (e.g. rat flea, Xenopsylla cheopis) bite, and thus, 
does not have to penetrate any body surface on its own (Cornelis, Boland et al. 1998). If 
Y. pestis causes pneumonia in infected persons, the bacteria can be transmitted by exhausted 
droplets. 
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Table B1. Distinguishing properties and virulence determinants of wild-type Y. pestis, Y. pseudo-
tuberculosis, and Y. enterocolitica (Brubaker 1991 with modifications). 
Gene product and location 
of genes  
Established or 
putative 
virulence 
function 
Y. pestis  Y. pseudotuberculosis  Y. enterocolitica  
pPla plasmid   +  -  -  
Pesticin  -  +  -  -  
Plasminogen activator  +  +  -  -  
Posttranslational 
degradation of Yops 
+  +  -  -  
pCD/pYV plasmid   + + + 
Yops  +  +  +  +  
YadA (protein 1 or YopA)  +  -  +  +  
V antigen  +  +  +  +  
pFra plasmid   + - - 
Fraction 1 or capsular 
antigen  
+  +  -  -  
Phospholipase D  +  +  -  -  
Chromosomal 
determinants  
    
Pigmentation or peptide F 
(hemin  
+  +  -  -  
storage at 26°C)  -    
Motility (26°C)  -  -  +  +  
Hydrophobic sugars in LPS 
(26°C)/O-antigen  
-  -  +  +  
Assimilation of low levels 
of NH4 (26°C)  
-  -  +  +  
Constitutive glyoxylate 
bypass  
-  +  -  -  
Aspartase  -  -  +  +  
Glucose 6-phosphate 
dehydrogenase  
-  -  +  +  
Urease  -  -  +  +  
Ornithine decarboxylase  -  -  -  +  
Host cell invasins      
Invasin (Inv)  +  -  +  +  
Attachment invasion locus 
(Ail)  
+  -  - + 
pH 6 antigen/Myf  +  +  +  +  
Antigen 5 (catalase)  +  +  + - 
Fermentation of      
Rhamnose  -  - + - 
Melibiose  -  - + - 
Sucrose  -  -  - + 
Sorbitol  -  -  - + 
Cellobiose  -  -  - - 
Biosynthesis of      
Methionine  -  - + + 
Phenylalanine  -  - + + 
Threonine-glycine  -  - + + 
Isoleucine-valine  -  - + + 
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Wild-type Y. pestis and Y. pseudotuberculosis show very high (97 %) chromosomal DNA 
homology, while chromosomal DNA of Y. enterocolitica is significantly less related, 
indicating that the event of its evolutionary divergence occurred prior to that separating 
Y. pseudotuberculosis and Y. pestis (Moore 1979; Achtman, Zurth et al. 1999; Motin, 
Georgescu et al. 2002). 
The medically significant yersiniae grow on suitable media at temperatures ranging from 5 to 
42 °C. In contrast to Y. pestis, which is immobile independently of the ambient temperature 
(Cover and Aber 1989; Bottone 1999), the enteropathogenic yersiniae are motile at 27 °C and 
loose their motility at 37 °C, which is the temperature typical in the host environment (Badger 
and Miller 1998). The organisms can be identified and differentiated by biochemical and 
serological reactions and in case of Y. enterocolitica also by phage-typing methods (Aleksic 
and Bockemuhl 1990). 
2. YERSINIA ENTEROCOLITICA PREVALENCE AND CLINICAL 
PICTURE 
Y. enterocolitica is widely distributed in nature in aquatic and animal reservoirs, with swine 
serving as a major reservoir for human pathogenic strains (Bottone 1997). Based on 
biochemical features Y. enterocolitica is divided in 6 biogroups, namely 1A (non pathogenic), 
1B (highly pathogenic) and biogroups 2, 3, 4 and 5 that are weakly pathogenic (Wauters, 
Kandolo et al. 1987). Serologically, Y. enterocolitica can be separated into almost 60 
serotypes of which only 11 serotypes have been most frequently associated with human 
infection (see Table B2).  
On a worldwide basis the majority of these infections are caused by serotypes O:3, O:9, 
O:5,27 and O:8. In the USA the dominant serotypes are O:4, O:8, O:13, O:18, O:20 and O:21, 
all belonging to the highly pathogenic biogroup 1B, while the dominant pathogenic serotypes 
in Europe are O:3, O:5,27 and O:9, which can be assigned to the weakly pathogenic 
biogroups 2 to 5 (Aleksic and Bockemuhl 1990). However, recently a Y. enterocolitica  O:8 
strain has also been isolated in Germany (Schubert, Bockemuhl et al. 2003). A United States 
population-based surveillance for Y. enterocolitica infections for the years 1996 to 1999 
reported an average annual incidence of 3.2 cases/100.000 population and a higher risk for 
disease in infants and minority populations (Ray, Ahuja et al. 2004). 
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Table B2. Virulence of Y. enterocolitica correlated with biogroup, serogroup, 
and ecologic and geographic distribution (Bottone 1999 with modifications). 
 
Associated 
with human 
infections  
Biogroup  Serotype(s)  Ecologic distribution  
Yes  1B  O:8, O:4, 
O:13a,13b, 
O:18, O:20, 
O:21  
Environment, pigs (O:8), mainly in 
the United States, Japan, Europe 
Yes  2 O:9, O:5,27  Pigs, Europe (O:9), United States 
(O:5,27), Japan (O:5,27), Sweden, 
The Netherlands 
Yes  3 O:1,2,3, 
O:5,27, O:3  
Chinchilla (O:1,2,3), pigs (O:5,27) 
Yes  4 O:3  Pigs, Europe, United States, Japan, 
South Africa, Scandinavia, Canada, 
The Netherlands 
Yes  5 O:2,3  Hare, Europe 
Noa 1A  O:5, O:6,30, 
O:7,8, O:18, 
O:46, 
nontypeable  
Environment, pigs, food, water, 
animal and human feces, global 
a Y. enterocolitica isolates comprising biogroup 1A may be opportunistic pathogens in patients with 
underlying disorders.  
 
Infection with Yersinia enterocolitica is typically initiated by uptake of contaminated food, 
following the oral route (Cover and Aber 1989; Aleksic and Bockemuhl 1990). Four to seven 
days after exposure Yersinia enterocolitica causes symptoms from mild self-limiting diarrhea 
(potentially accompanied by low-grade fever and vomiting) to acute mesenteric lymphadenitis 
(Bottone 1997). Gastroenteritis, caused by Y. enterocolitica, is the most frequent form of 
Yersiniosis, typically affecting infants and young children. In older children and young adults, 
acute Yersiniosis can present as a pseudoappendicular syndrome, which is frequently 
confused with appendicitis. Long-term sequelae, including reactive arthritis, erythema 
nodosum, glomerulonephritis and myocarditis, are mainly seen in young adults (Fredriksson-
Ahomaa, Stolle et al. 2006). Sepsis is a rare complication of Y. enterocolitica infection, 
except in patients who have a predisposing underlying disease or are in an iron-overloaded 
state. (Winblad 1969; Dequeker, Jamar et al. 1980). In most cases Y. enterocolitica infection 
is self limiting. 
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3. PATHOGENICITY OF YERSINIA ENTEROCOLITICA 
In the life cycle of enteropathogenic yersiniae, survival outside the host is essential and in 
order to achieve this Yersinia is able to adapt gene expression to its variable environments. 
Before ingestion by humans, Y. enterocolitica and Y. pseudotuberculosis survive in moist 
natural environments or in food by means of highly adaptable metabolic pathways that are 
typical for free-living enteric bacteria. Examples for properties that are strongly expressed at 
ambient temperatures in Y. enterocolitica and weakly or not at all at 37 °C are motility, 
smooth lipopolysaccharide (LPS), some metabolic properties, the adhesin invasin (Inv) and 
the heat stable enterotoxin Yst (Straley and Perry 1995). The resistance to the immune 
response of the host, the tropism of the bacteria for lymphoid tissue and the manner in which 
they are able to spread inside the host are accomplished by pathogenicity factors that are 
coded on the chromosome and also on extra-chromosomal elements.  
One of these chromosomally coded elements is a genomic island, called high-pathogenicity 
Island (HPI), essential for the mouse-virulence phenotype in Yersinia. The HPI is 
indispensable for pathogenicity of Yersinia and also certain pathotypes of Escherichia coli 
(Schubert, Rakin et al. 2004). Strains carrying this HPI, which mediates biosynthesis and 
uptake of the siderophore Yersiniabactin, are able to adapt to low iron conditions inside the 
host (Heesemann, Hantke et al. 1993; Carniel, Guilvout et al. 1996). 
During colonization Y. enterocolitica adheres to intestinal mucin of epithelial cells and passes 
through the epithelial layer (Hanski, Kutschka et al. 1989; Straley and Perry 1995). This 
translocation occurs in the small intestine where bacteria cross the intestinal epithelial barrier 
selectively through the M cells in the follicle-associated epithelium of the Peyer's patches. 
M cells are specialized cells that take up particles or antigens and transport these components 
to the gut-associated lymphoid tissue (Neutra, Mantis et al. 2001; Grassl, Bohn et al. 2003). It 
was shown in mouse models that localized infection of the gut by Yersinia was followed by 
dissemination into other organ sites and the ensuing growth of the organism in the liver and 
spleen leads to the eventual death of the animal (Autenrieth and Firsching 1996). 
The capability of Yersinia to resist the non specific immune defense of the host depends on 
the presence of a 70-kb virulence plasmid (pYV) that encodes a set of secreted proteins, 
termed Yops (Yersinia outer proteins) (Heesemann, Gross et al. 1986), the proteins necessary 
for injecting the Yops into host cells (termed type III secretion system) and the adhesin YadA 
(Snellings, Popek et al. 2001; Cornelis 2002; Barnes, Bergman et al. 2006). 
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4. ADHESION AND INVASION 
Many pathogenic bacteria assemble on their surface multifunctional protein structures that 
function as adhesins and/or defense shields against the various bactericidal weapons of the 
host. Bacterial adhesins can be found in the form of hair like structures with a diameter of 
2-10 nm (also referred to as pili) and as non-pilus-associated adhesins that are mono- or 
oligomeric proteins anchored to the bacterial outer membrane. Typical members of the non-
pilus-associated adhesins are the chromosomally-encoded invasin and the virulence plasmid-
encoded Yersinia adhesin (YadA) (Hultgren, Abraham et al. 1993; Hoiczyk, Roggenkamp et 
al. 2000). Especially Yersinia enterocolitica as a pathogen that colonizes the small intestine 
via the oral route needs to be able to adhere to the intestinal mucosa. Yersinia enterocolitica 
employs its surface adhesins to cross the mucosal membrane - preferentially through M cells 
in the ileum – in order to migrate to the underlying lymphoid tissue in Peyer´s patches 
(Autenrieth and Firsching 1996). 
4.1 Pla and pH6 antigen 
Y. pestis expresses neither YadA nor Invasin. The genes encoding these adhesins are present, 
but are not functional (Rosqvist, Skurnik et al. 1988; Simonet, Riot et al. 1996). Two potential 
adhesins expressed by Y. pestis are Pla (plasminogen activator protease) and pH6 antigen 
(pH6-Ag). Pla is localized at the outer membrane, has proteolytic activity that activates 
plasminogen and has been suggested to be important for the ability of Y. pestis to infect via 
flea bites (Sodeinde, Subrahmanyam et al. 1992; Makoveichuk, Cherepanov et al. 2003). It 
was also reported that adhesion and invasion of Y. pestis into epithelial cells was mediated by 
Pla (Cowan, Jones et al. 2000). 
pH6-Ag was first described more than 40 years ago (Ben-Efraim, Aronson et al. 1961) and 
was initially identified as an antigen expressed only at pH below 6 at 37 °C. Later it was 
discovered that pH6 antigen fimbrial structures on the surface of Yersinia pestis occur at 
pH 6.7 in host macrophage phagolysosomes as well as extracellularly in abscesses such as 
buboes (Zav'yalov, Abramov et al. 1996). The operon encoding pH6-Ag has been shown to 
mediate agglutination of erythrocytes from a wide variety of species and to mediate binding to 
epithelial cells (Yang, Merriam et al. 1996; Makoveichuk, Cherepanov et al. 2003). The 
in vivo role of pH6-Ag remains to be explored since expression in vitro is only seen at 37 °C 
at slightly acidic pH. Because ph6-Ag binds to apolipoprotein B (apoB)-containing 
lipoproteins in human plasma (mainly LDL) its suspected function is to prevent Yersinia 
pestis from host cell interaction. Covering the bacterial surface with host lipoproteins has 
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been speculated to prevent recognition of the pathogen by the host defense systems 
(Makoveichuk, Cherepanov et al. 2003).  
4.2 Attachment Invasion Locus (Ail) 
Ail is a chromosomally encoded membrane-associated protein that was shown to play a role 
in the attachment and subsequent invasion of eukaryotic cells by Yersinia enterocolitica. The 
ail gene, if transferred to laboratory E. coli strains, was shown to allow normally non adhesive 
E. coli to attach to several epithelial cell types (Hep-2) and efficiently enter select cell lines 
such as Chinese hamster ovary (CHO) cells (Miller and Falkow 1988). Several years later 
however it was also shown that non pathogenic strains of Y. enterocolitica (lacking the 
important adhesin invasin) even after introduction and expression of the ail gene, were neither 
able to adhere to nor to invade cultured animal cells. However, these strains became resistant 
to killing by human serum (Pierson and Falkow 1993). 
Epidemiologically the ail gene has been shown to be linked exclusively to pathogenic species 
of Y. enterocolitica (Miller and Falkow 1988; Miller, Farmer et al. 1989) and to be able to 
confer resistance to killing by serum complement not only to Y. enterocolitica, but also to 
E. coli. The ail gene confers resistance to serum killing also to Y. pseudotuberculosis (Pierson 
and Falkow 1993), but has no role in adherence or uptake in this species (Yang, Merriam et 
al. 1996). The Ail protein is a 17 kDa outer membrane protein with predicted 8 membrane 
spanning domains, which is expressed at 37 °C in contrast to invasin (Miller, Bliska et al. 
1990; Pierson and Falkow 1993). In the mouse infection model Ail has been demonstrated to 
be less important for pathogenicity of Y. enterocolitica than the other known adhesins invasin 
and YadA (Pepe, Wachtel et al. 1995).  
4.3 Invasin 
The chromosomal inv gene product invasin, which is generally expressed at low temperature 
(26 °C, pH 8 or at 37 °C, pH 5.5), but weakly at 37 °C (pH 8), is the principal invasion factor 
for both Y. enterocolitica and Y. pseudotuberculosis (Isberg, Voorhis et al. 1987; Pepe and 
Miller 1993; Revell and Miller 2000). Invasin binds directly to a subset of β1-chain integrin 
receptors with high affinity, which potentiates the ensuing internalization of bacteria (Isberg 
and Leong 1990; Van Nhieu and Isberg 1991). In a mouse infection model, a Y. enterocolitica 
inv mutant is severely impaired in its ability to cross the intestinal epithelium, but in later 
stages of disease invasin did not play a role in establishing mouse infection (Pepe and Miller 
1993). It was shown that invasin confers the ability to directly bind to the five integrin 
receptors α3β1, α4β1, α5β1, α6β1, and αvβ1 (Isberg and Leong 1990). In the small intestine, 
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the only cells presenting β1 chain integrins to the intestinal lumen are M cells, which thus 
explains the specificity of the microorganism for this cell type during early stages of disease 
(Clark, Hirst et al. 1998; Isberg and Barnes 2001).  
Invasin not only mediates internalization into epithelial cells, but was also shown to, 
independently of uptake, trigger signaling cascades leading to the activation of NF-κB and the 
production of various proinflammatory cytokines (Schulte and Autenrieth 1998; Kampik, 
Schulte et al. 2000; Schulte, Kerneis et al. 2000).  
The invasin protein (92 kDa) shares similarity to the intimin family of proteins that were 
shown to be essential for production of the 'attaching and effacing' histopathology 
characteristic of pathogenic E. coli strains (Yu and Kaper 1992; Zhang, Kohler et al. 2002).  
 
 
FIGURE 1. Functional domains of Yersinia invasin (Grassl et al., 2003 with modifications). 
The protein is anchored in the outer membrane with its transmembrane amino-terminus. 
Y. pseudotuberculosis invasin is made up by five extracellular domains (D1 ― D5) with D4 and 
D5 containing the integrin-binding features (highlighted aspartic acid residues Asp811 and 
Asp911 are critical for integrin binding). Invasin molecules from Y. pseudotuberculosis 
homomultimerize on domain D2 (self association). The Y. enterocolitica protein is highly 
homologous but the homomultimerization domain D2 is absent. Asp659 and Asp760 are the 
corresponding amino acids critical for integrin binding. 
 
Between the two enteropathogenic species Y. pseudotuberculosis and Y. enterocolitica the 
invasin proteins are highly homologous except for a homomultimerization domain which is 
only present in Y. pseudotuberculosis invasin (Dersch and Isberg 1999). The crystal structure 
of the C-terminal 497 amino acids, the extracellular part of Y. pseudotuberculosis invasin, was 
solved and it was shown that these amino acids form an 18 nm long rod that is made up of 
five domains. Domain D1 to D4 form structures similar to immunoglobulin superfamily 
domains while the C-terminal domain D5 is similar to C-type lectin-like domains of proteins 
(Hamburger, Brown et al. 1999). Studies with mutant α5β1 integrin receptors and competitive 
inhibition studies indicate that invasin recognizes a site that is either identical to or overlaps 
that bound by the natural substrate fibronectin (Van Nhieu and Isberg 1991). Nevertheless, 
the respective integrin binding regions of invasin and fibronectin seem to be different in three 
dimensional protein structure. In the case of fibronectin the aspartate at position 1495 
(Asp1495) of the Arg-Gly-Asp (RGD) sequence was identified as the most significant 
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contributor to binding energy besides several other residues located on the same face of the 
molecule as the RGD sequence (Aota, Nomizu et al. 1994). In invasin the carboxy-terminal 
D4-D5 adhesion module contains the Asp911 that was shown to be most critical for receptor 
binding (Leahy, Aukhil et al. 1996; Hamburger, Brown et al. 1999; Isberg and Barnes 2001). 
The striking difference between invasin and fibronectin is the significantly higher affinity of 
the bacterial invasin to the integrin receptor, which was shown to be essential for the 
translocation of bacteria into M cells (Marra and Isberg 1997). High-affinity integrin binding 
allows invasin to compete efficiently with other ligands for integrin receptors and allows 
stable contact between host cell and bacterial membranes, which after sequestration of a large 
number of integrin molecules subsequently leads to signaling events that promote uptake 
(Isberg and Barnes 2001). A series of studies have shown that the activity of tyrosine kinases 
(Fincham, James et al. 2000), phosphoinositide 3-kinase (Mecsas, Raupach et al. 1998) and 
Rho GTPase family members are involved in uptake (Black and Bliska 2000; Von Pawel-
Rammingen, Telepnev et al. 2000; Isberg and Barnes 2001).  
Latex beads coated with the C-terminal 192 amino acids of Y. pseudotuberculosis invasin or 
with the C-terminal 195 amino acids of Y. enterocolitica invasin were shown to be rapidly 
internalized by epithelial cells and that this type of internalization resembles the zipper 
mechanism of viable invasin expressing Yersinia (Dersch and Isberg 1999; Schulte, Grassl et 
al. 2000; Wiedemann, Linder et al. 2001; Grassl, Bohn et al. 2003). On the host cell side β1 
receptor density was shown to be critical, while on the other side the density of invasin 
protein on the particles determined if beads were internalized subsequent to attachment 
(Dersch and Isberg 1999; Isberg, Hamburger et al. 2000). During invasin-mediated 
phagocytosis Src and Wiskott-Aldrich syndrome (WASP) family proteins, the Arp2/3 
complex and the Rho GTPases Cdc42, Rac1 and RhoA were shown to be involved (Alrutz, 
Srivastava et al. 2001; McGee, Zettl et al. 2001; Wiedemann, Linder et al. 2001). 
4.4 Yersinia adhesin A (YadA) 
The non-fimbrial adhesin YadA of enteropathogenic Yersinia species is encoded by a gene on 
the Yersinia virulence plasmid (pYV) in Y. enterocolitica and Y. pseudotuberculosis strains 
(Bolin and Wolf-Watz 1984; Balligand, Laroche et al. 1985; Simonet, Riot et al. 1996). The 
yadA gene of Y. pestis has a single nucleotide deletion and this frameshift mutation leads to a 
reduced mRNA half-life, which in consequence leads to a lack of expression of the YadA 
protein in this highly pathogenic species (Rosqvist, Skurnik et al. 1988). Transcription is 
dependent on the activator VirF/LcrF that allows the expression of YadA at 37 °C but not 
below 30 °C (Lambert de Rouvroit, Sluiters et al. 1992). The protein can be detected in the 
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outer membrane of the bacteria within minutes after temperature shift to 37 °C (Bolin, 
Norlander et al. 1982).  
In a mouse intestinal colonization assay the Y. enterocolitica O:9 yadA mutant was cleared 
from the intestine more efficiently than the wild type strain (Kapperud, Namork et al. 1987). 
YadA was also shown to be an essential virulence factor of Y. enterocolitica O:8 and it was 
observed that the yadA mutant initially colonized the Peyer´s patches of mice as efficiently as 
did the wild-type bacteria, but after 42 hours 103-fold more wild-type bacteria were recovered 
from Peyer´s  Patches as compared to the yadA mutant (Pepe, Wachtel et al. 1995). In contrast 
to this, YadA does not appear to be needed for virulence in Y. pseudotuberculosis (Han and 
Miller 1997). 
 
FIGURE 2. Structure of YadA (El Tahir et al., 2001 with modifications). 
(A) Hypothetical ‘lollipop’ structure of the YadA trimer, modified from Hoiczyk et al., 2000. 
The three intertwined polypeptides are drawn with different shades of grey and the structural 
domains and their dimensions are indicated. (B) Schematic diagram of one 455-residue 
YadAYeO3 polypeptide (drawn with the N-terminus up and C-terminus down). The scale at left 
indicates the positions of amino acid residues. The NSVAIGXXS motifs, the variable and the 
hydrophobic regions, and linear antigenic epitopes are indicated inside the rectangle. The 
structural domains of YadA are indicated at the left and functions and properties of its different 
regions at the right. 
 
The YadA protein is a homotrimeric 200-240 kDa protein that gets expressed as a preprotein 
and is post-translationally modified, by cleaving off an N-terminal signal sequence of 25 
amino acids during incorporation into the outer membrane (Bolin and Wolf-Watz 1984). 
YadA was described as to form distinct “lollipop”-shaped surface projections with an overall 
height of ~23 nm (Hoiczyk, Roggenkamp et al. 2000). It consists of an N-terminal head 
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domain (~5 nm), a rod-like stalk-neck domain (~18 nm long) and a C-terminal membrane 
anchor that was shown to be responsible for oligomerization and membrane targeting. The 
stalk is predicted to be formed of a right-handed coiled-coil structure and since the YadA 
protein has no cysteine residue, the three individual polypeptide chains assemble dependent 
on ionic and/or hydrophobic interactions (Tamm, Tarkkanen et al. 1993; El Tahir and Skurnik 
2001).  
The YadA protein is multifunctional and promotes binding to epithelial cells, professional 
phagocytes, and various extracellular matrix (ECM) molecules, such as laminin, collagen, and 
fibronectin and additionally protects Yersinia against defensins and the bactericidal activity of 
serum complement, probably by masking surface lipopolysaccharides. (Balligand, Laroche et 
al. 1985; Roggenkamp, Ruckdeschel et al. 1996; Hoiczyk, Roggenkamp et al. 2000). 
Collagen binding 
Collagens are major constituents of the ECM, described to have structural and developmental 
functions, e.g. cell attachment and cell differentiation (Miller and Gay 1987). A collagen 
binding negative 22 amino acid deletion mutant of YadA was avirulent in a mouse model, 
demonstrating the importance of this property of YadA to virulence (Tamm, Tarkkanen et al. 
1993; Tahir, Kuusela et al. 2000). The high affinity binding of YadA to collagen is resistant to 
heat (20 min 80 °C), occurs at pH values between 5 and 8 and was shown to be dependent on 
the 3D structure of trimeric YadA, as any overlapping synthetic (16mer) YadA peptide was 
unable to bind collagen (Emody, Heesemann et al. 1989; Flugel, Schulze-Koops et al. 1994; 
Tahir, Kuusela et al. 2000). YadA does not recognize all collagen chains and collagen types; 
the specific YadA-binding site appears to be located on the α1 collagen chain. Experimental 
evidence indicates that the interaction of YadA with collagen occurs via the head domain of 
YadA (aa 26-195), where the histidyl residues in the HSSH motive (aa 159-162) and the 
repeated NSVAIGXXS motif were shown to play an important role  (Schulze-Koops, 
Burkhardt et al. 1992; Tamm, Tarkkanen et al. 1993; Roggenkamp, Neuberger et al. 1995; 
Schulze-Koops, Burkhardt et al. 1995; Tahir, Kuusela et al. 2000).  
Fibronectin and Laminin binding 
Collagen binding-deficient YadA mutants can still retain their ability to bind other ECM 
proteins, like laminin and fibronectin, and resist complement-mediated serum killing. YadA 
binds to laminin with significantly lower affinity than to collagen and the NSVAIGXXS 
motifs of YadA are not required for laminin binding (Tamm, Tarkkanen et al. 1993; Tahir, 
Kuusela et al. 2000). Similarly to collagen, YadA was shown to bind to immobilized cellular 
fibronectin with high affinity. The YadA-fibronectin interaction was shown to be heat 
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resistant (20 min 60 °C), it could be inhibited by a polyclonal anti-YadA antiserum and was 
shown to not involve the RGDS motif that FN uses to bind to cellular α5β1 integrin receptors 
(Tertti, Skurnik et al. 1992; Schulze-Koops, Burkhardt et al. 1993).  
Independently from uptake in mammalian cells the production of proinflammatory cytokines 
can by induced by YadA-expressing Yersinia and also by non-invasive E. coli strains 
heterologously-expressing YadA on their surface. Inhibitor studies revealed that 
serine/threonine kinases, as well as phosphatidylinositol-3-kinase are involved in the uptake 
process and that the YadA induced host cell signaling events leading to cytokine induction 
involve the same components as in invasin-mediated cytokine signalling, namely Rho 
GTPases and the MAP kinases MEK1, JNK, and p38 (Bliska, Copass et al. 1993; Yang and 
Isberg 1993; Eitel and Dersch 2002; Schmid, Grassl et al. 2004). 
In contrast to the uptake mediated by direct binding of invasin to β1 integrin cell receptors, 
YadA mediates a matrix-dependent internalization pathway involving indirect bridging of 
fibronectin and β1 integrin receptors. The uptake of Y. pseudotuberculosis YadA-expressing  
E. coli into HEp-2 cells was first shown to be inhibited by monoclonal antibodies specific 
against β1 integrin receptors and secondly, in contrast to invasin mediated uptake, to be 
inhibited by antibodies against human fibronectin (Yang and Isberg 1993; Eitel and Dersch 
2002). 
Recently a detailed study identified differences between the highly homologues YadA 
proteins of the enteropathogenic Yersinia species. The study identified an internal region in 
the head domain of YadA of Y. pseudotuberculosis, that is critical for YadA-mediated 
bacterial cell aggregation, the specificity of extracellular matrix (ECM) substrate binding, and 
bacterial internalization into human Hep-2 cells (Heise and Dersch 2006). This unique N-
terminal “uptake domain” (31 amino acids), present in Y. pseudotuberculosis YadA and not in 
Y. enterocolitica YadA, was shown to be crucial for mediating uptake in Hep-2 cells. For the 
internalization, as observed by Heise and Dersch, tight binding of Y. pseudotuberculosis 
YadA to fibronectin bound to α5β1 integrin receptors was required (Heise and Dersch 2006). 
Binding of Y. pseudotuberculosis YadA to the extracellular matrix proteins collagen and 
laminin was low. The low fibronectin-binding YadA from Y. enterocolitica, by contrast, had a 
higher affinity to collagen and laminin. Therefore, the N-terminal YadA sequence motif 
(uptake domain) determines matrix adhesion properties and consequently interaction with the 
respective matrix-associated cellular receptors (Heise and Dersch 2006). 
 
   B. INTRODUCTION 
 - 14 - 
5. TYPE III SECRETION AND TRANSLOCATED EFFECTOR 
PROTEINS (YOPS) 
5.1 Type III secretion and the Yersinia needle complex 
Type III secretion (TTS) is a mechanism by which gram-negative bacteria inject proteins 
across bacterial and host cell membranes into eukaryotic host cells. More than 20 type III 
secretion systems (TTSSs) have been discovered in animal, plant and even insect pathogens, 
all serving the purpose to interfere with the host cell by injecting effector proteins that 
generally have more sequence homology to eukaryotic proteins than to bacterial proteins 
(Cornelis 2002). 
The plasmid-encoded TTSS allows Yersinia to deliver effector proteins (called Yops for 
Yersinia outer proteins) into cells of the immune system in order to disturb the dynamics of 
the cytoskeleton, to block phagocytosis and the production of proinflammatory cytokines, to 
induce apoptosis, control cell proliferation and exert numerous other effects. This enables the 
survival and extracellular multiplication of yersiniae in lymphoid tissues and distribution to 
other organs (Simonet, Richard et al. 1990; Fallman, Andersson et al. 1995; Cornelis 2002). 
The sequenced Yersinia enterocolitica Serotype 0:8 virulence plasmid not only encodes for 
the device to inject bacterial proteins into cells, referred to as injectisome or needle complex, 
but also the secreted/injected Yops, their chaperones and additional regulatory factors 
(Snellings, Popek et al. 2001). 
The injectisome is an organelle that is spanning the outer membrane, the peptidoglycan layer 
and the cytoplasmic membrane of the bacterium. Its basal body, which spans the cytoplasmic 
inner membrane, consists of proteins that show homology to proteins in the bacterial 
flagellum. YscN is an essential part of the secretion complex and was shown to resemble the 
flagellar FoF1-ATPase proton pump (Woestyn, Allaoui et al. 1994; Aizawa 2001). The basal 
body is a ring shaped structure with a central pore that connects to a needle which is formed 
by the polymerization of the proteins YscC and YscF. (Hoiczyk and Blobel 2001). The needle 
has a hollow centre of about 20 Angstroem and it is generally assumed that the exported 
proteins travel inside the needle to cross the two membranes and the peptidoglycan layer in 
one step (Cornelis 2002; Cornelis 2006). 
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FIGURE 3. The Ysc injectisome (Cornelis 2002 with modifications). 
Schematic representation of the Ysc injectisome spanning the outer membrane (OM), 
the peptidoglycan layer (PG) and the cytoplasmic membrane (CM) of the bacterium. 
The ring spanning the OM is made of the secretin YscC, assisted by the lipoprotein 
YscW. YscJ is another lipoprotein. YscF, YscO, YscP and YscX are external parts of 
the injectisome. YscF is the main constituent of the needle. YscV, YscU, YscR, YscT 
and YscS are proteins of the basal body that are in contact with the CM. YscN is the 
ATPase of the pump. 
 
In order to translocate effector Yops across the eukaryotic cell membrane the translocator 
Yops (YopB, YopD and LcrV), that are not an integral part of the injectisome are absolutely 
required (Hakansson, Schesser et al. 1996). Therefore the injectisome structure can not be 
considered as a syringe that is able to penetrate the eukaryotic host cell membrane on its own. 
On the basis of the observation, that YopB and YopD can form pores in artificial liposomes, it 
was concluded that the injected effectors travel through a pore that is formed by the 
translocator Yops (Tardy, Homble et al. 1999).  
Yersinia do not release Yops when they are incubated in a cell free environment, but only 
after contact between the pathogen and the mammalian cell the polarized transfer into the 
eukaryotic cell is induced (Rosqvist, Magnusson et al. 1994). However the injectisome can be 
triggered to secret Yops in vitro by chelating Ca2+ ions in the culture medium. It became 
clear that the secretion mechanism of the Yops is different from the classical sec-dependent 
secretion pathway, where upon export the leading signal sequence gets cleaved off 
(Economou 1999). Studies analyzing whether Yops are recognized specifically by the 
injectisome by a signal in the N-terminus of the protein or by a signal encoded by the 
messenger RNA resulted in controversial models (Sory, Boland et al. 1995; Anderson and 
Schneewind 1997; Anderson and Schneewind 1999). For YopE it was shown that the amino-
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terminus and not the 5´ end of YopE mRNA serves as the targeting signal and for YopH it 
was shown, that bacterial protein synthesis was not required for macrophage inhibition, 
suggesting that YopH export and translocation are controlled at the posttranslational level 
(Bliska and Black 1995; Lloyd, Norman et al. 2001). The presence of YopQ in the cytosol of 
Y. enterocolitica, even with a closed secretion apparatus, as well as the post-translational 
secretion of YopQ could also be demonstrated (Trcek, Wilharm et al. 2002). 
Another peculiarity of the Yersinia injectisome is that several Yops to be secreted need 
assistance of specialized chaperones, called Syc proteins for specific Yop chaperone. These 
small acidic proteins have little or no sequence homology between them, but share a putative 
carboxy-terminal amphiphilic α-helix. They also bear no sequence and functional 
resemblance to ATP-dependent chaperones, such as heat shock protein 70 (Wattiau, Bernier 
et al. 1994; Cornelis 2002). Generally, they are encoded by a gene that is located next to the 
gene encoding the protein they serve and are, in contrast to the Yop protein, not secreted. The 
observed diameter of the needle is thought to be too small to allow folded, globular proteins 
to travel through it, so it is assumed that one function of the chaperones is to keep the Yops at 
least partially unfolded (Hoiczyk and Blobel 2001; Cornelis 2002). 
The six effector proteins Y. enterocolitica translocates into the host cell upon contact are 
called: YopM, YopH, YopP (called YopJ in Y. pestis and Y. pseudotuberculosis), YopE, 
YopT and YopO (called YpkA in Y. pseudotuberculosis). 
5.2 YopM – a leucine rich protein 
YopM is a leucine-rich repeat (LRR) virulence protein that exhibits heterogeneity of size and 
sequence among different Yersinia strains, while the functional consequences of this 
variability are not yet known. YopM has a size of approximately 42 kDa and, while being the 
only effector protein encoding no enzymatic activity, was shown to be necessary for virulence 
of Y. pestis and Y. enterocolitica in the mouse model (Mulder, Michiels et al. 1989; Leung, 
Reisner et al. 1990; Skrzypek, Myers-Morales et al. 2003). The crystal structure of Yersinia 
pestis YopM was resolved and it was shown that the YopM monomer has a horseshoe-like 
structure with four monomer units stacking together to form a hollow cylinder with an inner 
diameter of 35 Angstroem (Evdokimov, Anderson et al. 2001). 
YopM traffics to the nucleus via a vesicle-associated pathway, but it is not known how 
nuclear localization is related to YopM’s function (Skrzypek, Myers-Morales et al. 2003). 
Gene transcription microarray analysis performed on macrophages infected with 
Y. enterocolitica obtained divergent results, as one group found evidence that YopM regulates 
genes  involved in cell cycle and cell growth (Sauvonnet, Pradet-Balade et al. 2002), whereas 
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another group found no evidence for gene regulation by YopM (Hoffmann, van Erp et al. 
2004). In recent work the two cytoplasmic kinases PRK2 (protein kinase C-like 2) and RSK1 
(ribosomal S6 protein kinase 1) were identified to be direct interaction partners of and their 
activity to be stimulated by YopM (McDonald, Vacratsis et al. 2003).  
The subcellular localization of YopM is distinct from the other Yop effectors. YopM has been 
demonstrated to be injected into the cytoplasm of cells and translocate to the nucleus via a 
vesicle-associated pathway (Skrzypek, Cowan et al. 1998). The mechanism for transporting 
YopM into the nucleus and potential roles in immunomodulation, signaling to cell growth, 
apoptosis and transcription remain to be shown (Kerschen, Cohen et al. 2004; Viboud and 
Bliska 2005). 
5.3 YopH - a protein tyrosine phosphatase 
YopH is a highly active protein-tyrosine phosphatase (PTP) that targets an array of signaling 
pathways important for innate and adaptive immunity (Guan, Haun et al. 1990; Aepfelbacher 
2004; Viboud and Bliska 2005). The protein has 468 amino acids (50 kDa) with defined N- 
and C-terminal domains, linked together by a proline-rich sequence. The N-terminal domain 
contains type III secretion signals, a chaperone-binding site and a substrate targeting domain, 
while the C-terminal region (amino acids 206 to 468) contains the catalytic domain and is 
similar in structure to PTP catalytic domains found in eukaryotic cells  (Black, Montagna et 
al. 1998; Khandelwal, Keliikuli et al. 2002; Viboud and Bliska 2005). Many YopH substrates 
are components of focal adhesions, playing a role in regulating the dynamic interaction 
between the actin cytoskeleton and extracellular matrix-binding integrins (Brakebusch and 
Fassler 2003). Cytoskeletal uptake structures formed upon interaction of Yersinia adhesins 
with cellular integrins are thought to resemble focal adhesions, and their disruption by YopH 
may thus explain its antiphagocytic activity (Aepfelbacher 2004). 
YopH dephosphorylates focal adhesion kinase (Fak), the adaptor proteins p130Cas and 
paxillin, Fyn-binding protein (FyB), and the scaffolding protein SKAP-HOM in different cell 
types such as neutrophils, macrophages, and epithelial cells (Black and Bliska 1997; Persson, 
Carballeira et al. 1997; Hamid, Gustavsson et al. 1999). Previous studies using 
Y. enterocolitica or Y. pseudotuberculosis mutants suggested that YopH is responsible for up 
to 50 % of the antiphagocytic activity of yersiniae towards neutrophils and J774 macrophages 
(Fallman, Andersson et al. 1995; Ruckdeschel, Roggenkamp et al. 1996; Aepfelbacher 2004). 
Inhibition of phagocytosis was shown to be dependent on the enzymatic activity of YopH, 
when translocation of wild-type YopH but not of the catalytically inactive point mutant 
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YopHC403S into HeLa cells or J774 macrophages prevented invasin/β1 integrin-mediated 
uptake of Yersinia (Persson, Carballeira et al. 1997; Persson, Nordfelth et al. 1999).  
In addition to counteracting signaling pathways activated by phagocytic mechanisms, YopH 
counteracts other types of immune response pathways in host cells. Among the identified 
YopH activities are the inhibition of the production of macrophage chemoattractant protein 1 
in macrophages infected with Y. enterocolitica (Sauvonnet, Pradet-Balade et al. 2002) and the 
inhibition of signaling cascades associated with T cell or B cell activation by antigen (Yao, 
Mecsas et al. 1999; Cornelis 2002). YopH-mediated dephosphorylation is very fast and 
visible within 2 min of infection and this can explain why YopH is among the most effective 
Yops with regard to mouse virulence and antiphagocytic activity (Andersson, Carballeira et 
al. 1996; Cornelis 2002; Aepfelbacher 2004). 
5.4 YopP - an enzyme that inhibits MAPK and NF-κB signaling pathways 
The 33 kDa protein was first identified in Y. pestis and called YopJ (Straley and Bowmer 
1986) before it was discovered in Y. pseudotuberculosis and Y.  enterocolitica and named 
YopP (Cornelis, Vanootegem et al. 1987). In the mouse model YopP/J was shown to be 
important for virulence of the enteropathogenic yersiniae. A Y. enterocolitica yopP mutant 
was attenuated in an oral mouse infection assay (Trulzsch, Sporleder et al. 2004) and 
accordingly virulence of a Y. pseudotuberculosis yopJ mutant was reduced 64-fold in an oral 
LD50 assay (Monack, Mecsas et al. 1998).  
YopP/J functions as a potent inhibitor of the MAPK and NF-κB signaling pathways of the 
host. Its inhibitory actions result in suppression of cytokine production (IL-8 in epithelial cells 
and TNF-α in macrophages) and in the induction of macrophage apoptotic cell death 
(Aepfelbacher, Zumbihl et al. 1999; Orth 2002; Ruckdeschel 2002).  
YopP shows limited homology to the ubiquitin-like protease Ulp1 of yeast and therefore was 
thought to remove ubiquitin or a ubiquitin-like modification from target proteins in host cells. 
Protein ubiquitination can reversibly activate signaling molecules in addition to marking them 
for degradation (Orth 2002; Aepfelbacher 2004; Viboud and Bliska 2005). YopP/YopJ 
associates with members of the MAPK kinase (MAPKK) superfamily, which represent 
upstream MAPK activators and it furthermore binds and inhibits the IκB kinase-beta (IKK-β), 
which is the major NF-κB-activating kinase (Orth, Palmer et al. 1999; Aepfelbacher 2004). 
Detailed mass spectrometry analysis following the observation that YopJ selectively targets 
MAPKKs and IKK-b without any obvious changes in their migration on SDS/PAGE (Orth, 
Palmer et al. 1999; Orth 2002; Navarro, Alto et al. 2005; Viboud and Bliska 2005) provided 
mechanistic insight into the chemistry of YopJ: It was shown that YopJ acted as an 
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acetyltransferase to modify the critical serine and threonine residues in the activation loop of 
the MAPK activator MAPKK6 and thereby was able to block phosphorylation. The 
acetylation directly competed with phosphorylation and prevented the activation of the 
modified protein (Mukherjee, Keitany et al. 2006). 
5.5 YopE – GAP activity for specific downregulation of Rho GTPases 
YopE is a 25-kDa protein (219 amino acids) which, like the homologous domains within 
exoenzyme S from Pseudomonas aeruginosa and SptP from Salmonella typhimurium, works 
as GAP for Rho-family proteins (Fu and Galan 1999; Goehring, Schmidt et al. 1999; Black 
and Bliska 2000; Von Pawel-Rammingen, Telepnev et al. 2000; Andor, Trulzsch et al. 2001; 
Aepfelbacher 2004). At the N-terminus residues 54–75 have been shown to be both necessary 
and sufficient for targeting of YopE to an unidentified perinuclear compartment, while the 
residues 96 to 219 comprise the Rho GAP domain (Krall, Zhang et al. 2004). 
YopE binds to the GTPase and promotes efficient GTP hydrolysis via its GAP domain, where 
Arg-144 in the “arginine finger” motive is known to be essential for the GAP activity 
(Scheffzek, Ahmadian et al. 1998; Wurtele, Wolf et al. 2001; Aili, Telepnev et al. 2003; 
Aepfelbacher 2004). YopE causes disruption of actin filaments, rounding and detachment of 
infected cells in culture, a phenomenon referred to as cytotoxicity. Studies using epithelial or 
endothelial cells as model tissues for study of YopE targeting specificity showed that Rac-1 
and RhoA can be deactivated by YopE (Black and Bliska 2000; Aepfelbacher 2004; Aili, 
Isaksson et al. 2006). A YopE GAP mutant (R144A) was shown to be avirulent in mice and 
unable to induce cytotoxic effects in HeLa cells (Black and Bliska 2000; Von Pawel-
Rammingen, Telepnev et al. 2000; Aili, Isaksson et al. 2006). However, recently it was 
reported that other mutants of YopE lacking in vitro GAP activity towards RhoA, Rac1 and 
Cdc42 were still cytotoxic for HeLa cells (Aili, Telepnev et al. 2003), which suggests that 
these small GTPases are not the sole targets of YopE during infection (Aili, Isaksson et al. 
2006).  
YopE contributes to the antiphagocytic activity of Y. enterocolitica and Y. pseudotuberculosis 
in cooperation with fellow Yops (Aepfelbacher 2004). Loss of inhibition of phagocytosis in a 
Y. enterocolitica YopE knockout strain was observed in macrophages and neutrophils 
(Grosdent, Maridonneau-Parini et al. 2002), but in the mouse model, while no single Yop was 
found to be essential for colonization or persistence in intestinal tissues in single-strain 
infections, the absence of both YopH and YopE together almost eliminated colonization of all 
tissues (Logsdon and Mecsas 2003). In the process of Yop effector injection the GAP activity 
of YopE was shown to counteract the pore-forming activity of the injectisome (Viboud and 
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Bliska 2001). The fate of the Y. enterocolitica translocated YopE, in contrast to YopH and 
YopP, is determined by host proteasome degradation. This implies the proteasome as integral 
part of the cellular host immune response against the immunomodulatory activities of a 
translocated bacterial virulence protein (Ruckdeschel, Pfaffinger et al. 2006). 
These findings suggest that YopE has both individual and redundant functions and synergizes 
with other Yops during the complex infection cycle of yersiniae (Aepfelbacher 2004).  
5.6 YopT – a cysteine protease removing the isoprenoid group of Rho 
GTPases 
YopT is a 35 kDa protein (322 amino acids) that belongs to the CA clan of cysteine proteases. 
It is expressed by Y. pestis and Y. enterocolitica, but owing to a deletion on pYV is not 
expressed by virulent serotype O:3 strains of Y. pseudotuberculosis, (Iriarte and Cornelis 
1998; Shao, Merritt et al. 2002; Viboud and Bliska 2005). Three residues in the catalytic 
domain of YopT (Cys-139, His- 258 and Asp-274) are required for the enzymatic activity and 
are conserved among other members of the same clan of cysteine proteases in bacterial plant 
and animal pathogens (Zhu, Shao et al. 2004; Viboud and Bliska 2005). Cellular 
overexpression and in vitro studies revealed that YopT acts as a cysteine protease to remove 
the lipid anchor (geranylgeranyl isoprenoid moiety) from RhoA, Rac, or Cdc42 at a cleavage 
site that is just N-terminal from the cysteine linked to the prenyl group (Shao, Vacratsis et al. 
2003; Aepfelbacher 2004).  
Before the biochemical activity was characterized, the disruptive effect of YopT on actin 
stress fibers has been observed (Iriarte and Cornelis 1998). Later it was shown that bacterially 
translocated YopT in vivo has preferential activity for RhoA and less for Rac or Cdc42 
(Aepfelbacher, Trasak et al. 2003). Rho GTPase modification by removal of the isoprenoid 
group has the following consequences in Yersinia-infected cells: RhoA is released from the 
plasma membrane and from its cytoplasmic binding partner guanine nucleotide dissociation 
inhbitor-1 (GDI-1) and accumulates as a monomeric protein in the cytoplasm (Aepfelbacher, 
Trasak et al. 2003). 
On a cellular level it was shown that YopT-overexpressing Yersinia mutants disrupt actin rich 
phagocytic cups induced by Yersinia invasin as well as podosomal adhesion structures 
required for chemotaxis in macrophages (Aepfelbacher, Trasak et al. 2003). The role of YopT 
in preventing opsonized and unopsonized phagocytosis of Y. enterocolitica by human 
neutrophils and mouse macrophages was investigated also. Mutant bacteria lacking YopT 
were phagocytosed in significantly higher amounts than wild-type bacteria both under 
   B. INTRODUCTION 
 - 21 - 
opsonizing and nonopsonizing conditions. However, Yersinia mutants translocating only 
YopT were not resistant to phagocytosis by neutrophils or macrophages (Grosdent, 
Maridonneau-Parini et al. 2002; Aepfelbacher 2004).  
A recent study showed that overexpressed Rac1 was not completely inactivated after infection 
with Yersinia expressing solely YopT, but cleaved activated Rac1 molecules entered the host 
cell nucleus, allowing Rac1 to localize with nuclear guanosine nucleotide exchange factors. 
The infection of a Yersinia strain solely expressing YopT and YopE resulted in a pool of 
activated, nucleus-localized Rac1 and a pool of inactivated Rac1 in the cytoplasm (Wong and 
Isberg 2005). While studies on the potential synergistic or competitive cell biological role of 
YopT in the interplay with other effector Yops have to be pursued, also structural data 
supporting compartment dependent substrate specificity will have to bring more insight into 
the specific role of YopT (Aepfelbacher 2004; Viboud and Bliska 2005; Wong and Isberg 
2005). 
5.7 YopO – a serine/threonine kinase that binds to Rho GTPases and is 
activated by G-actin 
YopO from Y. enterocolitica (called YpkA in Y. pseudotuberculosis) is an 80-kDa (729 amino 
acids) protein with multiple functional domains. An N-terminal 
secretion/translocation/membrane binding region is followed by a serine/threonine kinase 
catalytic domain in the N-terminal half of the protein (amino acid residues 150–400). The C-
terminal half of YopO contains four regions (within amino acids 436–710) with homology to 
Rho-binding domains (RBDs) that were shown to mimic host cell GDIs (Prehna, Ivanov et al. 
2006). The last 20 residues (amino acids 709–729) display some homology to the actin 
bundling protein coronin (Dukuzumuremyi, Rosqvist et al. 2000; Juris, Rudolph et al. 2000; 
Aepfelbacher 2004). 
The morphological effects in HeLa cells infected with a Y. pseudotuberculosis mutant 
overexpressing YpkA are cell contraction (rounding) accompanied by the formation of 
pronounced retraction fibers (a phenotype referred to as “arborization”). In these experiments 
YpkA was localized at the plasma membrane, a property that was later shown to reside in the 
N-terminal half (amino acids 1-443) of the protein (Hakansson, Galyov et al. 1996; 
Dukuzumuremyi, Rosqvist et al. 2000; Aepfelbacher 2004). 
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5.7.1 Serine/Threonine kinase activity 
The YopO homolog YpkA (Yersinia protein kinase A; 732 amino acids) is the first reported 
prokaryotic secreted protein kinase that showed extensive homology to eukaryotic 
serine/threonine protein kinases (Galyov, Hakansson et al. 1993). Mutation of a critical lysine 
residue in YopO (K269A) or aspartic acid residue in YpkA (D270A), located within the 
putative catalytic domain, abolished most of the kinase activity (Cornelis, Boland et al. 1998; 
Dukuzumuremyi, Rosqvist et al. 2000). Binding of actin to YopO is necessary for kinase 
activation. Removal of the 21 C-terminal amino acids abolish actin binding and actin-induced 
autophosphorylation (Juris, Rudolph et al. 2000). Autophosphorylation and phosphorylation 
of basic artificial substrates was the only activity known until recently, when the first 
physiological substrate of YopO was identified as Otubain1 (Ovarian tumor domain ubiquitin 
aldehyde binding protein 1), a deubiquitinating enzyme implicated in immune cell clonal 
anergy (Juris, Rudolph et al. 2000; Juris, Shah et al. 2006). 
5.7.2 Rho-binding activity 
In yeast two hybrid assays and in immunoprecipitation experiments YpkA associates with the 
Rho GTPases RhoA and Rac1 but not Cdc42 and conclusively was also shown to reduce the 
level of GTP-bound RhoA in Y. pseudotuberculosis-infected HeLa cells (Barz, Abahji et al. 
2000; Dukuzumuremyi, Rosqvist et al. 2000; Aepfelbacher 2004). The C-terminal part of 
YpkA (amino acids 434-732) was recently crystallized in a complex with Rac1 and the 
interaction displayed intriguing similarities to the complexes between host cell GDIs and their 
target Rho family GTPases. However, a structural difference of host cell GDIs and YpkA is 
that YpkA does not posses any clear analog of the motive necessary to bind the prenyl group 
of Rho GTPases. (Prehna, Ivanov et al. 2006). 
5.7.3 Secretion/Translocation of YopO is dependent on the SycO chaperone 
The existence and requirement of a chaperone for YopO was unclear, until recently the open 
reading frame next to YopO (orf155) was demonstrated to encode the chaperone called SycO. 
SycO prevents the intrabacterial aggregation of YopO by covering the N-terminal membrane 
localization domain inside the bacterial cell. The chaperone-binding domain (residues 20-77) 
within YopO was shown to coincide with the membrane localization domain (Letzelter, Sorg 
et al. 2006). 
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5.7.4 Functional role of YopO 
YopO synergistically with other Yops contributes to the TTSS-dependent antiphagocytic 
activity of Y. enterocolitica. Increased uptake of yopO mutant bacteria by macrophages or 
neutrophils was most evident when non-opsonized bacteria were used, suggesting that YopO 
may primarily counteract β1 integrin-mediated uptake (Grosdent, Maridonneau-Parini et al. 
2002; Viboud and Bliska 2005). It also synergizes with other Yops to confer upon yersiniae 
the ability to colonize and persist in different tissues (Logsdon and Mecsas 2003; 
Aepfelbacher 2004). Early mouse oral infection experiments showed that deletion of either 
the catalytic domain or the C-terminal half of yopO in Y. pseudotuberculosis resulted in 
avirulence (Galyov, Hakansson et al. 1993; Galyov, Hakansson et al. 1994). However in 
recent studies Y. enterocolitica and Y. pseudotuberculosis yopO null mutants were shown to 
be able to spread and colonize murine liver or spleen comparable to their respective parental 
strains (Logsdon and Mecsas 2003; Trulzsch, Sporleder et al. 2004; Viboud and Bliska 2005). 
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6. STATE OF THE ART - BIOCHEMICAL CHARACTERIZATION OF 
YOPO 
The following chapter (6.1 and 6.2) describes properties of YopO that were characterized 
together with the cellular effects of YopO that were investigated in this thesis work. 
6.1 YopO is activated by G-actin not F-actin 
To identify which form of actin stimulates YopO autophosphorylation the recombinant YopO 
(amino acids 1-729) protein was assayed with G-actin or F-actin. No autophosphorylation 
occured in the absence of actin and G-actin was shown to be a potent activator of kinase 
activity, while F-actin did not stimulate YopO autophosphorylation (Trasak, Zenner et al. 
2007). 
6.2 Identification of autophosphorylated amino acids that regulate kinase 
activity  
 
FIGURE 4. Scheme of YopO point mutants used to identify phosphorylation sites. 
The first and the last amino acids of YopO89-729 and YopO protein organization is 
depicted. Kinase; region with homology to serine/threonine kinases. GDI-like; region 
containing homology to Rho GDI. CH; coronin homology region. Point mutants are 
indicated. cDNA’s encoding these constructs were cloned into vectors allowing expression 
of GST-fusion proteins in E. coli. 
 
The YopO protein has 66 serine residues and 34 threonine residues and it has not been known 
which amino acid(s) are targeted by autophosphorylation and if this occurs by an 
intramolecular mechanism (cis-phosphorylation) or an intermolecular mechanism (trans-
phosphorylation). Despite identification of the first physiological YopO substrate (Otubain1) 
it has not been known if YopO autophosphorylation regulates the phosphorylation of 
substrates. Mutants impaired in autophosphorylation had to be tested for their ability to 
phosphorylate substrates. 
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FIGURE 5. Activity of YopO phosphorylation site mutants (Trasak et al. 2007, with modifications).  
a) Quantified autophosphorylation of YopO single or double point mutants in kinase assay (upper panel 
radiography, lower panel CoomassieBlue staining, on the bottom values of autoradiography quantification are 
shown referenced to YopO89-720 control that was set to 1). b) Autophosphorylation of YopO controls substrate 
phosphorylation. Fully active control YopO89-729, kinase negative YopO151-729 and autophosphorylation 
deficient YopO89-729S90A/S95A were subjected to kinase reaction in the presence of artificial substrates 
histone and MBP (radiography shown). Molecular weights (MW) of standard marker proteins are indicated. 
 
Data from mass spectrometry (MS) analysis of in vitro phosphorylated YopO89-729 indicated 
two phosphorylated residues of four possible sites in amino acids 89 to 102 (T89, S90, S95, 
S102). Furthermore these data suggested that one amino acid lies within amino acids 89-94 
and the other one within 95-108 (Trasak, Zenner et al. 2007). 
To identify the phosphorylated amino acids by autoradiography equal amounts of the 
following single or double point mutants of Yop89-729 were subjected to kinase assays: 
S95A, S102A, T89A/S95A and S90A/S95A. Amino acid substitution S102A showed no 
reduction in incorporation of radioactivity (figure 5a). Autophosphorylation was reduced by 
about 50% in YopOS95A and YopOT89A/S95A and greatly diminished by about 95% in 
S90A/S95A. Values for quantified autophosphorylation were normalized to the fully active 
YopO89-729 control and displayed on the bottom in figure 5a. Coomassie staining indicates 
equal amounts of mutant protein. These results identify the autophosphorylation sites serine-
90 and serine-95 within YopO89-729 and show that threonine-89 and serine-102 are not 
involved in autophosphorylation. 
Because it was not known if the examined kinase activity, evident by autophosphorylation of 
YopO, plays a role in the phosphorylation of external substrates, the phosphorylation of 
artificial substrates was tested (Juris, Rudolph et al. 2000). Autophosphorylation deficient 
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YopO151-729, fully active YopO89-729 and YopO89-729S90A/S95A were incubated with 
myelin basic protein (MBP) or histone and [γ-32P] adenosine 5’ trisphosphate. 
Phosphorylation of MBP and histone by YopO89-729 was effective, while the 
phosphorylation site mutant protein YopO89-729S90A/S95A showed greatly diminished 
phosphorylation and YopO151-729 showed no phosphorylation of the given substrates 
(figure 5b).  
The data presented in figure 5b show that phosphorylation of artificial substrates is dependent 
on YopO autophosphorylation at amino acids serine-90 and serine-95 and implicate that the 
catalytic activity is dependent on the phosphorylation state of serine-90 and serine-95. 
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7. RHO GTPASES – PRIMARY TARGETS OF YOPS 
The Rho proteins constitute ideal targets for pathogens, because they act as eukaryotic 
switches to control a large variety of cellular processes. Rho GTPases are master regulators of 
the actin cytoskeleton, but also participate in controlling cell-cell contacts, integrin signaling, 
endocytosis, intracellular vesicle transport, gene transcription and cell cycle (Symons and 
Settleman 2000; Aepfelbacher 2004; Schwartz 2004; Aktories and Barbieri 2005).  
 
 
FIGURE 6. Interference of Yersinia virulence factors with the Rho activation/deactivation cycle 
(Aepfelbacher 2004, with modifications). 
The major biochemical mechanisms by which the respective factors modulate Rho GTPases are in 
brackets. CNF-Y, cytotoxic necrotizing factor of yersiniae; GAP, GTPase activating protein; GEF, 
guanine nucleotide exchange factor; GDI, guanine nucleotide dissociation inhibitor; RhoGDP, 
inactive, GDP-bound Rho GTPase; RhoGTP, active, GTP-bound Rho GTPase; Invasin, Yersinia 
adhesin binding to β1-integrins.  
 
Rho GTPases are inactive in the GDP-bound form, when they are associated with a guanine 
nucleotide dissociation inhibitor (GDI), and are activated by GDP/GTP exchange caused by 
guanine nucleotide-exchange factors (GEFs). The active state is terminated by GTPase-
activating proteins (GAPs) that greatly enhance the low basal GTPase activity. Furthermore, 
by binding to GDIs the hydrophobic isoprenoid moiety at the C-terminus of Rho GTPases is 
neutralized and this is involved in cytosol/membrane cycling (Bishop and Hall 2000; 
Aepfelbacher 2004). In the GTP-bound state the Rho proteins adopt a conformation that 
allows interaction and stimulation of a variety of downstream effector proteins, which include 
protein kinases, lipid kinases, and multidomain scaffolds (Van Aelst and D'Souza-Schorey 
1997). 
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The best-characterized Rho proteins are RhoA, Rac-1, and Cdc42. Each controls the 
formation of individual cytoskeletal elements in the cell: contractile actin/myosin stress fibers 
and the organization of focal contacts by RhoA, lamellipodia and focal complexes by Rac-1, 
and filopodia/microspikes as well as focal contacts by Cdc42 (Ridley, Paterson et al. 1992; 
Nobes and Hall 1995).  
7.1 Rho proteins and actin polymerization 
In eukaryotic cells, monomeric G-actin is in dynamic equilibrium with polymerized F-actin. 
Rapid signal-induced actin polymerization, including that occurring during host–pathogen 
interactions, can be triggered by different mechanisms, including de novo nucleation, which 
can involve the Arp2/3 (actin-related protein 2/3) complex (Boquet and Lemichez 2003). Rac 
and Cdc42 lead to morphologically distinct protrusions at the plasma membrane (i.e., 
lamellipodia and filopodia), but they both initiate actin polymerization through the Arp2/3 
complex. In mammalian cells Rho stimulates actin polymerization through diaphanous-related 
formin (DRF), mDia1 that directly binds actin filaments and promotes filament elongation 
(Bishop and Hall 2000; Raftopoulou and Hall 2004). A second effector protein directly 
regulated by Rho is Rho-kinase which in turn regulates LIM kinase-mediated  stabilization of 
filamentous actin structures and myosin light chain phosphatase-mediated actomyosin 
assembly and contraction (Bishop and Hall 2000).  
7.2 Rho proteins and phagocytosis 
Rho GTPases have an essential role in phagocytosis as shown in professional phagocytes such 
as macrophages. Immunoglobulin receptor (FcγR) mediated phagocytosis depends on Cdc42 
and Rac, and complement receptor (CR) mediated phagocytosis depends on RhoA (Caron and 
Hall 1998). Both pathways activate the Arp2/3 complex for actin polymerization but in a 
Cdc42/Rac- or RhoA-dependent manner (May, Caron et al. 2000; Jaffe and Hall 2005). 
The uptake, triggered by Yersinia invasin, has been shown to involve Rac, either individually 
or in cooperation with Rho and Cdc42Hs, dependent on the cell type (Alrutz et al. 2001; 
McGee et al. 2001; Wiedemann et al. 2001). The central role for Rho-GTPases in assembly 
and disassembly of peripheral actin filaments is necessary for phagocytosis and consequently 
can provide an explanation why they are common substrates for bacterial toxins and effectors 
(Aktories and Barbieri 2005). Phagocytosis mediated by Fcγ receptors is accompanied by an 
increase in the production of reactive oxygen species leading to the killing of phagocytosed 
bacteria. This phenomenon known as the phagocytic burst is mediated by membrane-
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associated NADPH oxidase complex and was shown to be dependent on Rac proteins 
(Roberts, Kim et al. 1999; Bokoch and Diebold 2002; Aktories and Barbieri 2005).  
Clostridial toxins and exoenzymes from other gram-positive bacteria (C3-like ADP-
ribosyltransferases) covalently modify and inactivate Rho GTPases, whereas Yersinia YopE 
acts as a Rho GAP. In both cases this prevents phagocytosis of bacteria (Aktories, Wilde et al. 
2004). Salmonella typhimurium, on the other hand, is an invasive bacterium exploiting host 
cell signaling by injecting SopE, which acts as a GEF, to activate Cdc42 and Rac and promote 
its own internalization (Aktories and Barbieri 2005). 
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8. AIM OF THIS STUDY 
The type III secretion system translocated YopO (729 amino acids) has a 
secretion/translocation domain at the N-terminus (amino acid 1-88). Sequence alignments 
predict the location of the kinase domain within amino acids 150-400, it has a C-terminal Rho 
GDI-like domain (amino acid 431-612) and an N-terminal (within amino acid 89-440) and a 
C-terminal (within amino acid 440-729) actin binding domain.  
YopO was shown to disrupt F-actin and cause rounding in Yersinia-infected cells (Hakansson, 
Galyov et al. 1996). Which of the known biochemical activities of YopO contribute to these 
cellular effects has not been clear. Whether these activities work independently or 
synergistically with each other was also unknown and discrepant results with regard to these 
issues were obtained in previous studies (Dukuzumuremyi, Rosqvist et al. 2000; Juris, 
Rudolph et al. 2000). Although there was indirect evidence for an antiphagocytic activity of 
YopO, an effect on a defined phagocytosis mechanism has not been identified (Grosdent, 
Maridonneau-Parini et al. 2002; Wiley, Nordfeldth et al. 2006).  
First it was necessary to establish and biochemically characterize recombinant YopO mutant 
proteins and eukaryotic expression vectors that allow defining the roles of kinase activity, 
actin binding, Rho GTPase binding and plasma membrane localization in inducing the known 
morphological effects of YopO. Furthermore, mechanistically distinct ways of Yersinia 
internalization like Fcγ-receptor-, complement receptor-, invasin- and YadA-mediated 
phagocytosis had to be evaluated and their sensitivity to YopO tested. The results had to be 
compiled to a coherent picture of how YopO functions in cells and how this may contribute to 
immune cell modulation during Yersinia infection. 
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C. RESULTS 
1. CHARACTERIZATION OF YOPO CONSTRUCTS USED IN THIS 
STUDY 
1.1 YopO protein organization and constructs 
 
FIGURE 7. Scheme of YopO protein organisation and YopO constructs used in this study. 
The first and the last amino acids of YopOwt or its fragments and mutants are indicated. cDNA’s encoding these 
constructs were cloned into vectors allowing expression of GST-fusion proteins in E. coli or GFP-fusion proteins 
in host cells. Sec/Trans; secretion and translocation region used by the Yersinia type three secretion system. 
Kinase; region with homology to serine/threonine kinases. D267 and K269 are amino acids critical for catalytic 
activity. GDI-like; region with homology to Rho GDI. CH; coronin homology region. 
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1.2 YopO has N- and C-terminal actin binding sites 
YopO forms a 1:1 complex with G-actin (Trasak, Zenner et al. 2007). To identify the 
region(s) in the YopO protein that is(are) involved in actin binding GST-pulldown assays and 
actin polymerization assays using actin and N- and C-terminal deletion mutants were 
performed. 
Wild type YopO and kinase defective YopO (K269A) bind G-actin with the same efficiency. 
Progressive truncation of the N-terminal amino acids resulted in mutant proteins that were 
able to pull down actin (YopO89-729, YopO151-729, YopO399-729, YopO441-729) and 
proteins that lost the actin binding property (YopO541-729 and YopO700-729). The C-
terminal truncations YopO89-710 and YopO89-440 were unable to pull down actin (Trasak, 
Zenner et al. 2007). The pulldown experiments indicate that YopO amino acids 441 to 729 
constitute an actin binding site. In the process of delineating the kinase domain of YopO, 
YopO89-440 was observed to display autophosphorylation dependent on the presence of G-
actin (see figure 8b) indicating that YopO89-440 also does bind actin. An alternative method 
used to determine G-actin binding of YopO was to measure the polymerization of G-actin to 
F-actin with fluorescently labeled G-actin monomers in the presence of YopO mutant 
proteins. The formation of F-actin was dose-dependently inhibited by YopO89-440, 
confirming the actin binding of the fragment harboring the catalytic domain. Consistent with 
the pull down data YopO441-729 inhibited F-actin formation. The YopO truncations 
YopO151-440 and YopO89-398 were shown to have no actin binding activity (Trasak, 
Zenner et al. 2007).  
In conclusion YopO was shown to have two independent actin binding sites, one located N-
terminally within amino acids 89-440 and the other located C-terminally within amino acids 
441-729 (overview shown in table C1). 
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Table C1. Interaction of YopO constructs with G-actin in pulldown and G-actin-polymerization 
experiments 
   
Actin binding in pulldown assay  Actin binding in G-actin polymerization assay 
YopO construct interaction  YopO construct interaction (Kd) 
WT +  89-729 + (Kd 1.9 µM) 
K269A +  441-729 + (Kd 6.1 µM) 
89-729 +  700-729 - 
151-729 +  89-440 + (Kd 4.1 µM) 
399-729 +  89-398 - 
441-729 +  151-440 - 
541-729 - 
700-729 - 
89-710 - 
+ indicating interaction of YopO construct with 
G-actin. Dissociation constant (Kd).  
- indicating no interaction of YopO construct 
with G-actin.  
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1.3 Kinase activity of N- and C-terminal YopO deletion mutants 
In order to characterize the actin-dependent kinase activity, YopO truncations were tested for 
incorporation of phosphate from radioactively labeled ATP ([γ-32P] adenosine 5’ tris-
phosphate) in the presence of actin. Bacterially expressed full length YopO (YopOwt) showed 
considerable degradation and required detergents such as Triton X-100 for purification and 
stability. Therefore a construct that lacks the N-terminal amino acids 1-88 (YopO89-729) that 
serve as bacterial secretion and translocation signal was established. 
YopO has an N-terminal G-actin binding site comprised by amino acid residues 89-440 and a 
C-terminal G-actin binding site comprised by amino acid residues 441-729. The YopO 
deletion mutants YopO89-398 and YopO151-729 have no functional N-terminal actin binding 
site, the C-terminal truncated YopO89-710 has no functional C-terminal actin binding site. 
 
FIGURE 8. Kinase activity of YopO mutants. 
a) Autophosphorylation of GST-fused YopO mutants in kinase assay (upper panel 
radiography, lower panel CoomassieBlue staining). 
b) Autophosphorylation of GST-YopO89-440 and GST-YopO89-398 in the presence and 
absence of actin (upper panel radiography, lower panel CoomassieBlue staining). Molecular 
weights (MW) of standard marker proteins are indicated 
c) Autophosphorylation of YopO point mutants. Double point mutant (D267A/K269A) and 
single point mutant (K269A) are shown. 
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YopOwt and YopO89-729 have the same actin binding properties and are shown here to 
incorporate the same amount of [32P]-phosphate during autophosphorylation reactions 
(Figure 8a). The full length active site kinase mutant YopOK269A showed very low residual 
autophosphorylation. For complete knockout of kinase activity the active site double mutant 
YopO89-729D267A/K269A was established and absence of residual autophosphorylation is 
shown in figure 8c. 
The YopO construct comprising amino acids 151-729 (YopO151-729) is kinase dead 
(figure 8a) which may be caused by the disruption of the N-terminal actin binding site, 
disruption of the kinase domain, or may be due to the removal of autophosphorylation sites. 
YopO89-440, consisting of the N-terminal kinase region and actin binding site, was capable 
of autophoshorylating dependent on the presence of G-actin (figure 8b). 
The constructs YopO89-710 and YopO89-440, lacking the C-terminal actin binding site, both 
show diminished autophosphorylation (compare figure 8a+b). In comparison, YopO89-398, a 
construct shown to have no actin binding activity, shows no autophosphorylation (figure 8b). 
The diminished autophosphorylation activities of constructs YopO89-710 and YopO89-440 
compared to YopO89-729 and YopOwt indicate that full actin binding by N- and C-terminal 
actin binding sites is necessary for full kinase activity. 
The point mutant YopOK269A shows drastically reduced autophosphorylation (figure 8c). 
Introduction of a second mutation in the kinase domain of YopO leads to complete loss of 
autophosphorylation  in YopOD267A/K269A (figure 8c). This double point mutant was used 
for the evaluation of kinase independent cellular effects. 
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1.4 Overview of the activities of YopO constructs used in this study 
 
Table C2. Overview of YopO constructs and their activities 
   Actin binding   
YopO construct PM kinase N-terminal C-terminal Rho-binding 
WT (1-729) + +++ + + + 
89-729 - +++ + + + 
89-710 - + + - + 
89-440 - + + - - 
399-729 - - - + + 
1-710 + + + - + 
1-440 + + + - - 
D267A/K269A + - + + + 
+ indicating activity; - indicating no activity. 
PM; plasma membrane localization. Rho-binding; intact GDI-like domain 
 
An overview of the established YopO constructs with their respective activities is shown in 
table C2. YopO mutants missing the first 88 N-terminal amino acids are deficient in plasma 
membrane binding. Truncation at the C-terminus (1-710, 1-440, 89-710, 89-440) leads to 
constructs with intact kinase domain, but very diminished actin binding. The YopO constructs 
1-440, 89-440 with C-terminal truncations lack the GDI-like domain and therefore Rho 
binding. The isolated Rho-binding GDI-like domain with intact C-terminal actin binding site 
is present in YopO399-729. Selective inactivation of the kinase was realized with two point 
mutations in construct YopOD267A/K269A. 
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2. MORPHOLOGICAL EFFECTS OF YOPO – F-ACTIN AND CELL 
SHAPE 
2.1 Microinjection and Transfection of YopO 
In order to examine if transfection of GFP-YopO expressing vectors, leading to eukaryotically 
expressed YopO fusion proteins, and injection of prokaryotically expressed YopO have the 
same cellular effects, the actin cytoskeleton and shape of cells was observed after transfection 
and microinjection. It has not been clear whether eukaryotically expressed YopO fusion 
proteins are able to elicit the same phenotype as untagged microinjected YopO. 
In hitherto performed studies on the effects of YopO in eukaryotic cells, either 
Y. enterocolitica strains expressing YopO, or eukaryotic expression vectors with bi-cistronic 
expression of YopO and a marker gene were used. 
In contrast to the N-terminally truncated YopO89-729 expression and purification of the full 
length YopOwt (1-729) protein could not be accomplished without detergent. Therefore the 
full length protein YopOwt was unsuitable for microinjection and YopO89-729 that was 
shown to have the same in vitro activities as YopOwt (see above) was used for 
microinjection. 
 
2.1.1 Microinjection of YopO89-729 leads to rounding and F-actin disruption 
Microinjection of YopO89-729 into endothelial cells (HUVEC) grown on glass coverslips 
showed two morphological effects. First TRITC-Phalloidin staining showed F-actin 
disruption in microinjected cells (arrowheads in figure 9a and 9b), secondly the cell shape of 
microinjected cells showed rounding with apparent retraction fibers (arrows in figure 9a and 
9b). Control injections with buffer containing only rat-IgG that was used for the identification 
of microinjected cells showed none of the effects visible at injection of YopO89-729 (figure 
9c and 9d). 
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FIGURE 9. Microinjection of YopO89-729 leads to rounding and F-actin disruption. 
a) Rat-IgG staining showing YopO-injected endothelial cells. b) F-actin staining of 
YopO-injected and uninjected cells. Arrow and arrowhead point to an arborized and F-
actin disrupted cell, respectively. c) Immunofluorescence staining of cells injected with 
Rat-IgG alone. d)  F-actin staining of injected cell and one uninjected control cell to the 
left. The bar represents 10 µm. 
2.1.2 Transfection of YopO fusion proteins leads to rounding and F-actin 
disruption 
In order to evaluate if the FLAG- or GFP-tag can interfere with the ability of YopO to disrupt 
the actin cytoskeleton and induce cell rounding, the phenotype after transfection of FLAG-
tagged and N- or C- terminally GFP-tagged YopO fusion proteins (compare table E7c) was 
evaluated in endothelial cells (HBMEC). As a control the empty vector expressing GFP was 
used.  
N- or C-terminal fusion to GFP had no effect on the ability of YopO to disrupt F-actin and 
induce rounding (figure 10). The majority (89 ± 5%) of the control cells transfected with GFP 
show no F-actin disruption and no rounding. A small fraction of cells (11 ± 4%) showed low 
F-actin staining. Low actin staining resembling F-actin disruption may be caused by the 
transfection procedure, may represent a motile state of the cell where stress fibers are reduced, 
or may simply be a normal variation in the control cells.  
FIGURE 9
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FIGURE 10. Expression of different YopO-wildtype fusion proteins 
causes similar cell rounding and F-actin disruption. 
Statistical evaluation of morphological effects upon expression of GFP 
(control), GFP-YopO(C1), GFP-YopO(N1) and Flag-YopO fusion proteins 
in endothelial cells (HBMEC). Fraction of cells displaying one of three 
phenotypes (arborization, F-actin disruption and no phenotype) are shown 
for every construct. Values are mean ± S.D. of 3 experiments with at least 
90 cells evaluated per experiment. 
 
While approximately 10% of the control cells showed reduced actin, less than 1% showed a 
phenotype that resembled rounding. In contrast, transfection of YopO fusion proteins induced 
rounding in roughly 30% of the cells (GFP-YopO(C1), GFP-YopO(N1) and FLAG-YopO 
show rounding in 32 ± 10%, 19 ± 15% and 27 ± 7% of the cells, respectively). The effects of 
the YopO fusion proteins on the cellular F-actin were drastic: 54 ± 9% (GFP-YopO(C1)), 
74 ± 10% (GFP-YopO(N1)) and 68 ± 11% (FLAG-YopO) of transfected cells showed F-actin 
disruption. Only a small fraction of cells (ranging from 5% to 14%) transfected with the 
YopO fusion proteins showed no alterations in the actin cytoskeleton and the cell shape. 
These data show that the known cellular effects described for YopO introduced by yersiniae 
are also induced upon expression of the YopO protein fused to a FLAG moiety (7 amino 
acids) or to GFP (265 amino acids). This validates YopO transfection as a suitable method for 
the evaluation of the cellular effects of YopO protein domains.  
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2.2 Cellular effects of N- and C-terminal YopO deletion mutants on F-
actin and cell shape 
2.2.1 F-actin disruption is mediated by C-terminal Rho-GDI-like domain 
Upon transfection of the GFP-fused N- and C-terminal YopO deletion mutants into 
endothelial cells (HBMEC), their effect on the actin cytoskeleton was visualized by staining 
of F-actin with AlexaFluor 568-phalloidin. Exemplarily F-actin disruption in a cell expressing 
GFP-YopO can be seen in figure 11a. In contrast to the GFP-YopO expressing cell, the 
surrounding cells show normal stress fibers. 
 
FIGURE 11. F-actin disruption is mediated by C-terminal Rho-binding domains. 
a) Image of a GFP-YopO expressing cell (left). F-actin staining with AlexaFluor 568 phalloidin 
of cells in the same field showing F-actin disruption in the transfected cell, but not the 
surrounding cells (right). The bar represents 10 µm. 
b) Statistical evaluation of F-actin disruption for GFP (negative control), GFP-YopOwt (WT) 
and designated GFP-YopO mutants. The percentage of cells showing clearly visible F-actin 
disruption is shown. Values are mean ± S.D. of 3 experiments with at least 90 cells evaluated 
per experiment. 
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Statistical evaluation shows that in cells containing the GFP-expressing empty vector only a 
small fraction (10 ± 4%; figure 11b) showed F-actin disruption, which could be explained by 
staining artifacts, a possible disruptive effect caused by transfection and/or the fraction of 
cells that naturally occurs with a diminished amount of F-actin at the moment of staining. 
YopO constructs carrying the intact C-terminal Rho GDI-like domain (Prehna, Ivanov et al. 
2006) showed comparable stress fiber disruption as YopOwt (54 ± 9%; figure 11b). These 
constructs include the kinase deficient YopOD267A/K269A (34 ± 11%), YopO399-729 
(45 ± 9%) and YopO1-710 (70 ± 6%). The YopO constructs that have residual kinase activity 
and are lacking the Rho-binding domain, namely YopO1-440 and YopO89-440, showed only 
minor stress fiber disruption with 24 ± 2% and 16 ± 1%, respectively. From the fact that the 
low actin binding constructs YopO1-710 and YopO399-729 disrupt stress fibers very 
effectively it can be concluded, that F-actin disruption is not dependent on the actin binding 
capacity of YopO. 
Conclusively these results show that the C-terminal Rho GDI-like domain alone is capable of 
inducing F-actin disruption and that this effect is independent on the YopO kinase activity and 
actin-binding activity.  
2.2.2 F-actin disruption can be rescued by RhoAV14 
The constitutive active RhoAV14 mutant is known to induce stress fibers (Ridley, Paterson et 
al. 1992). To test if RhoAV14 can prevent F-actin disruption caused by YopOwt, endothelial 
cells were co-transfected with mRFP-YopOwt and GFP-RhoAV14 and the F-actin staining 
was evaluated. 
Co-expression of GFP-RhoAV14 and mRFP-YopOwt is shown in figure 12a. The double-
transfected cell (arrow in figure 12a) shows characteristic GFP-RhoAV14 and mRFP-YopO 
staining together with an amount of F-actin comparable to the adjacent untransfected cell to 
the right (arrowhead in figure 12a). Upon cotransfection of RhoAV14 and YopO the 
disruptive effect of YopO on F-actin structures was no longer visible. 
For statistical evaluation the percentage of cells showing F-actin structures (stress fibers) was 
scored for cells expressing GFP (empty vector control), GFP-RhoAV14, GFP-RhoAV14 and 
mRFP-YopO (co-expression), mRFP-YopO and mRFP (empty vector control). The majority 
of the GFP-RhoAV14 expressing cells (78 ± 8%; figure 12b) as expected showed distinct 
cytoplasmic F-actin structures. Upon cotransfection of GFP-RhoAV14 and mRFP-YopOwt 
the phenotype of single transfected GFP-RhoAV14 was observed, with the majority 
(81 ± 9%) of the co-transfected cells showing induced F-actin (figure 12b). 
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FIGURE 12. F-actin disruption can be rescued by RhoAV14. 
a) Image series of an endothelial cell (HBMEC) expressing GFP-RhoAV14 (lower left) 
and mRFP-YopO (lower right) stained for F-actin (upper right) and visualized by 
phasecontrast microscopy (upper left). Arrow indicates double-transfected cell 
(RhoAV14+YopO coexpression) with F-actin fibers. Arrowhead indicates untransfected 
cell with F-actin fibers. The bar represents 10 µm. 
b) Statistical evaluation of cells showing F-actin fibers. Cells expressing GFP (empty 
vector), GFP-RhoAV14 (RhoAV14), GFP-RhoAV14 and mRFP-YopO (RhoAV14 
+YopO), mRFP-YopO (YopO) and mRFP (empty vector) were evaluated for formation 
of stress fibers. The fraction of cells showing F-actin fibers is displayed. Values are mean 
± S.D. of 3 independent experiments. For every designated construct 90 cells were 
evaluated per experiment. 
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This shows that co-expression of RhoAV14 and YopO does not result in F-actin disruption. 
Single expression of mRFP-YopOwt induced F-actin disruption in 86 ± 8% of the cells with 
only 14 ± 8% (figure 12b) of the cells showing cytoplasmic F-actin fibers. The control cells 
expressing the respective vector controls showed no reduction in stress fiber formation (GFP 
empty vector: 85± 6%; mRFP empty vector: 83 ± 7%). 
These data show that F-actin disruption mediated by YopO can be rescued by co-expression 
of constitutive active RhoAV14. Hence the RhoA inhibiting activity of YopO does not effect 
the interaction of RhoA with its downstream targets. 
2.2.3 Rounding/Arborization is dependent on kinase activity 
Transfection of GFP-YopO into endothelial cells not only leads to the described F-actin 
disruption, but also to a rounded phenotype with articulate retraction fibers. This phenotype is 
shown by cells that are retracting or rounding up without completely dissolving their focal 
adhesions that attach them to the substratum. Cells rounding up in this specific way end up 
showing a fine branching (arborized) structure, a treelike shape that resembles the form of 
dendrites of a nerve cell (figure 13a). 
Statistical analysis was performed and the fraction of arborized cells determined and 
displayed in figure 13b. Cells transfected with the GFP empty vector as negative control were 
scored for rounding and showed a minimal fraction of arborized cells of 1 ± 0.8%. Cells 
transfected with the full length, fully-active GFP-YopOwt construct showed a degree of 
arborization of 32 ± 10%. Compared to GFP-YopOwt the kinase dead GFP-
YopOD267A/K269A showed significantly less arborization (5 ± 4%). GFP-YopO1-440, 
GFP-YopO89-440 and GFP-YopO1-710 displaying greatly reduced kinase activity all showed 
significant reduction of arborization compared to YopOwt (figure 13b). 
These data indicate that the full degree of arborization is dependent on YopO kinase activity 
which in turn is dependent on actin binding. 
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FIGURE 13. Rounding/arborization is dependent on kinase activity of YopO. 
a) Image of GFP-YopO expressing cell (left). Phasecontrast image of cells in the same field 
showing rounding of the transfected cell (right). The bar represents 10 µm. 
b) Statistical evaluation of cell rounding/arborization for GFP (negative control), GFP-YopOwt 
(WT) and designated GFP-YopO mutants. Values are mean ± S.D. of 3 experiments with at least 
90 cells evaluated per experiment. 
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3. FUNCTIONAL ROLE OF YOPO IN PHAGOCYTOSIS 
3.1 Fcγ-Receptor (FcγR)- and Complement Receptor (CR)-mediated 
phagocytosis 
Phagocytosis, the uptake of particles (>0.5 µm) into cells, is a conserved cellular function that 
is driven by actin polymerization (Kaplan 1977; Castellano, Chavrier et al. 2001; May and 
Machesky 2001) and is important for host defense mechanisms as well as for tissue repair and 
morphogenetic remodeling. The molecular activators and effectors of the actin cytoskeleton 
involved in phagocytosis are very similar to those regulating other cell functions and include 
the small GTPases of the Rho family (Castellano, Chavrier et al. 2001). 
Two of the best characterized phagocytic receptors in macrophages, the complement 
receptor 3 (CR3) and Fc-gamma receptors (FcγRs), are involved in the uptake of opsonized 
microorganisms during infection. CR3 binds C3bi on complement-opsonized targets, whereas 
FcγRs bind to the conserved Fc domain of immunoglobulin G (IgG) coated targets. Although 
both uptake processes require actin polymerization, complement-receptor-mediated 
phagocytosis is morphologically distinct from that mediated by FcγRs. FcγR mediated 
phagocytosis is characterized by a dramatic, actin-dependent extension of the plasma 
membrane around the particle and is followed by the production of superoxide and the release 
of inflammatory cytokines, while complement-opsonized particles ‘sink’ into the phagocyte; 
there is minimal membrane disturbance, and internalization does not usually lead to an 
oxidative burst or inflammatory response (Caron and Hall 1998; May and Machesky 2001). 
Two distinct mechanisms of phagocytosis with regard to Rho GTPases and actin 
reorganization involved were identified by Hall in the year 1998: Type I phagocytosis, used 
by the immunoglobulin receptor is mediated by Cdc42 and Rac and type II, used by the 
complement receptor (CR), is mediated by Rho (Caron and Hall 1998). Both mechanisms are 
favorable targets for pathogens that have the strategy to avoid phagocytosis. 
YopO was shown to have a dramatic impact on the actin cytoskeleton and the cells ability to 
form or maintain cytoskeletal F-actin structures. To elucidate if F-actin disruption caused by 
YopO has a functional role in phagocytosis, CR- and Fcγ-R-mediated internalization of sheep 
red blood cells (SRBC) in the presence of YopO was quantified. 
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3.1.1 FcγR-induced actin polymerization is not inhibited by YopO 
Actin polymerization at the phagocytic cup is necessary to drive the uptake process. FcγR-
mediated phagocytosis is morphologically accompanied by articulate, actin-dependent 
extensions of the plasma membrane around the internalized particle. The pronounced F-actin 
structure formed is referred to as actin cup (May and Machesky 2001).  
YopO has drastic effects on F-actin structures in endothelial cells, but it was not known if 
YopO can inhibit the formation of phagocytic actin cups.  
Before Fcγ-R and CR-dependent internalization was evaluated, the effect of YopO on the 
formation of phagocytic actin cups during Fcγ-R mediated phagocytosis was evaluated. 
 
FIGURE 14. Actin cup formation during Fcγ-R- mediated uptake is not inhibited by YopO. 
Image series showing GFP-YopO expressing macrophage (lower left), AlexaFluor 568 outside-
stained SRBC (lower right), Marina Blue F-actin staining (upper right) and phasecontrast image 
(upper left). External SRBC triggering actin polymerization are marked with arrows. The bar 
represents 10 µm. 
 
The process of phagocytic F-actin cup formation during the FcγR-mediated uptake of IgG-
coated SRBC into a GFP-YopO transfected macrophage is visualized in figure 14. Outside 
staining (arrows, lower right) shows external SRBC that trigger the formation of F-actin at the 
site of attachment (arrows, upper right). The GFP-YopO expressing macrophage can be 
identified by green fluorescence (b/w capture, lower left). Phasecontrast (upper left) identifies 
FIGURE 14
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the GFP-YopO expressing macrophage and an adjacent untransfected macrophage. Attached 
IgG-coated SRBC (marked by arrows) were able to trigger actin polymerization in GFP-
YopO transfected macrophages. 
Thus de novo formation of F-actin structures surrounding the ingested SRBC is shown here to 
occur in the presence YopOwt. 
3.1.2 FcγR and CR-mediated phagocytosis are not inhibited by YopO 
To quantify the effects of YopO on the two distinct uptake mechanisms mediated by the 
phagocytic receptors FcγR and CR (complement receptor), the uptake of IgG- and 
complement-coated sheep red blood cells (SRBC) into GFP-YopOwt expressing human 
macrophages was evaluated. The adapted microscopic method employed allows to analyze 
phagocytosis of defined particles (SRBC) via defined receptors on the cellular level 
(Greenberg, el Khoury et al. 1991; Braun, Fraisier et al. 2004). Phagocytosed SRBC can be 
distinguished from attached SRBC by the use of fluorescence staining and phasecontrast. A 
peculiar property of SRBC is that they become visible by phase contrast inside a cell as 
swollen particles in vacuoles, but are almost invisible outside of cells. After fixation the 
attached external SRBC are fluorescently stained and appear only detectable by fluorescent 
staining and not by phase contrast. Internalized SRBC appear negative for staining, or weekly 
stained, but are detectable as distinct round particles by phase contrast. 
Potential inhibition of uptake by GFP-YopO can be caused by interference in phagocytic 
signaling, or by inhibition of macrophage-SRBC interaction. The latter is not the case for 
GFP-YopO transfected macrophages. Binding and uptake of particles in GFP-YopO 
transfected cells is not impaired as can be observed in figure 15a. Attachment and uptake is 
visualized for IgG-coated SRBC. A considerable amount of phagocytosed SRBC (arrows in 
figure 15a) and several attached SRBC (arrowheads) can be seen in the GFP-YopO 
transfected as well as in the untransfected cell.  
The number of phagocytosed and attached SRBC was determined for control cells expressing 
GFP or cells expressing GFP-YopO in three independent experiments. Statistical analysis of 
phagocytosis of IgG- and complement-coated SRBC was performed. Internalization in 
transfected cells was normalized to internalization in control cells and the fraction of 
phagocytosed SRBC in GFP-YopO expressing cells compared to the intracellular fraction in 
control cells (displayed in figure 15b). Phagocytosis of IgG-coated SRBC (FcγR-mediated 
phagocytosis) was not significantly inhibited in GFP-YopOwt transfected cells, which showed 
93 ± 9% SRBC internalization compared to the control. Complement receptor mediated 
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phagocytosis was also not significantly inhibited by GFP-YopO. Compared to control cells, 
internalization of complement-coated SRBC appeared to be lower in GFP-YopO transfected 
cells (80 ± 11%), but statistical analysis of internalization data revealed no significant 
reduction. 
These data indicate that GFP-YopOwt has no inhibitory effect on FcγR- and Complement 
Receptor-mediated phagocytosis in macrophages. 
 
FIGURE 15. Fcγ-R and CR-mediated phagocytosis are not inhibited by YopO. 
a) Image series showing a GFP-YopO expressing macrophage (left), phasecontrast image merged with outside 
staining of SRBC (middle) and AlexaFluor 568 outside-stained SRBC (right). The bar represents 10 µm. Arrows 
indicate internalized SRBC. Arrowheads indicate external SRBC. 
b) Statistical evaluation of internalization for GFP (control) and GFP-YopOwt (YopO) expressing macrophages. 
Uptake is shown as the percentage of total cell associated SRBC that is intracellular. Uptake was normalized to 
control (GFP expressing cells) that was set to 100%. Values are mean ± S.D. of 3 independent experiments with 
90 cells evaluated per experiment. 
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3.2 Invasin mediated phagocytosis  
3.2.1 Invasin-beads and Invasin-E. coli show similar invasion properties 
Heterologously expressed invasin can be coupled to the sulfate groups on the surface of 
fluorescent microspheres (beads). The advantage of fluorescent beads for microscopic 
evaluation of internalization is that the beads can be better detected and quantified in 
phasecontrast, do not have to be fluorescently stained and additionally do not get degraded 
after uptake. Internalized bacteria start to lose their antigenic epitopes upon degradation by 
lysosomal proteases. To evaluate fluorescent beads for internalization assays, triggering of 
phagocytic cups and uptake kinetics of beads coated with invasin (Invasin-beads) was 
examined and compared to Invasin-E. coli. 
After attachment of Invasin-beads the formation of actin cups is triggered with similar 
efficiency and kinetics as with Invasin-E. coli. Phasecontrast and F-actin staining in 
figure 16a show Invasin-beads (marked by arrows, upper pictures) that trigger the formation 
of distinct F-actin structures (actin cups) around them. The formation of actin cups at sites of 
Invasin-E. coli attachment is also shown in figure 16a (lower pictures). 
After it was shown that the actin cups triggered by attachment of Invasin-beads and Invasin-
E. coli are similar, uptake kinetics in endothelial cells (HBMEC) was determined. At several 
time points (10, 30 and 60 minutes) after attachment of Invasin-beads and Invasin-E. coli, 
cells were fixed and the respective uptake evaluated (displayed in figure 16b). Invasin-coated 
beads showed comparable uptake kinetics as Invasin-E. coli. After 10 minutes 51 ± 9% and 
64 ± 8% of the attached particles were internalized for Invasin-E. coli and Invasin-beads, 
respectively. After 60 minutes the majority of attached Invasin-E. coli (87 ± 7%) and Invasin-
beads (92 ± 11%) were localized inside the cell. 
Taken together the identical internalization morphology and the uptake kinetics, fluorescent 
Invasin-beads were shown to be a suitable model system to examine invasin-mediated 
phagocytosis on a cellular level. 
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FIGURE 16. Invasin-beads and Invasin-E. coli show similar invasion properties. 
a) Morphological effects in endothelial cells (HBMEC) induced by Invasin-beads (upper panels) and Invasin-E. 
coli (lower panels). AlexaFluor 568 F-actin staining shows discrete actin cups at sites of attached Invasin-beads 
(upper left). Beads are visible by phasecontrast (upper right). AlexaFluor 568 staining shows F-actin 
accumulation at sites of Invasin-E. coli attachment (lower left). Bacteria are visible in phasecontrast (lower 
right). Arrows indicate sites of Invasin-bead/E. coli-triggered actin polymerization. The bar represents 10 µm. 
b) Uptake kinetics of Invasin-E. coli  and Invasin-beads. Internalization was quantified after 10, 30 and 60 
minutes by double fluorescence staining. Uptake is shown as the percentage of total cell associated bacteria that 
is intracellular. Values are mean ± S.D. of 3 experiments with at least 90 cells evaluated per experiment. 
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3.2.2 Localization of YopO to phagocytic cup depends on amino acids 1-88 
YpkA has been shown to localize to the plasma membrane dependent on the amino acids 
1-443 (Dukuzumuremyi, Rosqvist et al. 2000). Localization of YopO to specific Yersinia- 
induced phagocytic structures has not been examined. Whether recruitment to phagocytic 
structures occurs and if it is dependent on the N-terminal membrane localization domain, the 
kinase domain, or the C-terminal Rho GDI-like domain has also not been known. 
It is shown here that GFP-YopO localization to invasin-induced uptake structures is 
dependent on the amino acids 1-88 and further that GFP-YopO1-440, which lacks the C-
terminal Rho GDI-like domain is enriched at theses sites (figure 17). 
 
FIGURE 17. Localization of YopO to phagocytic cup depends on amino acids 1-88. 
Localization of GFP-YopO1-440 to invasin-induced phagocytic cups (upper panels) versus 
diffuse cytoplasmic localization of GFP-YopO89-440 (lower panels). GFP-YopO1-440 is 
accumulated around attached beads (upper left). Alexa568 phalloidin staining shows Invasin-
bead-induced F-actin cups (upper right and lower right). YopO89-440 shows no discrete 
accumulation at sites of Invasin-bead attachment (lower left). Arrows indicate YopO 
localization to invasin-induced actin cups. The bar represents 10 µm.  
 
Confocal images of invasin-beads attached to endothelial cells (HBMEC) show phagocytic 
actin cups (red color) and accumulation of GFP-YopO1-440 (green color) at the sites of bead 
attachment (arrows, figure 17). This distinguished accumulation at the site of Invasin-bead 
YopO1-440
YopO89-440
F-actin
F-actin
FIGURE 17
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attachment is not visible for GFP-YopO89-440 indicating that amino acids 1-88 are necessary 
for targeting YopO to the phagocytic cup. GFP-YopO89-440 shows diffuse cytoplasmic 
localization (figure 17). Localization of the full length GFP-YopO to the invasin-induced 
uptake structure can be seen in figure 18. 
In conclusion the localization of YopO to the invasin-induced phagocytic cup is shown to be 
dependent on the N-terminal amino acids 1-88.  
3.2.3 Invasin-induced actin cup formation is not inhibited by YopO 
Interaction of Invasin-beads with endothelial cells causes actin polymerization at the site of 
attachment. In contrast, YopO causes drastic depolymerization of F-actin. To find out if 
YopO can inhibit the polymerization of actin at the site of bead attachment, GFP-YopO 
transfected cells (HBMEC) were inoculated with Invasin-beads. 
 
FIGURE 18. Invasin-induced actin polymerization is not inhibited by YopO. 
Image series showing GFP-YopO expressing cell (left), merged F-actin in red and Invasin-bead staining in blue 
(middle) and single channel with AlexaFluor 568 phalloidin stained F-actin (right). YopO expressing cell shows 
polymerization of actin at sites of Invasin-bead attachment (arrows) despite disruption of cytoplasmic F-actin 
fibers. Accumulation of GFP-YopO at the sites of Invasin-bead attachment is visible in the left picture (arrows). 
The bar represents 10 µm. 
 
Cells showing cytoplasmic F-actin disruption were examined for the formation of actin cups 
at the site of Invasin-bead attachment (figure 18). The GFP-YopO expressing cell (left 
picture) stained for F-actin (right picture) shows articulate F-actin disruption. Attached 
Invasin-beads (arrows), visualized in blue in the middle picture, were able to trigger the 
polymerization of actin in the GFP-YopO expressing cell. GFP-YopO localization at the site 
of bead attachment is visible in the left frame. 
In conclusion, in cells showing obvious F-actin disruption caused by YopO, invasin-induced 
actin cup formation at the site of Invasin-bead attachment (arrows) was not inhibited. 
YopO F-actin
F-actin
Invasin-beads
FIGURE 18
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3.2.4 Invasin-mediated internalization is not inhibited by YopO 
To test if YopO can interfere with the uptake triggered by invasin, GFP-, GFP-YopOwt- and 
GFP-RacN17 expressing endothelial cells (HBMEC) were microscopically evaluated for 
internalization of Invasin-beads. Internalization was normalized to GFP-control that was set to 
100%. The uptake of Invasin-beads was described to be dependent on the small GTPase Rac1 
(McGee, Zettl et al. 2001). Microinjection of dominant negative RacN17 inhibited actin cup 
formation upon uptake of Invasin-beads (Wiedemann, Linder et al. 2001). As a control for 
uptake inhibition, cells expressing GFP-RacN17 were evaluated for Invasin-bead 
internalization. 
 
FIGURE 19. Invasin-mediated internalization is not inhibited by YopO. 
a) Immunofluorescence image of GFP-YopO expressing endothelial cell (HBMEC, green) with 
internalized (blue) and extracellular Invasin-beads (red). External Invasin beads were stained red 
with AlexaFluor 568 secondary antibody (arrows). Internalized Invasin-beads appear in blue due 
to their default property (arrowheads). GFP-YopO expressing cell shows early signs of 
rounding/arborization. The bar represents 10 µm. 
b) Statistical evaluation of Invasin-bead internalization for GFP, GFP-YopOwt and GFP-RacN17 
expressing cells. Uptake is shown as the percentage of total cell associated Invasin-beads that is 
intracellular. Internalization was normalized to GFP control that was set to 100%. Significant 
reduction in internalization for GFP-RacN17 expressing cells is indicated by an asterisk. Values 
are mean ± S.D. of 3 experiments with 90 cells evaluated per experiment. 
 
A GFP-YopOwt expressing cell with Invasin-beads stained for discrimination of intra- and 
extracellular localization is shown in figure 19a. Outside staining with an anti-Invasin 
antibody shows extracellular beads in red (arrows). Phagocytosed intracellular beads are 
distinguishable inside the transfected cell (green) as blue spheres (arrowheads). Although the 
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GFP-YopO transfected cell shows morphological signs of rounding/arborization, uptake of 
Invasin-beads (arrowheads) was not inhibited. 
Statistical analysis of internalization experiments showed that there is no detectable inhibition 
of Invasin-bead uptake by GFP-YopO (figure 19b). Cells expressing GFP-YopO were as 
efficient in internalizing Invasin-beads as GFP expressing control cells. Due to the accuracy 
of the method (see standard deviation/error bars) the slightly higher internalization in GFP-
YopO transfected cells (106 ± 6%) can be regarded identical to the internalization in GFP 
control cells (set to 100%). GFP-RacN17 transfected cells showed significantly lower uptake 
(60 ± 8%) compared to GFP control cells, confirming the established role of Rac in invasin-
mediated uptake. 
These data suggest that YopO is not able to inhibit bacterial internalization mediated by 
invasin. 
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3.3 YadA mediated phagocytosis 
3.3.1 Adhesion of YadA-E. coli to fibronectin (FN) and collagen (COL) 
YadA was shown to mediate adhesion to matrix proteins like fibronectin and collagen. A 
recent publication relates invasion in Hep-2 cells to the ability of Y. pseudotuberculosis YadA 
to bind fibronectin (Heise and Dersch 2006). That study revealed that Y. enterocolitica YadA 
showed low fibronectin binding and minimal invasion in Hep-2 cells. The YadA-E. coli strain 
(DH5A-pBR-A1) used in this study is expressing Y. enterocolitica O:8 YadA on its surface 
(Roggenkamp, Neuberger et al. 1995). 
To characterize fibronectin and collagen binding of the YadA-E. coli strain used in this work, 
adhesion assays on fibronectin and collagen coated surfaces were performed. YadA-E. coli 
and control bacteria (DH5A-pBR) were incubated with surface-coated glass coverslips, 
washed, fixed and immunofluorescently stained. Adhesion was evaluated from fluorescent 
staining. Normalized values are displayed in figure 20. YadA-E. coli shows stronger adhesion 
to collagen (100 ± 27%) than to fibronectin (42 ± 18%). 
In line with the previously published results adhesion of the YadA-E. coli strain to fibronectin 
coated coverslips was lower than adhesion to collagen coated coverslips (figure 20). The 
parental E. coli strain (DH5A-pBR) was used as a control and showed minimal adhesion. 
 
FIGURE 20. Adhesion of YadA-E. coli to fibronectin (FN) and collagen 
(COL). 
Quantification of YadA-E. coli (DH5A-pBR-A1) adhesion to the ECM 
proteins fibronectin (FN) and collagen (COL) on glass coverslips. The non-
adhesive parental strain DH5A-pBR was used as control. Adhesion was 
quantified by measurement of immunofluorescence of adhered bacteria and 
is displayed in arbitrary units. Values are mean ± S.D. of 3 experiments 
with 10 objective fields measured per condition. 
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3.3.2 Internalization of YadA-E. coli is independent of fibronectin 
YadA dependent internalization was studied in Hep-2 cells with the YadA protein from 
Y.  pseudotuberculosis and shown to be dependent on fibronectin. The YadA protein from 
Y. enterocolitica was shown to be non-invasive in that cell type (Heise and Dersch 2006). 
Primary endothelial cells (HUVEC) used in this study to assay YadA-mediated internalization 
showed slow but considerable uptake mediated by the Y. enterocolitica YadA protein. 
To investigate internalization mediated by Y. enterocolitica YadA, YadA-E. coli and the 
parental control strain were attached to fibronectin knockout cells (FN-/-) or the parental 
control fibroblastic cell line (FN+/+) under serum free conditions. Internalization quantified 
by double fluorescence staining shows considerable uptake of YadA-E. coli in both cell lines 
(figure 21). Internalization is visualized for FN-/- cells in figure 21a.  
 
FIGURE 21. Internalization of YadA-E. coli is independent of fibronectin. 
a) Phasecontrast image of FN-/- fibroblasts merged with fluorescence images showing attached external 
YadA-E. coli (orange) and internalized YadA-E. coli (green). Extracellular and internalized YadA-E. coli  
were stained with AlexaFluor 568- (red) and AlexaFluor 488- (green) labeled secondary antibody, 
respectively. The bar represents 10 µm. 
b) Quantification of YadA-E. coli (DH5A-pBR-A1) and DH5A-pBR (control, non-adhesive parental 
strain) internalization in fibronectin knockout (FN-/-) and control (FN+/+) cells. Uptake is shown as the 
percentage of total cell associated bacteria that is intracellular. Internalization was quantified by 
immunofluorescence staining. Values are mean ± S.D. of 3 experiments with at least 90 cells evaluated 
per experiment. 
 
After 90 minutes 30 ± 9% of the FN+/+ attached YadA-E. coli and 34 ± 9% of the FN-/- 
attached YadA-E. coli were intracellular (figure 21b). The parental E. coli control strain 
showed minimal internalization of 3 ± 1% for FN-/- and 2 ± 4% for FN+/+ even when 
attached at a 100-fold higher ratio compared to YadA-E. coli. 
Uptake of YadA-E. coli therefore can be considered as specifically mediated by 
Y. enterocolitica YadA and to proceed independently of fibronectin. 
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3.3.3 Localization of YopO to the YadA uptake structure 
Upon uptake of YadA-E. coli in GFP-YopOwt expressing cells, localization of YopO at the 
site of bacterial internalization can be observed. 
 
FIGURE 22. YopO localizes to YadA-induced uptake structure. 
Left image shows 3 dimensional reconstruction of a confocal stack of an endothelial cell 
(HUVEC) expressing GFP-YopO (green) during phagocytosis of YadA-E. coli (red). 
Thumbnails on the right show channels (green, merge, red) of one confocal plane. The bar 
represents 5 µm. Outside staining of YadA-E. coli in red shows extracellular bacterial surface 
in bright red and the GFP-YopO protein (green) that is recruited to the site of bacterial uptake. 
A small extracellular fraction of a partially phagocytosed bacterium (arrow) is distinguishable 
from the intracellular part that is defined by the recruitment of GFP-YopO (arrowhead) 
 
Figure 22 shows external YadA-E. coli stained in red and a GFP-YopOwt expressing cell. 
Bacterial internalization is depicted exemplarily for a single bacterium, where the external 
part of the bacterial cell is stained red (arrow) and the internalized part shows accumulation of 
GFP-YopO (arrowhead). Adjacent internalized YadA-E. coli show no extracellular staining in 
red and are visible only by the GFP-YopO accumulation around their surface. 
 
FIGURE 22
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3.3.4 YadA-induced actin polymerization is not inhibited by YopO 
YopO does not inhibit actin polymerization induced upon binding of Invasin-beads (see 
above). Compared to invasin, indirect interaction of YadA with cells via an extracellular 
matrix bridge triggers substantially less prominent actin accumulation at the site of 
attachment. Internalization is slower and formation of the phagocytic actin cup is less 
pronounced. To investigate if the inhibitory effect of YopO is accompanied by disruption of 
F-actin at the YadA induced phagocytic cup, GFP-YopO expressing cells were evaluated for 
F-actin accumulation at the site of bacterial internalization by immunofluorescence staining. 
 
FIGURE 23. YadA-induced actin polymerization is not inhibited by YopO. 
Image series showing GFP-YopO expressing endothelial cell (HUVEC) in green, YadA-E. coli stained in blue 
and F-actin stained in red. Green channel shows GFP-YopO expression (left), channel merge in the middle 
shows localization of GFP-YopO and F-actin at the site of YadA-E. coli attachment (yellow) and channel merge 
on the right shows actin polymerization at the site of YadA-E. coli attachment. Arrows indicate actin 
polymerization and YopO recruitment to YadA-E. coli-induced uptake structure. The bar represents 10 µm. 
 
Confocal immunofluorescence data show that actin polymerization at the site of YadA-E. coli 
attachment is not inhibited in GFP-YopO expressing endothelial cells (figure 23). 
Extracellular structures of YadA-E. coli are visible in blue, F-actin is shown in red and GFP-
YopO accumulation at the site of bacterial uptake is visible in green. Colocalization of GFP-
YopO and F-actin at the site of YadA-E. coli internalization is visible in yellow (arrows in 
middle frame). 
GFP-YopO is shown here to localize to YadA-induced uptake structures. De novo formation 
of F-actin cups during the phagocytic process is not inhibited by YopO. 
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3.3.5 YadA-mediated internalization is inhibited by YopO 
To study the effects of YopO on YadA-mediated phagocytosis, GFP-YopO expressing 
HUVEC were inoculated with YadA-E. coli and after 90 minutes of invasion a double 
fluorescence staining method was used to identify uptake.  
YadA-mediated internalization in the presence of GFP-YopO was reduced to approximately 
50%. The GFP-YopO expressing cell in figure 24a shows attached YadA-E. coli, identified 
by red extracellular staining (arrows, bacteria appear orange due to overlay with green derived 
from GFP), with intracellular YadA-E. coli, identified by blue staining. In contrast to the 
GFP-YopO expressing cell, the neighboring untransfected control cell shows articulate 
internalization of YadA-E. coli, identified by blue staining (arrowheads). 
Internalization data from three independent experiments were statistically evaluated and are 
shown in figure 24b. Expression of GFP-YopO caused inhibition of YadA-mediated 
phagocytosis. Compared to control cells GFP-YopO expressing cells showed significantly 
reduced internalization (52 ± 5%) pointing to an inhibitory effect of GFP-YopO. The absolute 
numbers for internalization after 90 minutes were 64 ± 6% for control cells and 33 ± 5% for 
GFP-YopO expressing cells (not shown). 
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FIGURE 24. YadA-mediated internalization is inhibited by YopO. 
a) Internalization viewed by phasecontrast (left) and fluorescence (right) images of a GFP-YopO 
expressing endothelial cell (HUVEC) and adjacent control cell. Inside/outside staining identifies attached 
external YadA-E. coli (red, arrows) and internalized YadA-E. coli (blue, arrowheads) for GFP-YopO 
expressing cell (green) and untransfected control cell. Intracellular bacteria appear in dark blue for 
untransfected control cell and light blue for GFP-YopO expressing cell. Extracellular coverslip-
associated bacteria appear in red, while bacteria attached to the GFP-YopO expressing cell appear in 
bright red/orange (arrows). The bar represents 10 µm. 
b) YadA-mediated internalization is inhibited by the kinase activity of YopO. 
Quantification of YadA-E. coli (DH5A-pBR-A1) internalization in control cells, cells expressing GFP-
YopO (WT), or the designated GFP-YopO mutant proteins. Uptake is shown as the percentage of total 
cell associated bacteria that is intracellular. Uptake was normalized to control cells that was set to 100%. 
Values are mean ± S.D. of 3 experiments with 90 cells evaluated per experiment. Asterisk indicates 
statistically significant difference.  
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3.3.6 Inhibition of YadA-mediated internalization depends on the kinase activity 
of YopO 
To investigate to which YopO activity(ies) the inhibitory effect is connected to, YadA 
dependent internalization was evaluated in cells expressing GFP-YopO mutant proteins. 
YadA-mediated uptake was significantly reduced (52 ± 5% of control) only by the full length 
kinase-active GFP-YopOwt construct, while the kinase-dead GFP-YopOD267A/K269A 
(86 ± 3% of control), the GDI-like domain containing GFP-YopO399-729 (88 ± 3% of 
control) showed no significant inhibition of uptake (figure 24b) The cells expressing the GFP-
YopO1-440 construct with low in vitro kinase activity (see above) showed an internalization 
capacity (89 ± 4%) as high as the control cells. 
In summary only GFP-YopO with full kinase activity was able to significantly reduce YadA-
mediated internalization. 
3.3.7 RhoA inhibition by Edin-B does not inhibit YadA-mediated internalization 
The bacterial exotoxin EDIN-B (epidermal cell differentiation inhibitor) from Staphylococcus 
aureus belongs to the group of C3 like exoenzymes that catalyze the covalent modification of 
Rho proteins. The specificity of the C3 exoenzymes for the ADP-ribosylation of RhoA, B, 
and C at asparagine residue 41 (Asn41) make these proteins useful biological tools to 
characterize cell biological functions of these GTPases. (Inoue, Sugai et al. 1991; Aktories, 
Wilde et al. 2004). Upon incubation with EDIN-B, ADP-ribosylation leads to specific  
inactivation of RhoA, B, C, E and Rnd3 and can be monitored in cells by depolymerization of 
stress fibers (Aktories, Wilde et al. 2004; Aktories and Barbieri 2005).  
In mammalian cells Rho activates F-actin formation via the effector proteins mDia1 and Rho-
kinase (ROCK) leading to actin filament elongation and stabilization/contraction of 
filamentous actin fibers. To confirm that YadA-mediated uptake is independent from the 
GTPase Rho, internalization of YadA-E. coli in endothelial cells (HUVEC) treated with the 
inhibitor EDIN-B was compared to internalization in untreated control cells. This should also 
confirm the results from above (see 3.3.6) where inactivation of Rho by transfection of the 
Rho GDI-like domain (YopO399-729) had no effect on YadA-mediated internalization. 
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FIGURE 25. RhoA inhibition by EDIN-B does not inhibit YadA-mediated internalization. 
a) Image series showing F-actin staining (left) and outside/inside staining (right) of endothelial cell 
(HUVEC) treated with EDIN-B. Green channel with FITC –phalloidin staining (left) showing F-actin 
disruption due to inactivation of RhoA by EDIN-B. Channel merge on the right shows cortical F-actin 
(green), attached extracellular YadA-E. coli (red) and internalized YadA-E. coli (blue). The bar represents 
10 µm. N marks the nucleus. 
b) Statistical evaluation of YadA-E. coli (DH5A-pBR-A1) internalization in untreated endothelial cells 
(HUVEC, control) and EDIN-B treated cells. Uptake is shown as the percentage of total cell associated 
bacteria that is intracellular Values are mean ± S.D. of 3 experiments with at least 90 cells evaluated per 
experiment. 
 
Inhibition of RhoA in evaluated cells was visible through disruption of cytoplasmic F-actin 
structures. These cells were only visible by cortical F-actin staining (figure 25a, left frame). 
YadA-mediated internalization was not inhibited in HUVEC treated with EDIN-B. Uptake in 
cells with disrupted stress fibers is visualized by double fluorescence staining in figure 25a 
(right frame). Internalized YadA-E. coli (blue staining) can be distinguished from 
extracellular YadA-E. coli stained in red. 
Statistical evaluation of internalization showed no inhibitory effect of EDIN-B treatment. 
Endothelial cells (HUVEC) that showed F-actin disruption due to the inhibition of RhoA 
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showed 58 ± 2% internalization compared to 57 ± 7% internalization in control cells 
(figure 25b). 
These data show that inhibition of Rho by EDIN-B does not inhibit YadA-mediated 
internalization. GFP-YopO and EDIN-B inhibition of RhoA becomes apparent in the 
disruptive effect on F-actin. Because GFP-YopO is able to inhibit YadA-mediated uptake and 
EDIN-B is not, the target RhoA seems not to be crucial for the inhibitory effect of YopO on 
YadA-mediated phagocytosis. 
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D. DISCUSSION 
Kinase activity of YopO 
Bacterially produced YopO is not autophosphorylated and the role of auto-activation 
dependent on G-actin is unclear. One explanation for the exclusive activation only in the 
presence of G-actin is that Yersinia is protected from possible toxic effects of YopO. The 
absence of G-actin in the bacterial cytoplasm ensures activation of YopO only inside the 
mammalian host cell. A more complex explanation for the activation of YopO by G-actin 
takes into account the local subcellular G-actin concentration at the designated site of YopO 
action. Kinase activation might not only be regulated by an “all or none”-mechanism, but can 
be thought to be regulated at a higher degree depending on the local G-actin concentration. In 
this model YopO would sense G-actin concentration and fulfill its kinase function 
accordingly. Besides the cytoskeletal role of actin in cellular motility and phagocytosis, it has 
been identified as an important cofactor for RNA polymerases and additionally to regulate the 
localization and activity of transcriptional co-activators. The myocardin-related serum 
response factor (SRF) coactivator MAL associates with and is regulated by G-actin. 
Depending on the concentration of unpolymerized actin the coactivator MAL is targeted to 
the nucleus to act together with the transcription factor SRF to promote the transcription of 
growth-factor-regulated immediate-early genes (Miralles, Posern et al. 2003; Visa 2005). 
YopO has not been observed to target to the nucleus, but to the host cell membrane where it 
could phosphorylate target proteins dependent on the local G-actin concentration at sites 
important during Yersinia infection. An interesting site during Yersinia infection is the site of 
bacterial attachment where translocation of effector proteins via the injectisome occurs. 
Translocation of effector proteins from the bacterial cell through the host cell membrane is 
not accompanied by leakage of cytoplasmic proteins. The regulation of the injectisome-
formed translocation pore was shown to be influenced by the injected effector YopE (Viboud 
and Bliska 2001). The GTPase-downregulating function of YopE is involved in preventing 
the cytotoxic pore-forming activity of the type III secretion system. The role for YopO in the 
regulation of this highly tuned system has not been examined. It could also be necessary and 
important for Yersinia to efficiently target a cellular substrate by a mechanism that involves 
dynamic regulation of YopO activity by G-actin. 
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Morphological effects of YopO 
In this work the C-terminal GDI-like domain of YopO was shown to be responsible for F-
actin disruption in host cells. F-actin disruption is independent of kinase activity and actin 
binding in YopO. A recent publication solved the crystal structure of a YpkA-Rac1 complex 
and finds that YpkA mimics host guanidine nucleotide dissociation inhibitors of Rho GTPases 
(Prehna, Ivanov et al. 2006). YpkA was shown in vitro to lock the small GTPases RhoA and 
Rac1 in the GDP bound, or physiologically “off”, conformation and cell experiments show 
the disruptive role of the YpkA GDI-like domain. The data on YpkA support the results from 
YopO obtained in this study. Here it is additionally shown that the constitutive active 
RhoAV14 can rescue F-actin disruption caused by the GDI-like domain of YopO. In contrast 
to sequestration of endogenous RhoA, sequestration of RhoAV14 by YopO is not sufficient to 
block activation of effector proteins. This indicates that RhoA inactivation by YopO 
mechanistically is not achieved by displacement of RhoA from its site of action, but by 
(additional) inhibition of the GEF-induced activation of RhoA. Otherwise the interaction of 
RhoAV14 with effector proteins would also be blocked by displacement mediated by the Rho 
GDI-like domain of YopO. Although GDI can bind to the GDP- and GTP bound forms of 
Rho GTPases, it clearly prefers the GDP-bound form. This binding preference was shown for 
the interaction of YpkA with RhoA (Dukuzumuremyi, Rosqvist et al. 2000). 
Rounding/arborization was shown here to be induced by the kinase activity of YopO, which is 
dependent on the presence of N- and C-terminal domains. Compared to the wild-type protein 
the kinase-dead point mutant YopOD267A/K269A caused significantly less rounding but 
similar F-actin disruption. N- and C-terminal truncations were unable to produce rounding at 
the level of wildtype YopO. The critical amino acids in YpkA responsible for GDI-like 
interaction with RhoA and Rac1 have been identified as Tyr591, Asn595 and Glu599 (Prehna, 
Ivanov et al. 2006). With this data a corresponding full length YopO mutant could be 
generated that will allow examination of YopO kinase activity without functional interference 
of the GDI-like domain. Isolated effects of the kinase activity on the actin cytoskeleton, cell 
morphology and cellular targets should be possible to examine with this mutant protein that 
shows intact three-dimensional protein structure. 
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Role of YopO in Fcγ-R- and CR-mediated phagocytosis 
Transient expression of YopO in primary monocyte-derived macrophages is neither able to 
inhibit RhoA-dependent complement receptor-(CR)-mediated phagocytosis, nor Rac1 
dependent Fcγ-receptor-mediated phagocytosis. Modulation of immune cell responses such as 
chemotaxis and phagocytosis were earlier shown to be influenced by other Yop effectors that 
target Rho GTPases (Cornelis and Wolf-Watz 1997; Aepfelbacher and Heesemann 2001; 
Juris, Shao et al. 2002). Inhibition of Rac and Rho by dominant negative GTPase mutants 
leads to reduced Fcγ-receptor and CR-receptor-mediated phagocytosis, respectively, in CHO 
cells (Caron and Hall 1998). Inhibition of Rho by YopO was evident in stress fiber disruption 
in endothelial cells, but did not result in significant Fcγ-R/CR3-mediated phagocytosis 
inhibition in primary macrophages. Potentially the mild Rho-inhibitory effect due to 
sequestration by a GDI-like activity does not suffice for blocking Rho activation in the 
context of phagocytosis. Comparing Fcγ-receptor and CR-mediated phagocytosis a slight 
inhibition of the Rho-dependent CR-mediated internalization by YopO could be observed, but 
during several independent experiments we did not find any statistically significant difference 
based on a 1% level of significance. 
Formation of F-actin cups at the site of Fcγ-receptor-mediated phagocytosis was not disturbed 
upon expression of YopO in primary macrophages. In line with the results for the Fcγ-
receptor-mediated uptake, this indicates that YopO does not sufficiently inactivate Rac during 
this specific phagocytosis mechanism. 
 
Invasin-mediated internalization 
Efficient invasin-mediated uptake was shown in non phagocytic cultured cell lines like HeLa 
(human epithelial), COS-1 (monkey kidney) and was also characterized in macrophages 
earlier (Isberg and Barnes 2001; Wiedemann, Linder et al. 2001).  Endothelial cells used in 
this study (HUVEC and HBMEC) showed efficient bacterial internalization triggered by 
invasin. In macrophages inhibition of Rho, Rac or Cdc42 leads to reduced formation of 
Invasin-induced phagocytic cups indicating that the uptake mechanism might employ all of 
the three Rho GTPases (Wiedemann, Linder et al. 2001).  
In contrast to the dominant negative GTPase mutant RacN17, YopO was neither able to 
inhibit Invasin-bead internalization, nor able to block Invasin-bead induced actin-cup 
formation in endothelial cells. Cells with apparent morphological signs of YopO activity 
showed effective Invasin-bead internalization. Obvious RhoA-dependent effects of YopO 
were visible in stress fiber disruption, but apparently YopO was unable to block Rho GTPase 
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activation upon stimulation by integrin-mediated signals. This points to incomplete blocking 
of Rho and Rac or an activity of YopO that goes beyond inhibition of Rho and Rac.  
Invasin plays an important role in the initial step of infection when the enteropathogenic 
yersiniae are translocated through the M cells in the small intestine. Invasin that is repressed 
at host-temperature (37 °C) is thought to play a minor role in the later stages of infection. 
Therefore the inhibition of Invasin-mediated phagocytosis would not be the primary object in 
the survival strategy of enteropathogenic yersiniae. 
 
YadA mediated internalization 
In later stages of disease, when Yersinia enterocolitica persists in the hostile environment of 
lymphatic tissue, mouse experiments indicate that the adhesive surface protein YadA plays a 
crucial role (Kapperud, Namork et al. 1987; Pepe, Wachtel et al. 1995). In addition to 
conferring resistance to serum the YadA protein is also able to trigger phagocytosis. In 
HUVEC, this matrix-dependent internalization mediated by YadA was significantly slower 
than that triggered by invasin. The endothelial cell line HBMEC that was used to study 
Invasin-bead uptake showed attachment of YadA-E. coli but very low internalization for 
unidentified reasons (not shown). The low-invasion phenotype of Y. enterocolitica YadA was 
also reported for HEp-2 cells (Heise and Dersch 2006). In contrast, primary endothelial cells 
(HUVEC) showed efficient YadA-mediated internalization and were therefore used to study 
YadA-mediated uptake under the influence of heterologous expression of YopO. 
Internalization in HEp-2 cells, described for the Yersinia pseudotuberculosis YadA protein, is 
dependent on fibronectin, whereas Yersinia enterocolitica YadA–mediated uptake observed in 
this work occurred also in the absence of fibronectin. The Y. pseudotuberculosis YadA-uptake 
domain is not present in the YadA protein used in this study. Therefore an alternative matrix-
dependent internalization mechanism can be inferred. Here, collagen as a matrix protein that 
is strongly bound by Y. enterocolitica YadA could serve as an alternative bridging molecule 
to target cellular integrin receptors. Detailed information on the ECM-binding sites of YadA 
is still missing. However, an approach that studied crystallographic data of the YadA-trimer 
structure showed that collagen binding of Yersinia enterocolitica YadA is very sensitive to 
conformational changes of 3D-trimer structure and that the collagen triple helix makes several 
surface contacts on two YadA-monomers within the head domain (Nummelin, Merckel et al. 
2004). YadA-mediated internalization is little characterized in regard to the cellular receptors 
and their subsequent intracellular signaling. Whether the two Yersinia species only target 
different extracellular matrix proteins or also trigger different intracellular signaling events is 
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unknown. Proteins involved in YadA-induced signaling have only been roughly described for 
cytokine induction (Schmid, Grassl et al. 2004). Inhibitor studies showed that the signaling 
cascade induced by YadA or invasin that leads to IL-8 secretion, involves β1-integrins, Rho 
GTPases and MAP kinases (MEK1, JNK, p38). Studies of the intracellular signaling cascades 
specifically involved in matrix-dependent YadA-mediated uptake have not been performed.  
Yersinia enterocolitica YadA-specific internalization is significantly reduced by 50% by 
YopO. Kinase-deficient YopO mutants that retained the ability to reduce Rho-dependent F-
actin fibers lost their ability to interfere with YadA-mediated uptake. Specific inhibition of 
Rho by EDIN-B had no influence on YadA-mediated uptake. This points to an unidentified 
YopO kinase target that plays a role in this specific phagocytosis-mechanism. The Rho 
inactivating GDI-like domain does not seem to play a role in this specific inhibition, although 
a potential role for the GDI-like domain in targeting the YopO kinase to its unidentified 
substrate can not be ruled out. To answer the question of the role of the GDI-like domain in 
targeting the YopO kinase a contact-site mutant (Prehna, Ivanov et al. 2006) with retained 
kinase activity and membrane targeting will have to be established. The role of the N-terminal 
membrane localization domain in targeting the active kinase to its potential substrate will also 
have to be addressed.  
The YopO kinase does not interfere with YadA-mediated uptake simply by inhibition of F-
actin polymerization at the site of bacterial internalization. Formation of actin cups at the site 
of YadA-E. coli attachment was clearly detectable, although the dynamics of F-actin 
formation at the sites of bacterial internalization was not examined. Here YopO could play a 
role in disturbing the actin dynamics involved, thus leading to impairment of the matrix-
dependent internalization process. The first recently identified YopO kinase target Otubain1 is 
unlikely to play a role in the inhibition of YadA-mediated internalization. Otubain1 is a 
cytoplasmic ubiquitin-specific cysteine protease that cleaves only isolated branched 
polyubiquitin chains in vitro and was characterized to regulate polyubiquitination and stability 
of GRAIL (gene related to anergy in lymphocytes), a RING-type E3 ligase that is involved in 
the regulation of immune responses during infection (Balakirev, Tcherniuk et al. 2003; 
Mueller 2004; Juris, Shah et al. 2006). This newly identified kinase target that regulates T cell 
growth factor production and proliferation implicates a function of YopO in 
immunomodulation. The role of the actin-binding activity and the Rho GDI-like domain of 
YopO in regulating Otubain1 phosphorylation has not been investigated. How these activities 
of YopO contribute to phosphorylation of Otubain1 and further how Otubain1 can influence 
Yersinia infection has not been explored. 
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The property of YopO to localize to the cytoplasmic membrane, the Rho GDI-like activity 
and the ability of YopO to interfere with YadA-mediated uptake give reason to speculate for 
at least one additional target of the YopO kinase. It would be reasonable to suspect a kinase 
target that has a function in the field of phosphorylation-state dependent outside-in signal 
transduction, especially in the regulation of (Rho-) GTPase and actin-dependent signaling 
processes. A large part of the cellular effects of YopO that have been observed are mainly 
induced by the Rho GDI-like domain of YopO. Targets of the only presently known kinase 
that is regulated by actin are starting to get discovered and YopO could serve as model for yet 
unidentified actin-regulated cellular kinases. 
Because Yersinia kinase activity of YopO is relevant in vivo considering the loss in mouse 
virulence in YopO kinase-deficient mutants (Galyov, Hakansson et al. 1993; Wiley, 
Nordfeldth et al. 2006), studies investigating the phosphorylation of cellular substrates by the 
serine/threonine kinase YopO in the context of Rho- and actin-binding will have to bring 
answers to the question of how this essential effector protein contributes to the complex 
immunomodulatory manipulation of host cells by Yersinia. 
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E. MATERIALS AND METHODS 
1. EQUIPMENT AND MATERIAL 
1.1 Equipment 
1.1.1 Laboratory Equipment 
Table E3. Laboratory Equipment 
Laboratory Equipment  
Casette for film exposure Rego 
Centrifuge Sigma, Deisenhofen 1K1S, Table-centrifuge 
3K30 with Rotor Nos. 12156 and 19776;  
Eppendorf table centrifuge 5417 C/ 5417 R 
Biofuge A, Heraeus Sepatech, Osterode, 
Germany 
Electrophoresis/Agarose Gel chamber Agagel, Biometra, Goettingen, Germany 
Electrophoresis/SDS-PAGE  Bio-Rad, München Mini-Protean -II Cell and 
Western Blot Apparatus 
Mini-Protean 3, Bio-Rad Laboratories 
Hoefer SE 400, Amersham Biosciences 
French Press  French Pressure Cell 40K SLM Aminco  
Gel Dryer BioRad, Munich, Germany 
Glass coverlips, round (12 mm diameter) Hartenstein GmbH, Wuerzburg, Germany 
Incubator Heraeus, BBD 6220, Hanau Typ B20  
Incubator (shaking) Thermomixer compact, Eppendorf, Hamburg, 
Deutschland 
Microinjection and Femtotips Transjector 5246 und Micromanipulator 5171, 
Eppendorf, Hamburg, Deutschland 
Microscope (binocular) Carl Zeiss, Axiovert 25 
Microscope slides Marienfeld GmbH, Lauda-Königshofen, 
Germany 
Microwave AEG 
PCR-Cycler  PE Applied Biosystems, Weiterstadt Gene 
Amp 2400 
pH Meter  Mettler, Toledo 320 pH Meter  
Phosphoimager FLA 3000 Fujifilm, Tokyo, Japan 
Photometer Pharmacia Biotech, Ultraspec 3000 
Pipettes  Eppendorf, Hamburg Research P10-P1000 
Pipetman (10, 20, 200 und 1000 µl), Gilson 
International B.V., DenHaag, The Netherlands 
Power supply Bio-Rad, Power Pac 200 
Processor for X-ray film development Agfa Curix 60 
Refrigerator Liebherr, profi line 
Scale  Sartorius, Göttingen Model R 160P and Pt 
1200  
Scanner ScanJet 4c/ScanJet 5470c Hewlett Packard 
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Thermocycler PCR Perkin Elmer, Gene Amp PCR System 2400 
Transilluminator  Heralab, Wiesloch, UVT-20M/W  
Tweezers NeoLab Heidelberg, Germany 
Ultracentrifuge Beckmann, Optima T2 Ultracentrifuge 
UV-Transilluminator Herolab, E.A.S.Y., UVT-20M/W 
Vacuum blot  Pharmacia,-LKB, Uppsala, LKB 2016 Vacu 
GeneR-Chamber  
Video-equipment  Sigma, Deisenhofen, EASY (Enhanced 
Analysis System)  
Vortexer ProScientific, Oxford, USA 
Water bath GFL Typ 1013; GFL, Burgwedel, Germany 
 
1.1.2 Microscopical Equipment 
In order to observe specimen by fluorescence-, brightfield- or phasecontrast-microscopy, two 
microscopic settings were used. For evaluation of morphological effects and phagocytosis a 
non-confocal setup, for evaluation of subcellular localization a confocal setup was employed.  
Non-confocal setups for fluorescence and phasecontrast microscopy: 
Leica DM IRE2 microscope equipped with 63x (oil, NA 1.4, phasecontrast) and 100x (oil, 
NA 1.4, phasecontrast ) objectives with mercury lamp and filters for blue (365/460nm), red 
(570/603nm) and green (488/505nm) and a SPOT SLIDER camera system (Diagnostic 
Instruments, Sterling Heights, USA). 
Zeiss Axioplan microscope equipped with 40x (oil, NA 1.3), 63x (oil, NA 1.4) and 100x (oil, 
NA 1.4) objectives with mercury lamp and filters for blue (365/460nm), red (570/603nm) and 
green (488/505nm) and a SPOT 1.4MP camera system (Diagnostic Instruments, Sterling 
Heights, USA). 
Confocal setup: 
Leica DMIRE2 automatic microscope equipped with 63x (water, NA1.3), 63x (oil, NA 1.4) 
objectives and a Leica TSC SP2 AOBS filter free confocal point scanner with Ar (458nm, 
488nm, 496nm, 514nm) and HeNe (633 nm) laser lines. The confocal setup was used with 
green (488/505nm), red (570/603nm) and far red (633/680nm) staining.  
 
Images were further viewed and processed using ImageJ software (Research Services Branch, 
NIMH), Adobe Photoshop, Volocity software (Improvision, Coventry, England) and Leica 
LCS Lite software (Leica Microsystems, Wetzlar, Germany). 
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1.2 Chemicals and Enzymes 
1.2.1 Chemicals and antibiotic solutions 
All chemicals and antibiotics were supplied by Amersham/GE Healthcare (Munich, 
Germany), Biozym (Oldendorf, Germany), Dianova (Hamburg, Germany), Fermentas (St. 
Leon-Rot, Germany), Invitrogen (Karslruhe, Germany), Merck (Darmstadt, Germany), Roche 
(Mannheim, Germany) and Sigma-Aldrich (Munich, Germany). 
Table E4. Antibiotic solutions 
antibiotic solutions   
 abbreviation 
dissolved 
in 
final 
concentration 
µg/ml 
Ampicillin Amp H2Odd 
100 (E. coli), 
400 (Yersinia) 
Kanamycin Kan H2Odd 100 
Nalidixic acid Nal 
0.5 N 
NaOH 35 
Chloramphenicol Cm 70 % EtOH 20 
Streptomycin Sm H2Odd 100 
Tetracycline Tet 70 % EtOH 15 
Gentamicin Gen H2Odd 50 
1.2.2 Kits and Enzymes 
Table E5. Kits and Enzymes 
Kits  
name supplier 
ECL Western blotting detection reagents  Amersham Biosciences, Freiburg, Germany 
Plamid Miniprep Kit Qiagen GmbH, Hilden, Germany 
EndoFree Plasmid Maxi Kit Qiagen GmbH, Hilden, Germany 
QIAquick Gel Extraction Kit  Qiagen GmbH, Hilden, Germany 
QIAquick PCR Purification Kit Qiagen GmbH, Hilden, Germany 
Quiaprep spin Miniprep Kit Qiagen GmbH, Hilden, Germany 
QuickChangeII Site Directed Mutagenesis Kit Stratagene, Amsterdam, The Netherlands 
HUVEC Nucleofection Kit Amaxa, Cologne, Germany 
Nuceofection solution nr.6857 for primary 
macrophages Amaxa, Cologne, Germany 
Complete Protease Inhibitor Cocktail Tablets Roche, Mannheim, Germany 
Alligator Quick Ligation Kit Genaxxon GmbH, Biberach, Germany 
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Enzymes  
name supplier 
Age I New England Biolabs/Fermentas  
BamHI New England Biolabs  
Bgl II New England Biolabs/Fermentas  
Eco RI New England Biolabs/Fermentas  
Hind III New England Biolabs  
Sal I New England Biolabs  
Xho I New England Biolabs/Fermentas  
DeepVent DNA-Polymerase New England Biolabs  
T4 DNA-Ligase Roche Diagnostics 
TripleMaster PCR System Eppendorf 
AmpliTaq Applied Biosystems 
AmpliTaq Gold Applied Biosystems 
1.3 Bacterial strains and plasmids 
1.3.1 Bacterial strains  
Table E6. Bacterial strains 
strain genotype/description reference 
E. coli   
DH5A 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZ∆M15 ∆(lacZYA-
argF)U169, hsdR17(rK- mK+), λ– Hanahan 1985 
BL21 
 
F– ompT gal dcm lon hsdSB(rB- mB-) λ Studier & Moffat, 1986 
BL21-Inv397 
pGEX-4T-3-pINV397; protein 
expression/purification Wiedemann et al. 2001 
M15-EDIN-B 
His-tagged EDIN-B protein 
expression/purification Motoyuki Sugai 
DH5A-pBR 
DH5A with pB8-5 low-copy-number vector 
coding for VirF (Tet resistance) Roggenkamp et al. (1995) 
YadA-E.coli/ 
DH5A-pBR-A1 
YadA-E.coli; DH5A-pBR with pUC-A1 (YadA 
from Y. enterocolitica O:8 full length, GenBank 
accession no. X13881,  Amp resistance) pB8-5 
low-copy-number vector coding for VirF (Tet 
resistance) Roggenkamp et al. (1995) 
HB101/ 
HB101inv- 
F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 
ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 
rpsL20(SmR) glnV44 λ- 
Bolivar & Backman, 1979, 
Schulte, Zumbihl, et al. 
(1998). 
Invasin-E.coli/ 
HB101inv+ 
Invasin-E.coli; HB101 carrying pInv1914; 
constitutively expressing invasin on bacterial 
surface 
Schulte, Zumbihl, et al. 
(1998). 
Yersinia enterocolitica  
WA-P 
WA-314 O:8 with pYVO8 virulence plasmid, 
biogroup 1B, intrinsic Nalidixin resistance Heesemann 1987 
WA-C plasmid cured WA-314 Heesemann 1987 
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1.3.2 Plasmids 
Table E7a. Plasmids for bacterial and mammalian expression 
plasmid description reference 
bacterial expression   
pUC-A-1 
pUC13 with insertion of 5 kb EcoRI-HindIII fragment 
from pYVO8, including the yadA gene (Amp 
resistance) 
Roggenkamp 
et al. (1995) 
pB8-5 
vector with 5-kb BamHI fragment of pYVO8 
encoding VirF in the low-copy-number vector 
pRK290B (Tet resistance) 
Roggenkamp 
et al. (1996) 
GST-Inv397 
pGEX-4T-3-pINV397, GST-Invasin procaryotic protein 
expression for in vitro use 
Wiedemann et 
al. 2001 
pInv1914 
invasin coding sequence under control of lpp-promotor 
of pNIV136 expression vector; constitutive invasin 
expression in bacterial outer membrane (Amp 
resistance) 
Schulte, 
Zumbihl, et al. 
(1998). 
"Wortmannin…
pGEx-4T-1 prokaryotic protein expression, empty vector Amersham 
pGex4T-2 prokaryotic protein expression, empty vector Amersham 
mammalian expression   
pEGFP-N-1 
mammalian expression vector; enhanced green 
fluorescent protein; MCS N-terminal of GFP BD Clontech 
pEGFP-C1 
mammalian expression vector; enhanced green 
fluorescent protein; MCS C-terminal of GFP BD Clontech 
pmRFP-N1 
mammalian expression vector; monomeric red 
fluorescent protein; MCS N-terminal of mRFP This study 
pCDNA3.1 mammalian expression vector Invitrogen 
GFP-RhoAV14 
mammalian expression of constitutive active 
RhoA(V14/N25) B. Schroder 
GFP-RacN17 mammalian expression of dominant negative RacN17 B. Schroder 
 
Plasmids for bacterial expression of YopO 
The GST gene fusion system (Amersham/GE Healthcare, Munich, Germany) is an integrated 
system for the expression, purification and detection of fusion proteins produced in E. coli. 
The pGEX plasmids supplied with the system are designed for inducible, high-level 
intracellular expression of genes or gene fragments as fusions with Schistosoma japonicum 
GST (Glutation-S-Transferase). GST occurs naturally as a 26 kDa protein that can be 
expressed in E. coli with full enzymatic activity. Fusion proteins are easily purified from 
bacterial lysates by affinity chromatography using Glutathione Sepharose 4B (Amersham 
Biosciences/GE Healthcare, Munich, Germany). In this study N-terminally GST-tagged 
YopO fusions were constructed and purified. 
The pGex-4T vectors encode the recognition sequence for site-specific cleavage by thrombin 
between the GST domain and the multiple cloning site. For biochemical analysis mutant 
GST-YopO fusion proteins were constructed: This includes N-and C-terminal deletion 
mutants and amino acid substitution mutants (see mutagenesis). The FLAG-YopO fusion 
proteins were a generous gift from Juris and Dixon (University of Michigan, USA). YopO 
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was amplified from pYV (from the WA-P strain) and sequence identity to the published 
sequence on pYV8081 (accession number NP_863565) was verified. 
Table E7b. Plasmids for bacterial expression 
plasmid  description reference 
FLAG-YopO-fusions     
YopO1-729 pGEX-6p-2 
Juris and 
Dixon (2000) 
YopO1-729K269A pGEX-6p-2 
Juris and 
Dixon (2000) 
GST-YopO-fusions     
YopOwt pGex-4T-1 with wild type YopO1-729 (full length)  
N-terminal truncations   
YopO89-729 pGex-4T-1 with YopO89-729, (soluble protein) This study 
YopO151-729 pGex-4T-1 with Yop151-729 This study 
YopO399-729 pGex-4T-1 with Yop399-729 This study 
YopO441-729 pGex-4T-1 with Yop441-729 This study 
YopO541-729 pGex-4T-1 with Yop541-729 This study 
YopO700-729 pGex-4T-1 with Yop700-729 This study 
C-terminal truncations   
YopO89-398 pGex-4T-1 with Yop89-398 This study 
YopO89-440 pGex-4T-1 with Yop89-440 This study 
YopO89-710 pGex-4T-1 with Yop89-710 This study 
YopO151-440 pGex-4T-1 with Yop151-440 This study 
point mutants YopO89-729   
D267A/K269A pGex-4T-1 with Yop89-729D267A/K269A This study 
S95A pGex-4T-1 with Yop89-729S95A This study 
S102A pGex-4T-1 with Yop89-729S102 This study 
T89A/S95A pGex-4T-1 with Yop89-729T89A/S95A This study 
S90A/S95A pGex-4T-1 with Yop89-729S90A/S95A This study 
D267A/K269A/S90A/S95A pGex-4T-1 with Yop89-729D267A/K269A/S90A/S95A This study 
 
Plasmids for mammalian expression of YopO 
Expression of GFP-YopO fusion proteins was accomplished by insertion of the respective 
YopO fragments into vectors suitable for mammalian expression. FLAG-tagged YopO was 
expressed from pCDNA3.1 carrying the yopO gene (generous gift from Juris and Dixon, 
University of Michigan, USA) and GFP-tagged YopO was expressed from eukaryotic 
expression vectors pEGFP-C1 and pEGFP-N1 (BD Clontech, Mountain View, USA) carrying 
the yopO gene. 
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pEGFP carries a red-shifted variant of wild-type green fluorescent protein (GFP) which has 
been optimized for brighter fluorescence and higher expression in mammalian cells 
(excitation maximum = 488 nm; emission maximum = 507 nm).The multiple cloning site 
(MCS) in pEGFP-C1 is between the EGFP coding sequences and the SV40 poly A. Genes 
cloned into the MCS will be expressed as fusions to the EGFP C-terminus. Genes cloned into 
the MCS of pEGFP-N1 will be expressed as fusions to the N-terminus of EGFP. 
Table E7c. Plasmids for mammalian expression 
plasmid  description reference 
pCDNA3.1-FLAG-
YopOK269A FLAG-YopO8-729K269A 
Juris and 
Dixon (2000) 
mRFP-YopO C-terminal fusion YopO-mRFP This study 
GFP-YopO fusions     
YopOwt (N1) N-terminal fusion YopO1-729-EGFP This study 
YopOwt (C1) C-terminal fusion EGFP-YopO1-729 This study 
N-terminal truncations   
YopO89-729 EGFP-YopO89-729 in pEGFP-C1 This study 
YopO399-729 EGFP-YopO399-729  in pEGFP-C1 This study 
C-terminal truncations   
YopO1-710 EGFP-YopO1-710  in pEGFP-C1 This study 
YopO1-440 EGFP-YopO1-440  in pEGFP-C1 This study 
YopO89-440 EGFP-YopO89-440  in pEGFP-C1 This study 
point mutants YopO1-729   
D267A/K269A EGFP-YopO1-729D267A/K269A  in pEGFP-C1 This study 
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1.3.3 Invasin surface-expression and adhesion of Invasin-E. coli (HB101inv+)  
Heterologous expression of the inv gene of Y. enterocolitica O:9 is achieved in Invasin-E. coli 
(HB101inv+). The noninvasive E. coli HB101 (HB101inv-) strain was engineered to express 
Y. enterocolitica invasin on its surface as described by Schulte et al. (1998). Invasin surface 
expression in the non-invasive E. coli HB101 leads to specific interaction of this strain with 
eukaryotic cell receptors (Schulte and Autenrieth 1998; Schulte, Zumbihl et al. 1998; Grassl, 
Bohn et al. 2003). 
For adhesion and uptake experiments, overnight cultures were diluted 1:20, bacteria were 
grown for 3 hours in LB at 37 °C, were collected by centrifugation and washed twice in sterile 
cold phosphate-buffered saline (PBS) pH 7.4. After measurement of the OD, appropriate 
dilutions of the bacteria in PBS were performed. Bacteria were added to the cells at a ratio of 
bacteria/cell = 20-60/1. 
Expression of Invasin was controlled by SDS/PAGE – Western Blot in bacterial lysates and 
by fluorescence staining of the bacterial surface. For detection of invasin the primary α-
invasin antibody (rabbit IgG) was used. 
Invasin expression in HB101inv+ is illustrated in figure E1a. Immunofluorescence labeling of 
invasin shows expression on the bacterial surface. 
 
FIGURE E1a. Invasin surface expression in Invasin-E. coli 
Invasin-E. coli (HB101inv+) attached to endothelial cells (HBMEC) visualized by 
immunofluorescence staining (left) with anti-Invasin antibody. Phasecontrast (right) shows 
endothelial cells and attached Invasin-E. coli (HB101inv+). The bar represents 10 µm. 
α-Invasin phasecontrast
FIGURE E1a.
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FIGURE E1b. Adhesion of Invasin-E. coli and control strain HB101inv- 
Invasin-E. coli  (HB101inv+) and control strain (HB101inv-) were attached to endothelial cells. After 
washing and fixation adhesion on endothelial cell surface was visualized by phasecontast: For Invasin-
E.coli (left) many adhered bacteria can be seen. The parental control strain HB101inv- (right) shows no 
adhesion to cell surface. The bar represents 10 µm. 
 
Attachment of HB101inv+ and the invasin-negative control strain (HB101inv-) is illustrated 
in figure E1b. The parental strain HB101inv- shows no adhesion in contrast to Invasin-E. coli 
(HB101inv+). 
 
Invasin-E.coli HB101 inv-
FIGURE E1b. 
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1.3.4 YadA surface-expression and adhesion of YadA-E. coli (DH5A-pBR-A1) 
The E. coli DH5A strain expressing YadA from Yersinia enterocolitica O8 (GenBank 
accession no. X13881) was engineered and described in detail by Roggenkamp et al. (1996). 
In summary, the non-adhesive E. coli DH5A was engineered to incorporate YadA in the outer 
membrane by introducing a plasmid coding for YadA (pUC-A1) and a low-copy-number 
vector (pB8-5) coding for the YadA transcriptional activator VirF.  
The production of YadA in YadA-E. coli (DH5A-pBR-A1) was verified by SDS/PAGE – 
Western Blot and by immunofluorescence staining. For detection of YadA the primary α-
YadA antibody 9H11 was used. 
 
FIGURE E2. YadA surface expression and adhesion of YadA-E. coli and control strain DH5A-pBR. 
a) YadA-E. coli  (DH5A-pBR-A1) were attached to coverslips and stained with anti-E. coli antibody (left) and 
anti-YadA antibody (right). Phasecontrast image (middle) shows attached bacteria. 
b) YadA-negative parental control strain (DH5A-pBR) was attached to coverslips and stained with anti-E. coli 
antibody (left) and anti-YadA antibody (right). Phasecontrast image (middle) shows low attachment of bacteria. 
The control strain DH5A-pBR is not detected by YadA staining (right). The bar represents 10 µm.
E. coli phasecontrast YadA
YadA-E. coli (DH5A-pBR-A1)
E. coli YadA
DH5A-pBR (yadA-)
phasecontrast
FIGURE E2
a
b
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Immunofluorescent staining shows expression of YadA on the surface of YadA-E. coli 
(DH5A-pBR-A1, figure E2a) and specificity of the YadA antibody for the YadA epitope. The 
YadA-negative parental strain (DH5A-pBR) shows no detectable expression of YadA (figure 
E2b). 
 
1.3.5 Antibodies for Western and Immunofluorescence 
Table E8. Antibodies 
primary antibodies  
anti- species supplier 
actin MAB1501; anti-aktin mouse  Chemicon/Millipore 
SRBC rabbit IgG ICN Pharmaceuticals 
SRBC rabbit IgM 
WAK-Chemie Medical 
GmbH 
Invasin rabbit IgG (1:500) Schulte et al. (2000) 
YadA mouse IgG (1:200); 9H11 (aa29-81 YadA) Roggenkamp et al. (1995) 
GST rabbit IgG Molecular Probes 
YopO rabbit polyclonal Barz et al. (2000) 
E. coli rabbit IgG Biodesign Int. Maine, USA 
   
secondary antibodies  
anti-     
rabbit AlexaFluor® 488 IgG (H+L) goat (495/519nm) Molecular Probes 
rabbit AlexaFluor® 568 IgG (H+L) goat (578/603nm) Molecular Probes 
rabbit MarinaBlue® 365 IgG (H+L) goat (365/460nm) Molecular Probes 
rabbit Cy5 IgG (H+L) goat (650/670nm) Invitrogen 
rabbit IgG horseradish peroxidase goat Amersham-Biosciences 
mouse AlexaFluor® 488 IgG (H+L) goat (495/519nm) Molecular Probes 
mouse AlexaFluor® 568 IgG (H+L) goat (578/603nm) Molecular Probes 
mouse MarinaBlue® 365 IgG (H+L) goat (365/460nm) Molecular Probes 
mouse IgG horseradish peroxidase goat Amersham-Biosciences 
mouse Cy5 IgG (H+L) goat (650/670nm) Invitrogen 
rat AlexaFluor® 488 IgG (H+L) goat (495/519nm) Molecular Probes 
rat AlexaFluor® 568 IgG (H+L) goat (578/603nm) Molecular Probes 
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2. MOLECULAR BIOLOGY METHODS 
2.1 Digestion of DNA with Restriction Enzymes 
Restriction enzymes specifically bind to mainly palindromic recognition sites within a DNA 
molecule and cut it by hydrolyzing two phosphodiester bonds. Depending on the restriction 
enzyme “blunt” (no 5´or 3´ overhang) or “sticky” (5´and 3´overhangs) ends will be generated. 
The restriction enzymes were purchased together with their corresponding 5x or 10x buffers 
from NEB (New England Biolabs GmbH, Frankfurt, Germany), Invitrogen (Invitrogen 
GmbH, Karlsruhe, Germany) or Fermentas (Fermentas GmbH, St. Leon-Rot, Germany). 
Restriction enzyme digests were performed at temperatures recommended by the 
manufacturer (mostly 37 °C) in a thermo block or an incubator for 90 to 120 min. Usually 5 
units of enzyme were used to cut one microgram of DNA. The digestion was performed in the 
presence of an appropriate 10x buffer, BSA (10 mg/ml) and H2Odd, following the 
manufacturer’s directions. For double digestions the recommended buffers were used. 
 
2.2 Ligation of DNA fragments 
In order to ligate a vector DNA with the desired insert DNA, both cut with the same or 
compatible set of restriction enzymes, T4-DNA-ligase which catalyzes the formation of a 
phosphodiester bond between the 3’-OH and 5’-phosphate ends was applied. 
Ligation reaction: 
  
 Vector DNA  10 - 100 ng 
 Insert DNA  3 - 10x the molar amount of vector DNA 
 5x ligase buffer 4 µl 
 T4-DNA-ligase (1 unit/µl) 1 µl 
 ad 10-20 µl with H2Odd 
The ligation reaction was prepared in 1.5 ml reaction tubes and incubated overnight at 16 °C. 
 
Ligation using Alligator Ligation Kit 
For fast ligation of DNA-fragments the Alligator Ligation Kit was used (Genaxxon 
Bioscience GmbH, Biberach, Germany). Following the manufacturer’s instructions, vector 
and insert DNA was mixed with the two solutions provided and after 30 min of ligation the 
mix was added to competent cells for transformation. 
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2.3 Oligonucleotides/Primer 
Table E9. Oligonucleotides/Primer for cloning, sequencing and mutagenesis 
cloning into pGex4T-1/2   
name YopO site primer sequence 
YopO1-440 aa1 
5´- [GATCTGAATTCATGAAAATCATGGG]-3´ 
(sense oligonucleotide) 
YopO 1-710 aa8 
 5´- [ACAAGGACGACGGAATTCAGTCACCTTCG]-3´ 
(sense oligonucleotide) 
YopO 89-729 aa89 
5´-[CAGAAAACTGAATTCACTTCGCAGGAGCTAAGGTCTGATATCCCC] -
3´ (sense oligonucleotide) 
YopO 89-440 aa89 
5´- [GCCCAGGAATTCACTTCGCAGG]-3´ 
(sense oligonucleotide) 
YopO 151-729 aa151 
5´- [ATTAGTATAGAATTCACTAAGGATAAGCAGCGG TTGG] -3´ 
(sense oligonucleotide) 
YopO 399-729 aa399 
5´- [ACCTGATTCCGAATTCGCCAGACTCCACG] -3´ 
(sense oligonucleotide) 
YopO 441-729 aa441 
5´- [GATAACAGAATTCAAGCTTCGGGAGCTC] -3´  
(sense oligonucleotide) 
YopO 541-729 aa541 
5´- [GAA CCT GAA TTC CAG AGG ATC CAG] -3´  
(sense oligonucleotide) 
YopO 89-398 aa398 
5´- [TCGTGCTCGAGTCATTCGTTGGAATCAGG] -3´ 
(antisense oligonucleotide) 
YopO 1-440 aa440 
5´- [TCCCGCTCGAGTCACTTGGGTGTTATC]-3´ 
(antisense oligonucleotide) 
YopO 1-710 aa710 
5´- [TGGTTGTCAGCTCGAGTCACTTTTCTCTCTGTTCAACCA] -3´ 
(antisense oligonucleotide) 
YopO 441-729 aa729 
5´- [CTGCACTCGAGTCACATCCATTCCCG]-3´ 
(antisense oligonucleotide) 
   
cloning into pEGFP-C1   
name YopO site primer sequence 
YO-C1XhoF aa1 
5´- AT GCT CGA GGC ATG AAA ATC ATG GGA –3´ 
(sense oligonucleotide) 
N88YO-C1XhoF aa89 
5´- GCC CCT CGA GCT ACT TCG CAG –3´ 
(sense oligonucleotide) 
N150YO-C1XhoF aa151 
5´- AGT ACT CGA GAA ACT AAG GAT AAG CAG CGG-3´ 
(sense oligonucleotide) 
N398YO-C1XhoF aa399 
5´- AGA CCT GAT TCT CGA GAA GCC AGA CTC -3´ 
(sense oligonucleotide) 
d440YO-C1EcoR aa440 
5´- GAG CTC GAA TTC CTA CTT GGG TGT TAT CCG –3´  
(antisense oligonucleotide) 
d710YO-C1EcoR aa710 
5´- TGT CAG GAA TTC TCA CTT TTC TCT CTG -3´ 
(antisense oligonucleotide) 
YO-C1EcoRs aa729 
5´- GGC GAA TTC TCA CAT CCA TTC CCG CT –3´ 
(antisense oligonucleotide) 
   
cloning into pEGFP-N1   
name YopO site primer sequence 
YO-N1XhoF aa1 
5´- GAG CTC GAG ATG AAA ATC ATG GGA ACT –3´ 
(sense oligonucleotide) 
YO-N1EcoR aa729 
5´- G CCG AAT TCG CCA CAT CCA TTC CCG CT –3´ 
(antisense oligonucleotide) 
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Sequencing primer   
name annealing site primer sequence 
YopO internal sequencing primer   
YopO-P1 YopO aa186 
5`- AAA CAT CCT AAT CTT GCC –3´ 
(sense oligonucleotide) 
YopO-P2 YopO aa367 
5´- ATC GAC CTG GTA TAG CTG G –3´ 
(sense oligonucleotide) 
pGex vector sequencing primer   
GEX-F (GEX5)    
5´- CTTTGCAGGGCTGGCAAG -3´ 
(sense oligonucleotide) 
GEX-R(GEX3)  
5´- GAGCTGCATGTGTCAGAGG -3´ 
(antisense oligonucleotide) 
pEGFP-C1 vector sequencing primer   
EGFP-C1-F  
5´- GAAGCGCGATCACATGGTC -3´ 
(sense oligonucleotide) 
EGFP-C1-R  
5´- AACCATTATAAGCTGCAATAAAC -3´ 
(antisense oligonucleotide) 
pEGFP-N1 vector sequencing primer   
EGFP-N1-F  
5´- GAGGTCTATATAAGCAGAGC -3´ 
(sense oligonucleotide) 
EGFP-N1-R   
5´- ACTTGTGGCCGTTTACGTC -3´ 
(antisense oligonucleotide) 
   
Mutagenesis primer   
name mutation primer sequence 
D267A_K269A_Fw aa267+aa269 5´- GG ATA GTA CAT AAC GCA ATC GCA CCC GGT AAT GTG G -3´ 
D267A_K269A_R aa267+aa269 5´- C CAC ATT ACC GGG TGC GAT TGC GTT ATG TAC TAT CC -3´ 
YO-T89A_Fw aa89 5´-  GGA TCC CCG GAA TTC GCG TCG CAG GAG CTA AGG 
YO-T89A_R aa89 5´- CCT TAG CTC CTG CGA CGC GAA TTC AGG GGA TCC -3´ 
YO-S90A_Fw aa90 5´- GGA TCC CCG GAA TTC ACT GCG CAG GAG CTA AGG 
YO-S90A_R aa90 5´- CCT TAG CTC CTG CGC AGT GAA TTC CGG GGA TCC -3´ 
YO-S95A_Fw:  aa95 5'- CT TCG CAG GAG CTA AGG GCC GAT ATC CCC AAT GC  -3' 
YO-S95A_R aa96 5'- GC ATT GGG GAT ATC GGC CCT TAG CTC CTG CGA AG -3' 
YO-S102A_Fw aa102 5´- GG TCT GAT ATC CCC AAT GCT CTC GCG AAT CTC TTT GGA G -3´  
YO-S102A_R aa102 5'- C TCC AAA GAG ATT CGC GAG AGC ATT GGG GAT ATC AGA CC -3´ 
2.4 Agarose Gel Electrophoresis 
Agarose gels were prepared by mixing an appropriate proportion of agarose (to a final 
concentration of 0.7 - 2 % (w/v) depending on the MW of the sample DNA) with 1 x TAE 
buffer (40 mM Tris /Acetate, pH = 8.3, 10 mM EDTA), the mixture was cooked and after 
cooling poured into agarose gel chambers. The DNA was then mixed with loading buffer 
(30% (v/v) glycerol, 0.25% (w/v) bromphenole blue, 0.25% (w/v) Xylene blue), loaded on the 
gel and electrophoretically separated by application of voltage (50-120 V) utilizing the 1 x 
TAE solution as the running buffer. Following the electrophoretic run, gels were stained in 
ethidium bromide solution (1 µg ethidium bromide pro ml H2Odd) and the DNA visualized 
under ultraviolet light. For size markers the ready to load solutions “1kb ladder” and “1kbplus 
ladder” from Invitrogen (Karslruhe, Germany) were used. 
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2.5 Extraction of DNA from Agarose Gels 
To isolate DNA fragments from agarose gels, the desired DNA fragments were excised from 
the gel, weighed and extracted using the QIAquick Gel Extraction Kit (Qiagen, Hilden 
Germany) according to the protocol of the manufacturer. DNA concentration and purity grade 
was determined by measurement of OD260 nm and OD280 nm, respectively (Ultraspec 3000, 
Amersham Pharmacia Biotech). 
2.6 Preparation of Calcium-Competent Bacteria 
Calcium-competent cells (E. coli: DH5α, BL21) for heat shock transformation were produced 
according to a simplified method from Current Protocols (Ausubel et al., 2000) as follows: 
• 2 ml of an overnight culture was inoculated into 100 ml LB medium and incubated 
with vigorous shaking at 37 °C until an OD600 of 0.6 was reached 
• Cells were collected in 50 ml falcon tubes, cooled for 15 min on ice and centrifuged in 
a pre-cooled centrifuge (3000 g for 10 min at 4 °C) 
• cells were washed in 50 ml ice cold MgCl2 (100 mM) and incubated on ice for 30 
min, followed by centrifugation (at 3000 g for 10 min at 4 °C) 
• cells were washed in 50 ml ice cold CaCl2 (100mM) and incubated on ice for 30 min, 
followed by centrifugation (at 3000 g for 10 min at 4 °C) 
• cells were resuspended in 2 ml cold CaCl2 (100 mM) and incubated on ice overnight 
• after incubation 2.5 ml cold CaCl2 (100 mM) and 0.5 ml sterile glycerol (10 % 
glycerol final concentration) was added and mixed 
• Aliquots of 50-200 µl were prepared and transferred to -80 °C for storage 
2.7 Transformation of bacteria 
Competent bacteria were thawed on ice, 50-100 µl of cells were mixed with plasmid DNA 
(0.5-50 ng) or ligation mix (1-10 µl) in sterile 1.5 ml reaction tubes and maintained on ice for 
30 min. Cell membranes were disrupted by subjection of cells to a heat-pulse (42 °C) for 45-
90 sec. Commercial competent cells were heat shocked following the manufacturer’s 
recommendations. After heat shock cells were incubated on ice for 5 min. Subsequently cells 
were mixed with 200-1000 µl antibiotic-free LB medium (or SOC medium) and incubated at 
37 °C with shaking for 60 min. Bacterial cells were then plated in 100 - 200 µl aliquots onto 
LB-agar plates containing the required antibiotics for selection of recombinants. 
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2.8 Preparation of Plasmid DNA (Miniprep and Maxiprep) 
Mini-preparation of plasmid DNA (Miniprep) 
In order to isolate analytical amounts of plasmid DNA, 5 ml LB medium was inoculated with 
a bacterial colony and incubated with shaking overnight at 37 °C. Cells were collected in a 
2 ml tube by centrifugation at maximum speed for 1 min. After removing the supernatant, the 
pellet was processed due to the manufacturer’s instructions (Quiagen, Hilden, Germany). 
Plasmid DNA was eluted in supplied (TRIS-buffered) elution buffer and DNA concentration 
and purity grade was determined by measurement of OD260 nm and OD280 nm, respectively 
(Ultraspec 3000, Amersham Pharmacia Biotech). The DNA was stored at -20 °C. 
Maxi-preparation of plasmid DNA (Maxiprep) 
Maxi-preparation was performed to obtain preparative amounts of plasmid DNA. The 
maxiprep was performed according to the QIAGEN Plasmid Maxi Protocol (Qiagen, Hilden 
Germany) with QIAgentip 500. The DNA concentration and purity grade was determined by 
measurement of OD260 nm and OD280 nm, respectively (Ultraspec 3000, Amersham 
Pharmacia Biotech). The DNA was stored at -20 °C. 
2.9 Determination of DNA concentration and purity 
Nucleic acids have a maximum absorption at 260 nm wavelength. The isolated DNA was 
diluted with distilled water (H2Odd) and the absorbance at 260 nm against H2Odd measured 
spectrophotometrically (Pharmacia Biotech, Ultraspec 3000).  
For determination of DNA purity, the A260/280 coefficient was photometrically determined. An 
A260/280 < 1.8 indicated contamination of the DNA preparation with protein, while an A260/280 
> 2.0 indicated contamination with RNA. 
2.10 Mutagenesis 
All mutations in the YopO proteins were introduced by means of the QuickChangeII in vitro 
Mutagenesis System (Stratagene, Amsterdam, The Netherlands) according to the protocol of 
the manufacturer. In brief, the method relies on linear amplification of template DNA by 
mutagenesis-grade PfuUltra high fidelity DNA polymerase. Mutagenic primers are extended 
during temperature cycling, incorporating the mutation of interest into the newly synthesized 
strands. Final treatment with Dpn I ensures the digestion of only the dam-methylated parental 
strand. The mutagenic strands were finally transformed into competent cells and 
transformants were checked for the desired mutation(s) by DNA sequencing. 
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2.11 DNA Sequencing 
In order to verify the correct sequence of a given DNA, 1 - 2 µg of plasmid DNA per 
sequencing reaction was send for sequencing, together with adequate primers to the Agowa 
sequencing lab (AGOWA-Gesellschaft für molekularbiologische Technologie mbH, Berlin, 
Germany). The ensuing chromatograms were processed with Chromas software and BLASTN 
and BLASTX programs provided by NCBI (National Center for Biotechnology Information). 
Additionally DNA sequences were analyzed using VectorNTI (Invitrogen, GmbH, Karlsruhe, 
Germany) and DNAMan (Lynnon Corporation, Quebec, Canada) software. 
2.12 PCR 
Polymerase chain reaction is an easy and quick method to specifically amplify DNA from 
smallest amounts of DNA. This technique was routinely used to genotype clones and to 
amplify fragments of a desired genomic or vector DNA. 
All PCR reactions were prepared in 0.2 ml tubes (TreffLab, Degersheim, Switzerland), on ice, 
in a volume of 20 µl or 50 µl for preparative PCR, respectively. Polymerase enzymes were 
used according to the manufacturer’s recommendations. A typical reaction was set up as 
follows: 
 1 µl template DNA (Maxiprep 1:100) 
 2 µl  Taq-buffer (10x) 
 0.4 µl  dNTP-Mix (10 mM each) 
 2 µl  5’ Primer (5 pmol/µl) 
 2 µl  3’ Primer (5 pmol/µl) 
 0.2 µl  Taq-Polymerase (5 Units/µl) 
 12.4 µl H2O  
After mixing of these components the tubes were placed in the PCR machine at 95 °C and run 
with the following protocol. The annealing temperature was chosen dependent on the primer 
pair.  
 Initial Denaturation 5 min, 95 °C  1x 
 Denaturation  30 sec, 95 °C 
 Annealing  30sec, 45-65 °C 12-36 cycles 
 Elongation  30 -90sec, 72 °C 
 Final elongation 5min, 72 °C 1x 
 Hold at 4 °C 
The PCR products were analyzed by agarose gel electrophoresis. 
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3. BIOCHEMICAL METHODS 
3.1 Protein expression and purification 
Plasmids were transformed into E. coli BL21 using a heat shock procedure. For protein 
expression, over night bacterial cultures were diluted 1:20 in Luria Bertani medium (LB) 
containing the selective antibiotic and grown at 37 °C to an OD600 of 0.6 to 0.8. Bacterial 
cultures were shifted to 18 °C and protein expression was induced by 0.4 mM IPTG 
(isopropyl- b-D-thiogalactopyranoside) for 3 to 4 hours. Cells were harvested (3000 g for 10 
min at 4 °C) and french-pressed or sonificated in lysis buffer containing 50mM Tris, pH7.4, 
100 mM NaCl, 10% glycerol (and additional 0.1% Triton X-100 for purification of GST-
YopOwt and GST-YopOK269A).  
The soluble fractions with the GST fusion protein from bacterial lysates were rapidly purified 
with Glutathione-Sepharose 4B (Amersham, Freiburg, Germany). The principle is based on 
the strong affinity of the GST protein for Glutathione, allowing other proteins to flow through 
the column packed with the Glutathione-Sepharose beads. Through several wash steps with 
lysis buffer, the unspecific bound proteins are washed through the column. The GST-fusion 
protein was either eluted under mild conditions with lysis buffer containing reduced 
glutathione (30mM glutathione pH8.8 in lysis buffer) or cleaved overnight at 4 °C with 50 
units of thrombin per ml settled beads. 
If required (e.g. for microinjection) supernatants containing the desired protein were dialyzed 
against buffer containing 10 mM Tris pH 7,5, 150 mM NaCl, 2 mM MgCl2, 0.1 mM DTT. 
3.2 GST-Invasin expression for coating of fluorescent beads 
For bacterial expression of invasin (Schulte, Grassl et al. 2000; Schulte, Kerneis et al. 2000; 
Wiedemann, Linder et al. 2001) E. coli BL21 harboring pGEX-4T-3 with an insertion of the 
inv397 gene (BL21-inv397), coding for the 397 carboxy-terminal amino acids of invasin, was 
grown at 24 °C in LB to an OD of 0.7. Expression of the GST-Invasin fusion protein was 
induced with IPTG (isopropyl- b-D-thiogalactopyranoside) at a final concentration of 
0.3 mM. Cells were grown for 3 additional hours at 37 °C before being harvested by 
centrifugation and frozen at -20 °C. Frozen cells were resuspended in lysis buffer (50 mM 
Tris, pH 7.4, 100 mM NaCl, 10 % glycerol) supplemented with complete protease inhibitor 
mix (Roche, Mannheim, Germany) and disrupted by French press. Lysates were cleared by 
centrifugation and GST-Inv397 was purified with glutathione Sepharose 4B (Amersham, 
Freiburg, Germany). GST-fused protein was eluted with reduced glutathione (30 mM, pH 8.9, 
in lysis buffer). 
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3.3 Determination of protein concentration (Bradford) 
Concentration of solubilized protein was determined with the BioRad protein Assay (BioRad, 
Munich, Germany) based on the method of Bradford. The Bio-Rad Protein Assay is a dye-
binding assay in which a differential color change of a dye occurs in response to various 
protein concentrations. The absorbtion maximum for the used acidic solution of Coomassie 
Brilliant Blue G-250 dye shifts from 465 nm to 595 nm upon binding to protein. As a standard 
bovine serum albumin (BSA, Sigma-Aldrich, Munich, Germany) was used in the 
concentrations 20 µg/ml, 15 µg/ml, 10 µg/ml, 5 µg/ml und 1 µg/ml. To 800 µl of sample or 
standard solution 200 µl of dye reagent were added and after vortexing and an incubation of 5 
minutes at room temperature the absorbance at 595nm was measured. 
3.4 SDS/PAGE  
In SDS/PAGE (Sodium-dodecyl-sulphate/polyacrylamide gel electrophoresis) proteins are 
separated on the basis of their molecular weights as they migrate through a gel. SDS is an 
anionic detergent that denatures proteins. The SDS also disrupts hydrogen bonds, blocks 
hydrophobic interactions, and substantially unfolds the protein molecules by eliminating the 
tertiary and secondary structures. In the discontinuous gel system employed in this work, a 
stacking gel (non-restrictive large-pore gel, 5% acrylamide) was layered on top of a 
separating gel (resolving gel, 8-12% acrylamide). Samples were mixed with 5x Laemmli SDS 
loading buffer (2-mercapto-ethanol added for a final concentration of 5 %) incubated at 95 °C 
(5 min) and subjected to electrophoresis. With the aid of a protein marker (prestained high 
range maker, Peqlab, Erlangen, Germany) the molecular weight of the proteins applied could 
be estimated. 
 
5x SDS-sample buffer (Laemmli) 
0.5 M Tris/HCl pH 6,8 5 ml 
Glycerol 2 ml 
SDS 0.8 g 
0.5 % Bromophenol blue 1 ml 
H2Odd 2 ml 
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Stacking Gel (5%) 
ddH2O 5.5 ml 
0.5M Tris-HCl, pH6.8 1 ml 
30% acrylamide 1.3 ml 
10% SDS 800 µl 
10% ammonium persulfate (APS) 800 µl 
TEMED (Sigma) 8 µl 
 
Resolving Gel (10%) 
ddH2O 7.9 ml  
0.5M Tris-HCl. pH8.8 5 ml  
30% acrylamide 6.7 ml  
10% SDS 200 µl  
10% ammonium persulfate (APS) 200 µl 
TEMED (Sigma) 8µl 
 
SDS/PAGE running buffer (10%) 
Tris-Base 30.3 g 
Glycine 144 g 
SDS 10 g 
ad 1 l ddH2O 
3.5 Coomassie Staining 
Gels were stained for 30 minutes in Coomasie staining solution (0.1% Coomassie Brilliant 
blue , 25% methanol, 10% acetic acid) and subsequently destained in Destain solution (33% 
[v/v] Methanol, 10% [v/v] glacial acetic acid).  
3.6 Western Blot 
Western blot is a technique that employs electrophoretic transfer of proteins separated by 
SDS/PAGE to a membrane and subsequent detection of the proteins by antibody-coupled 
chemiluminescence or autoradiography. The separated proteins were transferred to a 
polyvinylidene fluoride (PVDF) membrane (Immobilon–P, Millipore, Schwalbach, Germany) 
by electrophoretic transfer. For this, a SDS/PAGE gel was placed directly on a piece of 
methanol-activated PVDF membrane (10 seconds in 100% methanol) and "sandwiched" 
between two electrodes. For tank-blotting the gel and the membrane were submerged in a 
container (Mini Protean-II, BioRad, Munich Germany) with blotting buffer (25 mM Tris-
Base, 96 mM Glycin) and an electric field applied (100V, 100min or 30V over night, 4 °C). 
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For semi-dry-blotting the gel and the membrane were transferred to a semi-dry blotting device 
and proteins transferred onto PVDF membrane for 1 hour at 1.2 mA/cm2. 
 
The PVDF membrane was blocked for 1 hour or overnight at room temperature or 4 °C, 
respectively, in PBS pH 7.4, 3% bovine serum albumin (BSA), 0.05% Tween 20. The 
membrane was incubated with primary antibody for 1 hour at room temperature (or 4 °C 
overnight), washed three times for 5 minutes followed by incubation with horseradish 
peroxidase-coupled secondary antibody (1:2000 to 1:10.000) for 1 hour. After a final washing 
step the detection solution (ECL Western blotting detection reagent, Amersham Biosciences, 
Freiburg, Germany) was applied according to the protocol of the manufacturer. Detection is 
based on a chemoluminescence reaction in which Luminol is oxidized in the presence of 
H2O2 by the peroxidase conjugated to the secondary antibody. The emitted light was detected 
by exposing the membrane to an X-ray film (Kodak, Stuttgart, Germany). The exposed film 
was developed in a processor for X-ray film development (Agfa Curix 60) and, in case of 
quantification of chemiluminescence signals, two dimensional densitometry was performed 
using a Gel Doc EQ System with Quantity One software (BioRad, Munich, Germany). 
3.7 Kinase Assay and Kinase Quantification 
Kinase reactions were performed with 3-10 µg of GST-YopO protein or indicated fragments 
in 20 µl kinase buffer containing 20mM Hepes pH 7.4, 1 mM ATP, 1mM DTT, 10 mM 
MgCl2, 2 mM MnCl2 supplemented with 5µCi [γ-32P] adenosine 5’ trisphosphate 
(Amersham Biosciences, Freiburg, Germany) and 3-10µg G-actin from Dictyostelium 
discoideum (generous gift from Michael Schleicher). 
Reactions were incubated at 30 °C for 30 minutes and phosphorylation was stopped by 
addition of SDS/PAGE sample buffer and heating for 5 minutes at 95 °C. Reactions were 
subjected to SDS/PAGE and/or Western blot transfer and radioactivity in dried gels or on 
membranes was visualized and quantified using a Phosphoimager (FLA 3000, Fujifilm, 
Tokyo, Japan) with Aida 4.0 Image Analyzer software (Raytest, Straubenhardt, Germany) or 
X-ray film (Kodak, Stuttgart, Germany). For autoradiography quantification of single and 
double point mutant YopO proteins autophosphorylation of YopO89-729 was set to 100% and 
autophosphorylation of mutant proteins normalized. 
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3.8 Phosphorylation of artificial substrates 
Kinase reactions were performed as described (see above) with designated artificial substrates 
(histone and myelin basic protein, MBP) added to kinase assay, run on SDS/PAGE and 
subjected to autoradiography. 
Reactions were incubated at 30 °C for 30 minutes and phosphorylation was stopped by 
addition of SDS/PAGE sample buffer and heating for 5 minutes at 95 °C. Reactions were 
subjected to SDS/PAGE and/or Western blot transfer and radioactivity in dried gels or on 
membranes was visualized and quantified using a Phosphoimager (FLA 3000, Fujifilm, 
Tokyo, Japan) with Aida 4.0 Image Analyzer software (Raytest, Straubenhardt, Germany) or 
X-ray film (Kodak, Stuttgart, Germany).  
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4. CELL CULTURE AND CELL BIOLOGICAL METHODS 
4.1 Cell culture 
TableE10. Cells and Cell Culture Media 
cells, cell lines and culture conditions   
name description culture conditions 
HBMEC Human Brain Microvascular Endothelial 
Cells. Endothelial cell line. 
ECGM-Endothelial Cell Growth Medium 
(PromoCell) with 2-10% FCS and 
optional 100 µg/ml penicillin and/or 
streptomycin 
HUVEC Human Umbilical Vein Endothelial 
Cells. Primary cells. 
ECGM-Endothelial Cell Growth Medium 
(PromoCell) with 2-10 % FCS and 
optional 100 µg/ml penicillin and/or 
streptomycin 
FN+/+ mouse embryo fibroblast-like cell line Nyberg et al. 2004 
FN-/- mouse embryo fibroblast-like cell line, 
fibronectin gene knockout 
Nyberg et al. 2004 
monocytes human monocyte-derived 
macrophages. Primary cells 
RPMI 1640 (PromoCell) containing 20% 
autologous serum and optional 100 µg/ml 
penicillin and/or streptomycin 
   
Cell Culture Growth Media   
name description supplier 
ECGM Endothelial Cell Growth Medium PromoCell, Heidelberg, Germany 
OptiMem Serum free medium Invitrogen, Karlsruhe, Germany 
RPMI RPMI 1640 with L-glutamine Invitrogen, Karlsruhe, Germany 
FBGM Fibroblast Growth Medium (serum free) PromoCell, Heidelberg, Germany 
additives/other  
FCS Fetal Bovine Serum Invitrogen, Karlsruhe, Germany 
PBS PBS with Na+ and K+ Sigma-Aldrich, Munich, Germany 
 
HBMEC 
Human Brain Microvascular Endothelial Cells -derived endothelial cell line (Greiffenberg, 
Goebel 2000) that was immortalized by transfection with simian virus 40 large T-antigen and 
described to maintain their morphologic and functional characteristics at least until passage 
30. In this study HBMEC passage from 15 to 28 was used and cultivated in ECGM with 2-
10% heat-inactivated serum. 
HUVEC 
Human Umbilical Vein Endothelial Cell – primary cells isolated from umbilical veins (see 
isolation of HUVEC), used from passage 2 to 6 and cultivated in ECGM with 2% heat-
inactivated serum. 
FN+/+ and FN(-/-) fibroblast-like cells 
The fibronectin knockout cell line (FN-/-) and the cell line with undeleted floxed fn gene 
(FN+/+) are a generous gift from Reinhard Faessler (Sakai, Johnson et al. 2001; Nyberg, 
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Sakai et al. 2004). Primary fibroblast-like cells from a fibronectin knockout mouse embryo 
(E13.5 Fn (flox/flox)) were immortalised by the transfection of SV-40 large T antigen, 
cloned, and several immortalised and clonal fibroblast-like cell lines were generated. Clonal 
lines were treated with a cre-transducing adenovirus to delete the floxed Fn genes. The 
deletion of Fn alleles in cre-treated clones was confirmed by PCR and the lack of Fn protein 
expression by immunoprecipitation. 
4.2 Isolation and culture of HUVEC and human monocytes 
Isolation of human monocytes 
Human peripheral blood monocytes were isolated by centrifugation of heparinized blood in 
Ficoll (Seromed, Berlin, Germany). Monocytes were isolated with magnetic anti-CD14 
antibody beads and an MS1 Separation Column (Miltenyi Biotec, Bergisch Gladbach, 
Germany) according to the manufacturer's instructions and seeded onto coverslips (50.000 per 
coverslip) or into multi-well plates (Nunc, Wiesbaden Germany). Cells were cultured for 5-7 
days in RPMI containing 20% autologous serum at 37 °C, 5% CO2 and 90% humidity. The 
medium was changed every 3-4 days. Within 5-7 days, monocytes differentiate into adherent, 
spread out macrophages (Linder, Nelson et al., 1999).  
 
Isolation of HUVEC 
Human umbilical vein endothelial cells (HUVEC) were obtained by trypsin treatment of 
umbilical cord veins and used at passages 2-6. The method was adapted from Jaffe et al., 
1973:  
The cord was inspected, and all areas with clamp marks were cut off. The umbilical vein was 
cannulated with a blunt 2 cm long needle and the needle was secured by clamping the cord 
over the needle with 2 compressors. After perfusing the umbilical vein with sterile PBS to 
wash out the blood, the other end of the umbilical vein was clamped shut and warm 0.1 % 
[w/v] α-chymotrypsin in PBS was infused into the umbilical vein. The umbilical cord was 
incubated at 37 °C for 20 minutes. After incubation, the chymotrypsin solution containing the 
endothelial cells was flushed from the cord by perfusion with sterile PBS. The effluent was 
collected in a sterile 50 ml conical centrifuge tube (BD Biosciences) containing 2 ml of fetal 
calf serum (Gibco/Invitrogen, Karlsruhe, Germany) to stop the trypsinization. The cells were 
sedimented at 130 g for 10 min at 25 °C, resuspended in endothelial cell growth medium 
containing 2% serum (ECGM, PromoCell, Heildelberg, Germany), transferred to collagen-
coated (Sigma-Aldrich. Munich Germany) culture flasks (Nunc, Wiesbaden, Germany) and 
 E. MATERIALS AND METHODS 
 - 94 - 
incubated at 37 °C, 5% CO2 and 90% humidity. After 3h non-adhered cells were removed by 
replacement of culture medium. Cell culture medium was replaced every 3-4 days. 
4.3 Coating of glass coverslips and culture flasks 
Glass cover slides (coverslips, diameter 12mm, Hartenstein, Wuerzburg, Germany) were 
treated with 100% ethanol moved through a Bunsen burner flame and then added to the wells 
of a 6-, 8-, or 12-well-plate (Nunc, Wiesbaden, Germany). To facilitate adhesion of 
endothelial cells, a 0.1 % solution of gelatin in PBS (Gelatin solution TypeB from bovine 
skin, 2%; Sigma-Aldrich, Munich, Germany) was applied and the surface was allowed to dry 
for at least 3 hours before cells and medium was introduced. Correspondingly the surface of 
culture flasks (Nunc, Wiesbaden, Germany) was treated with 0.1% gelatin solution to 
facilitate adhesion. 
4.4 Passaging and detachment of adherent cells 
After removal of growth medium, cells were washed once with sterile PBS. HUVEC/HBMEC 
were removed with Trypsin-EDTA (0.05% Trypsin 0.53 mM EDTA x 4 Na; 
GIBCO/Invitrogen, Karlsruhe, Germany) and for primary human macrophages AccutaseII 
(Fa. PAA Laboratories, Linz, Austria) was used. In contrast to the fast detachment of HUVEC 
after trypsin treatment, monocytes were incubated with AccutaseII for 15-25 minutes at 37 °C 
for detachment (500µl AccutasII per 10cm2 surface area). Trypsin and Accutase activity were 
stopped by addition of culture medium with 10% heat-inactivated serum, cells were 
sedimented for 5 min at 450 g at 24 °C and afterwards either cells were used for 
nucleofection, or resuspended in medium for seeding on coverslips or further cultivation in 
flasks or multi-well plates. 
4.5 Freezing and thawing of cells 
Freezing of cells 
Cells were detached from cell culture dishes, re-suspended in pre-warmed growth medium 
and spun down at 450g for 5 min. The cell pellet was resuspended in sterile-filtered pre-
cooled freezing medium (growth medium + 10% dimethysulfoxide, DMSO; Sigma-Aldrich, 
Munich, Germany). Cells were transferred to 1.5 ml cryo-vials, incubated at -20 °C for 3 
hours and subsequently transferred to -80 °C and optionally into liquid nitrogen for longer 
storage. 
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Thawing of cells 
Cryo-vials were removed from -80 °C or liquid nitrogen and placed into a 37 °C water bath, 
until the frozen medium had melted. The thawed cells were transferred into 5 ml of warm 
growth medium, centrifuged for 5 min at 450g, re-suspended in growth medium and 
transferred to culture flasks. 
4.6 Transfection with Metafectene 
Transfection with the polycationic agent Metafectene (Biontex, Martinsried, Germany) is 
based on liposome technology. Transfection of endothelial cells (HBMEC and HUVEC) was 
performed in serum free conditions. Prior to transfection the cells were incubated in serum 
free OptiMem medium (Invitrogen, Karlsruhe, Germany) for 2 hours. The transfection-mix 
was prepared from two solutions: One solution was prepared with vector DNA (0.5-2µg 
vector per 20.000 cells) in OptiMem and the second solution was prepared with Metafectene 
in OptiMem. The two Metafectene lipid and DNA solutions were mixed (lipd:DNA ratio in 
the range of 2-7:1) and added to seeded endothelial cells. After 3 hours of incubation (37 °C, 
5% CO2) the transfection mix was replaced by cell growth medium (ECGM with 2% serum). 
4.7 Transfection with Nucleofector (Amaxa) 
Transfection of vectors, leading to transient expression of proteins, was also performed with a 
Nucleofector device (Amaxa Biosystems, Cologne, Germany). Transfer of vectors in 
eukaryotic cells by this method (a combination of electroporation and lipofection) resulted in 
higher cellular expression and higher transfection efficiencies compared to methods using 
only lipid agents. Nucleofection with the Amaxa device is the only suitable method for 
successful transfection of primary macrophages. Nucleofection was used in the phagocytosis 
assays for transfection of primary macrophages and endothelial cells (HUVEC). 
Nucleofection was performed due to the manufacturer’s recommendations. For macrophages 
the coded solution Nr.6857 was used and HUVEC were transfected with the HUVEC 
Nucleofector Kit. For transfection reactions the recommended amount of cells (0.5-1 million) 
with an average of 2 µg vector DNA per reaction was used. 
4.8 Coating of fluorescent beads with invasin 
For non-covalent coating of beads, purified protein was dialyzed against PBS pH 7.0. 
Fluorescent polystyrene microspheres (beads, diameter 1 µm, blue, Exc./Em.=350/440nm) 
with sulfate groups on the surface for passive adsorption of proteins were purchased from 
Molecular Probes (Invitrogen, Karlsruhe, Germany). 
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About 200 µl of beads slurry (approximately 600.000 beads/µl; were washed with 1 ml of 
PBS and resuspended in 500 µl of PBS. Purified GST-Inv397 fusion protein (1 mg) was 
added and allowed to adsorb to the beads for 3 h at room temperature (RT). After adding 
500 µl of 1 % BSA (in PBS), the solution was incubated at RT for another 1 h. Next, beads 
were washed in PBS containing 1 % BSA and stored at 4 °C in 500 µl of PBS containing 1 % 
BSA.  
To determine the coupling efficiency, the protein concentration of the starting solution and of 
the supernatant before adding BSA was determined. Integrity of coated GST-Inv397 protein 
was checked using Western blot analysis and Immunofluorescence. 
 
FIGURE E3. Recombinant expression of invasin and Invasin detection on Invasin-beads. 
a) Western blot detection of purified invasin with anti-Invasin antibody after expression in 
BL21-Inv397 (labeled BL21inv+). Invasin-negative control strain (labeled BL21inv-) shows 
no expression of invasin. 
b) Immunofluorescence detection of Invasin on the surface of invasin-beads. 
Immunofluorescence staining with anti-invasin antibody (left) shows surface staining. Beads 
are visible by blue autofluorescence (right). The bar represents 10 µm. 
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4.9 Microinjection 
The protein to be injected was added to microinjection buffer (150 mM NaCl, 50 mM Tris pH 
7.4, 5 mM MgCl2) with the concentration limit of 10 µg protein per µl solution. High 
concentrations of protein lead to highly viscous solutions that can plug up the injection 
needle. As a marker for injected cells rat-IgG (Dianova, Hamburg, Germany) was added to 
the microinjection buffer (200 ng/ml). To remove aggregates the solution to be injected was 
centrifuged (4 °C, 30min, 14000 x g) before it was loaded into the injection needle (Femtotip, 
Eppendorf, Hamburg, Germany). The Femtotip was controlled by the microinjection device 
(Transjector 5246 with micromanipulator 5171, Eppendorf, Hamburg, Germany) via a 
personal computer. Cells to be microinjected were placed on the heated stage of the 
microscope, the Femtotip was moved to the cell layer and computer controlled injection of 
cells was performed after marking the cells on the monitor screen. Approximately 90-150 
cells per coverslip were injected and either immediately fixed with 3.7% (v/v) formaldehyde 
in PBS, or after an incubation time (37 °C, 5% CO2) of 30 to 90 minutes. Injected marker IgG 
was detected with AlexaFluor-coupled secondary antibodies (see below). Control experiments 
were done with microinjection buffer containing marker (rat IgG) and no YopO protein. For 
microinjection of YopO89-729 the GST-tag was cleaved off by incubation with thrombin (see 
above). 
4.10 Immunofluorescence methods 
4.10.1 Formaldehyde/Acetone fixation/permeabilization  
Cells seeded on coverslips were fixed by incubation in 3.7 % [v/v] formaldehyde in PBS for 8 
minutes at room temperature. After a washing step in PBS, the permeabilization was carried 
out in cold (-20 °C) acetone for 3 minutes. Formaldehyde fixation was performed when 
partial disruption of cell membranes by the common additive methanol was not critical. 
4.10.2 Formaldehyde/Triton fixation/permeabilization 
Cells seeded on coverslips were fixed and permeabilized in one step by incubation with 3.7% 
formaldehyde containing 0.18% Triton X-100 in PBS for 10 min at room temperature. 
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4.10.3 Paraformaldehyde fixation 
Fixation of cells for minimal disruption of cell membranes was performed with freshly made 
4 % paraformaldehyde in PBS. For the preparation of a 4 % paraformaldehyde solution an 8% 
solution was prepared by dissolving 2 g of paraformaldehyde in 25 ml of H2Odd (addition of 
NaOH and heating required for dissolving). Subsequently 25ml of 2x PBS were added to 
obtain the 4 % solution. Cells on glass coverslips were fixed in 4% parafornaldehyde for 8 
minutes and transferred to PBS to remove traces paraformaldehyde. This fixation was used 
for the phagocytosis assays where discrimination of intra and extracellular bacteria was 
essential. 
4.10.4 Methanol fixation 
Cells seeded on coverlips were fixed and permeabilized in a one step procedure by incubation 
in cold (-20 °C) methanol for 60 seconds. Subsequently the coverslips were washed in PBS to 
remove traces of methanol.  
4.10.5 Immunofluorescence staining 
Indirect immunofluorescence staining of cells attached to glass coverslips was performed in a 
wet chamber on a layer of parafilm (American National Can, Menasha, USA). A drop (27 µl) 
of staining solution was placed on the parafilm and the coverslips were applied with the 
cellular side oriented downwards. 
In general, staining with antibodies followed a two step procedure with intermediate steps for 
washing and blocking. Unspecific binding of antibody was blocked with 1% BSA in PBS, 
followed by application of the primary antibody for 45 minutes. After 3 washing/blocking 
steps with 1 % BSA in PBS the secondary antibody was applied for 45 minutes. After 3 
terminal washing steps with PBS the coverslips were partially dried, mounted on a drop 
(2.7µl) of Mowiol (including p-Phenylendiamin as antibleach) and sealed with nail polish. 
4.10.6 F-actin staining 
Direct staining with labeled phallotoxins 
Phalloidin that can be coupled to fluorescent dyes is a toxin from the toadstool Amanita 
phalloides that serves as a high affinity probe for F-actin (Wulf, Deboben et al. 1979). 
Phallotoxins interact specifically with small and large actin filaments and show minimal 
background staining. For F-actin staining with fluorescently-labeled phalloidin the cells were 
permeabilized with acetone before application of the staining solution. Dependent on other 
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antibodies used in the experiment one of the following three labeled phalloidins 
(Invitrogen/Molecular Probes, Karlsruhe, Germany) was used: AlexaFluor 568-phalloidin 
(Exc/Emm=578/603nm), AlexaFluor 488-phalloidin (Exc/Emm=495/519nm) or AlexaFluor 
350-phalloidin (Exc/Emm=346/446nm). 
Indirect staining with Actin antibody 
After cell fixation and permeabilization with formaldehyde/acetone a primary α-actin 
antibody (MAB1501 α-actin mouse IgG; Chemicon/Millipore, Schwalbach, Germany) was 
used as an alternative to the fluorescently-labeled phallotoxins. With the choice of a 
secondary antibody, F-actin could not only be labeled in blue, green and red, but additionally 
with a secondary antibody labeled with the far-red fluorescent dye Cy5 (Invitrogen, 
Karlsruhe, Germany). 
4.10.7 Inside/outside staining (double fluorescence staining) 
The microscopic technique for differentiation of cell-attached (extracellular) and ingested 
(intracellular) bacteria or particles was adapted from a method described elsewhere 
(Heesemann and Laufs 1985; Wiedemann, Linder et al. 2001). This method is based upon the 
observation that membranes of mammalian cells are impermeable for antibodies after fixation 
with paraformaldehyde but become permeable after treatment with acetone. Consequently, 
before permeabilization extracellular bacteria can be exclusively stained by primary and 
secondary antibodies, and intracellular bacteria (together with extracellular bacteria) can be 
visualized by treatment with specific antibodies after permeabilization. This results in 
extracellular bacteria being stained in one color during the first step and all bacteria being 
stained with the second color after permeabilization. By comparison of the two fluorescent 
channels the number of extracellular bacteria and the number of all bacteria present can be 
determined microscopically. 
The double fluorescence staining method was used to determine internalization of Invasin-
E. coli (HB101inv+), internalization of invasin-beads (only outside staining necessary for 
blue-fluorescent Invasin-beads) and internalization of YadA-E. coli (DH5A-pBR-A1) into 
endothelial cells and fibroblast-like cells (FN-/- and FN+/+). Uptake of SRBC was 
determined using fluorescent outside staining and phase contrast microscopy (see below). 
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4.11 Quantification of Adhesion of YadA-E. coli to Fibronectin (FN) and 
Collagen (COL) 
To analyze the ability of YadA (from Yersinia enterocolitica) to interact with extracellular 
matrix (ECM) proteins glass coverlips were coated with fibronectin (1 µg/ml FN in PBS 
pH 7.4, bovine plasma fibronectin, Calbiochem/Merck, Darmstadt, Germany) or collagen 
(1 mg/ml COL in PBS pH7.4, 0.1% Gelatin solution TypeB from bovine skin, Sigma-Aldrich, 
Munich, Germany) at room temperature overnight. 
Overnight cultures of YadA-E. coli (DH5A-pBR-A1) were induced for YadA expression at 
37 °C for 3 hours, washed in ice cold PBS pH7.4 and added in equal amounts to ECM-coated 
coverslips in a 12 well plate.  
After 60 minutes incubation at 37 °C non-bound bacteria were removed, adherent bacteria 
were fixed with 4% formaldehyde in PBS for 8 minutes and stained with anti-E. coli-antibody 
followed by AlexaFluor 488-labeled secondary antibody. The YadA-negative non-adhesive 
parental E. coli strain (DH5A-pBR) was used as negative control. 
Stained bacteria were quantified by a microscopic method: Therefore, 10 representative 
microscopic fields were captured with a Zeiss Axioplan microscope, a 40x objective lens, 
Spot Pursuit 1.4MP monochrome camera (Diagnostic Instruments, Inc, Sterling Heights, 
USA) and Spot software (Diagnostic Instruments, Inc, Sterling Heights, USA), the total area 
covered by bacteria measured using ImageJ software (Research Services Branch, NIMH) and 
the data imported into a graphic and spread sheet program (MS Excel, Unterschleissheim, 
Germany) for statistical analysis. The measured unit was pixel2 (square pixel) directly 
reflecting the number of attached bacteria. The values for the measured area were divided by 
100 and displayed as adhesion in arbitrary units. Adhesion to fibronectin (FN) was 
normalized to collagen (COL) that was set to 100%. 
Data presented are mean +/- standard deviation (+/-S.D) of three independent experiments. 
For each experiment 10 objective fields per matrix protein were evaluated.  
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4.12 Quantification of expression of GFP-YopO mutants 
YopO effects were observed at the cellular level in cells identified by green fluorescence 
originating from GFP-YopO fusion proteins. To ensure that different effects of GFP-YopO 
mutants are not based on different cellular expression levels, transfected cells (HBMEC) that 
had the brightness to be chosen for evaluation of cellular effects were measured for GFP-
fluorescence. Fluorescence intensity of GFP directly reflects the cellular expression level of 
GFP-YopO mutant proteins. 
Therefore, at least ten transfected cells per construct were captured with a Zeiss Axioplan 
microscope, a 100x objective lens (numerical aperture 1.4), Spot Pursuit 1.4MP monochrome 
camera (Diagnostic Instruments, Inc, Sterling Heights, USA) and Spot software (Diagnostic 
Instruments, Inc, Sterling Heights, USA) using identical exposure settings. Average pixel 
intensities of three outlined regions per cell were obtained using ImageJ software (Research 
Services Branch, NIMH) and imported into a spreadsheet and graphics program for statistical 
analysis. 
 
FIGURE E4. Expression levels of evaluated GFP-YopO fusion proteins 
Mean expression level (arbitrary units) determined by immunofluorescence-
intensity measurement is shown for background, GFP empty vector (GFP) and the 
respective GFP-YopO mutant proteins. Values are mean ± S.D. of 3 experiments 
with 10 cells (30 regions of interest) evaluated per experiment. 
 
The expression levels directly reflected in the brightness of GFP fluorescence were measured 
for background (control with no cells present), for GFP empty vector expressing control and 
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for cells expressing GFP-YopOwt and the designated GFP-YopO mutant proteins. The GFP 
empty vector showed maximal expression, while the different GFP-YopO constructs were 
mostly expressed at a lower level (see figure E4). Transfection efficiency (not shown) and 
additionally the expression level were shown to be dependent on the size of the GFP-YopO 
fusion protein. The truncated GFP-YopO fusion proteins GFP-YopO1-440 and GFP-
YopO89-440 showed higher expression than to the full length proteins GFP-YopOwt and 
GFP-YopOD267A/K279A and the C-terminally truncated GFP-YopO1-710 (figure E4). 
Although smaller YopO mutant proteins tended to show a higher expression level compared 
to the larger YopO mutant proteins, the expression levels of all GFP-YopO constructs 
evaluated in this study were comparable. 
In conclusion, the different effects on cell morphology, F-actin disruption and phagocytosis 
can not be attributed to different expression levels of the YopO constructs. 
4.13 Evaluation of cellular effects 
4.13.1 F-actin disruption and rounding/arborization 
To observe F-actin disruption caused by GFP-YopO and its mutants, endothelial cells 
(HBMEC) were transfected with Metafectene and 2µg of the respective vector DNA. After 20 
hours of expression, cells were fixed with formaldehyde, permeabilized with acetone and 
stained for F-actin with AlexaFluor 568-phalloidin (see above). Cells showing GFP 
fluorescence were scored for unaltered phenotype showing normal stress fibers (named no 
phenotype in figure 10), F-actin disruption or rounding/arborization. Cells showing F-actin 
disruption (reduced amount and size of actin filaments) and cells showing no cytoplasmic F-
actin were scored positive for F-actin disruption. Cells with completely rounded phenotype 
determined by phase contrast and the green fluorescence channel (apparent retraction fibers) 
were scored positive for rounding/arborization. 
Data presented are mean +/- standard deviation (+/-S.D) of at least three independent 
experiments. For each experiment at least 90 cells per condition were evaluated. 
4.13.2 RhoAV14 rescue assay 
F-actin disruption was examined by staining of the actin cytoskeleton with an anti-actin 
antibody (mouse IgG, Chemicon/Millipore, Schwalbach, Germany) followed by MarinaBlue 
365-coupled secondary antibody (Molecular Probes, Karlsruhe, Germany). Actin staining was 
evaluated in the blue channel and the green and red channels were used for GFP-RhoAV14 
and mRFP-YopO, respectively. 
 E. MATERIALS AND METHODS 
 - 103 - 
Endothelial cells (HBMEC) were transfected with Nucleofector technology (Amaxa, Cologne, 
Germany) using GFP (empty vector), GFP-RhoAV14, a mixture of GFP-RhoAV14 and 
mRFP-YopO, mRFP-YopO or mRFP (empty vector). For single transfections 2 µg of vector 
and for the double transfection 1 µg of each vector was introduced. Cells were fixed 18 hours 
after transfection and stained with anti-actin antibody. 
For statistical evaluation of transfected cells two phenotypes were distinguished: Cells 
showing F-actin disruption (reduced amount and size of actin filaments) and cells showing no 
cytoplasmic F-actin were scored positive for F-actin disruption. The other phenotype that was 
scored had articulate cytoplasmic F-actin fibers comparable to untransfected control cells. 
Data presented in the results are mean +/- standard deviation (+/-S.D) of three independent 
experiments. For each experiment at least 90 cells per condition (GFP, GFP-RhoAV14, GFP-
RhoAV14+mRFP-YopO, mRFP-YopO, mRFP) were evaluated. 
4.14 Phagocytosis assays 
4.14.1 Invasion properties of Invasin-beads and Invasin-E. coli (HB101inv+) 
Endothelial cells (HBMEC) cultured on gelatin coated glass coverslips (Hartenstein GmbH, 
Wuerzburg, Germany) were inoculated with either bacteria expressing invasin on their surface 
(Invasin-E. coli/HB101inv+; ratio bacteria:cell of 60:1), or with Invasin-beads (ratio 
beads:cell of 50:1). For synchronization of attachment bacteria and beads were centrifuged 
(1 min, 18x g) onto the cells and incubated at 37 °C, 5% CO2 in a humidified atmosphere. 
Morphological effects (F-actin) 
Ten minutes after centrifugation cells were fixed, permeabilized (formaldehyde/acetone) and 
stained for F-actin with AlexaFluor 568-phalloidin. Actin phenotype elicited at attachment 
sites of Invasin-E. coli (HB101inv+) or Invasin-beads was observed by phasecontrast and 
immunofluorescence microscopy. 
Uptake kinetics 
At time points 10, 30 and 60 minutes after attachment of bacteria or beads cells were fixed in 
paraformaldehyde and stained for discrimination of intra- and extracellular particles (see 
above). Double fluorescence staining (outside AlexaFluor 568; inside/all AlexaFluor 488) was 
performed for Invasin-E. coli. Attached extracellular Invasin-beads were stained with 
AlexaFluor 568 (red) secondary antibody, while all beads (including intracellular) were 
detected by their blue staining. Per experiment for each time point 90 cells were evaluated for 
attached and internalized particles. Data presented in the results are mean +/- standard 
deviation (+/-S.D) of three independent experiments. 
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4.14.2 Invasin-mediated phagocytosis 
To evaluate the effect of YopO on invasin-mediated phagocytosis, Invasin-beads were 
attached to endothelial cells (HBMEC; ratio 50:1) expressing GFP (control), GFP-YopOwt or 
GFP-RacN17. Transfection of HBMEC was performed with Metafectene (Biontex, 
Martinsried, Germany). Invasin-beads were added 18 hours after transfection, attachment was 
synchronized by a 1 min, 18x g centrifugation step, after 30 minutes cells were fixed with 
paraformaldehyde and extracellular Invasin-beads were stained with anti-invasin primary 
antibody (rabbit IgG) followed by AlexaFluor 568-labeled (red) secondary antibody. Blue 
fluorescence of Invasin-beads makes the inside/all staining after permeabilization dispensable. 
Outside staining enabled to distinguish the red-labeled extracellular beads from the blue 
intracellular beads. In cells expressing the respective GFP protein statistical analysis of 
attached and internalized bacteria was performed using a microscope with the red, green and 
blue fluorescent channels. Internalization was normalized to the construct showing the highest 
internalization (GFP-YopOwt; undistinguishable from GFP within standard error) that was set 
to 100%. 
Data presented in the results are mean +/- standard deviation (+/- S.D) of three independent 
experiments. For each experiment at least 90 cells per condition (GFP, GFP-YopOwt, GFP-
RacN17) were evaluated. Student-t test was used to determine statistical significance (99% 
level).  
4.14.3 FN-dependent phagocytosis 
To clarify if the uptake of YadA-E. coli is strictly dependent on the presence of fibronectin, 
fibronectin knockout cells (FN-/-) and the corresponding fibronectin-positive control cells 
(FN+/+) were assayed for internalization of YadA-E. coli . The fibroblasts (a generous gift 
from Reinhard Faessler; (Nyberg, Sakai et al. 2004)) were grown in serum free medium 
(FBGM) on collagen coated surfaces for 7 days, the medium was replaced every 2 days. 
Internalization was evaluated for YadA-E. coli (DH5A-pBR-A1) and as a control, to verify 
that internalization is exclusively dependent on YadA, for the parental control strain DH5A-
pBR. The parental control strain showed very low adhesion and therefore was added at a ratio 
of 3000:1 to cells, while YadA-E. coli was added at a ratio of 30:1. Internalization was 
synchronized by centrifugation (1 minute, 18x g), cells were incubated at 37 °C for 90 
minutes and fixed with paraformaldehyde. Double fluorescence staining discriminated red-
labeled extracellular YadA-E. coli from intracellular green-labeled YadA-E. coli.  
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Statistical analysis of attached and internalized bacteria (YadA-E. coli or DH5A-pBR) was 
performed on a microscope using phasecontrast and the red and green fluorescent channels. 
Data presented in the results are mean +/- standard deviation (+/- S.D) of three independent 
experiments. For each experiment at least 90 cells per condition were evaluated. Student-t test 
was used to determine statistical significance (99% level). 
4.14.4 FcγR- and CR-mediated phagocytosis 
FcγR- and CR-mediated phagocytosis was evaluated for GFP-YopO expressing monocytes 
using an adapted method described before (Braun, Fraisier et al. 2004). Hereby, complement 
coated or IgG-coated sheep red blood cells (SRBC) were subjected to phagocytosis by 
macrophages in serum-free complete RPMI (Invitrogen, Karlsruhe, Germany) phagocytosis 
medium. 
FcγR phagocytosis 
SRBC (MP Biomedicals, Eschwege, Germany) were washed three times with sterile PBS 
(containing Ca2+ and Mg2+; Sigma-Aldrich, Taufkirchen, Germany), resuspended in sterile 
PBS and then incubated with rabbit IgG anti-SRBC (ICN Pharmaceuticals, Ohio, USA) at RT 
for 30 minutes. After one wash in PBS, IgG-opsonized SRBC were resuspended in pre-
warmed phagocytosis medium. 
Opsonized IgG-SRBC were added at a ratio of 15:1 to GFP- or GFP-YopO expressing 
monocytes grown on glass coverslips. Phagocytosis was synchronized by centrifugation for 2 
minutes at 400 g at RT and cells were subsequently incubated at 37 °C, 5% CO2 for 10 to 60 
minutes, before phagocytosis was stopped by fixation with 4% paraformaldehyde.  
Outside staining of IgG-SRBC: 
After fixation coverslips were washed in PBS and incubated in 1 % BSA in PBS for 5 
minutes to block unspecific binding of antibody. Coverslips with IgG (rabbit IgG anti-SRBC) 
opsonized SRBC were incubated with AlexaFluor 568 labeled secondary antibody (anti-rabbit 
AlexaFluor 568 IgG (H+L) goat, Molecular Probes/Invitrogen, Karlsruhe, Germany) for red 
outside staining.  
CR phagocytosis 
SRBC (MP Biomedicals, Eschwege, Germany) were washed three times with sterile PBS 
(containing Ca2+ and Mg2+; Sigma-Aldrich, Taufkirchen, Germany), resuspended in sterile 
PBS and then incubated with rabbit IgM anti-SRBC (WAK-Chemie Medical GmbH, 
Steinbach, Germany) at RT for 30 minutes. After one wash with PBS IgM-opsonized SRBC 
were further incubated for 20 min at 37 °C in phagocytosis medium containing 10% C5-
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deficient complement (Sigma-Aldrich, Taufkirchen, Germany). Complement-coated SRBC 
were washed once with warm PBS and resuspended in warm phagocytosis medium. In order 
to activate the CR3 receptors for CR3-mediated phagocytosis, macrophages were incubated 
with 150 ng/ml PMA (Phorbol 12-Myristate 13-acetate, Sigma-Aldrich, Taufkirchen, 
Germany) in phagocytosis medium for 15 min at 37 °C before the start of phagocytosis assay. 
Complement coated SRBC were added to activated GFP- and GFP-YopO expressing 
monocytes at a ratio of 15:1. Phagocytosis was synchronized by centrifugation for 2 minutes 
at 400 g at RT and cells were subsequently incubated at 37 °C, 5% CO2 for 10 to 60 minutes, 
before phagocytosis was stopped by fixation with 4% paraformaldehyde. 
Outside staining of complement coated SRBC 
After fixation coverslips with monocytes and complement opsonized SRBC were washed in 
PBS and incubated in 1% BSA in PBS for 5 minutes to block unspecific binding of antibody. 
In the first step coverslips were incubated with rabbit IgG anti-SRBC (ICN Pharmaceuticals, 
Ohio, USA) primary antibody and then stained with AlexaFluor 568-labeled secondary 
antibody (anti-rabbit AlexaFluor 568 IgG (H+L) goat, Molecular Probes/Invitrogen, 
Karlsruhe, Germany) for red outside staining. 
Microscopic evaluation of FcγR- and CR-mediated phagocytosis 
Internalized SRBC can be distinguished from attached SRBC by their appearance in 
phasecontrast and fluorescence microscopy, respectively (Greenberg, el Khoury et al. 1991). 
Phagocytosed SRBC become visible by phasecontrast as swollen particles in vacuoles, but 
they are almost invisible by phasecontrast when they are extracellular. Fluorescent outside 
staining in red (AlexaFluor 568) identifies extracellular SRBC. 
 
Statistical analysis of attached and internalized SRBC (IgG-opsonized or complement-coated) 
was performed for monocytes expressing GFP or GFP-YopO. Internalization was normalized 
to the GFP control that was set to 100%. The results presented are mean +/- standard 
deviation (+/-S.D) of three independent experiments. For each experiment 90 transfected cells 
were evaluated. Student-t test was used to determine statistical significance (99% level). 
Preliminary experiments showed that uptake of IgG- and Complement-coated SRBC was best 
to be evaluated after 60 minutes. Uptake after 10 and 30 minutes was considerably lower than 
after 60 minutes (not shown), therefore the data presented in the results refer to experiments 
with 60 minutes of internalization at 37 °C before fixation. 
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4.14.5 YadA-mediated phagocytosis 
YadA-mediated internalization was examined in primary endothelial cells (HUVEC) 
expressing the GFP-YopO fusion proteins. To examine the effects of YopO on YadA-
mediated phagocytosis YadA-E. coli (DH5A-pBR-A1) were attached to endothelial cells 
(ratio 30:1) expressing the respective GFP-fusion protein. 
Transient expression of GFP-YopO fusion proteins was initiated by Nucleofection (Amaxa, 
Cologne, Germany; see above). YadA-E. coli were added to cells 19 hours after transfection. 
A centrifugation step (1 minute, 18x g) for synchronization of attachment was employed, 
subsequently cells were incubated at 37 °C (5 % CO2). Phagocytosis was stopped after 90 
minutes with 4% paraformaldehyde. For evaluation of internalization in GFP expressing cells, 
a double fluorescence staining method was used (see above). Outside staining was performed 
with mouse anti-YadA primary antibody (mouse IgG, 9H11) and red-labeled anti-mouse 
secondary antibody (AlexaFluor 568, goat IgG, Molecular Probes/Invitrogen, Karlsruhe, 
Germany). After permeabilization internalized YadA-E. coli were stained with rabbit anti-
E. coli (Biodesign, Maine, USA) and mouse anti-YadA primary antibodies followed by blue 
anti-rabbit (MarinaBlue 365 IgG goat, Molecular Probes/Invitrogen, Karlsruhe, Germany) and 
anti-mouse (MarinaBlue 365 IgG goat, Molecular Probes/Invitrogen, Karlsruhe, Germany) 
secondary antibodies. Green fluorescence identified the cells expressing the respective GFP-
YopO fusion protein, red fluorescence identified extracellular bacteria and blue fluorescence 
all bacteria present. Inside staining of YadA-E. coli with a combination of two primary 
antibodies (one antibody against YadA (mouse IgG, 9H11) and one against several E. coli 
epitopes (rabbit IgG, Biodesign, Maine, USA)) proved to be better for the detection of 
internalized bacteria. Detection of internalized bacteria when using solely the anti-YadA 
primary antibody was more difficult, because of the ongoing digestion of antigenic epitopes in 
formed phagocytic vesicles. 
Internalization was statistically evaluated for green (GFP-expressing) cells and adjacent 
control cells showing no GFP expression. Internalization was normalized to control cells that 
were set to 100%. Data presented in the results are mean +/- standard deviation (+/-S.D) of 
three independent experiments. For each experiment at least 90 cells per condition were 
evaluated. Student-t test was used to determine statistical significance (99% level). 
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4.14.6 EDIN-B inhibition of RhoA and YadA-mediated phagocytosis 
Expression of EDIN-B in E. coli BL21 was performed following a standard procedure. 
Therefore, E. coli bearing the plasmid for recombinant production of His-tagged EDIN-B 
were induced with 0.4 mM IPTG in the logarithmic growth phase and expression was 
performed for 3 hours at 20°C. Bacteria were harvested, lysed and the recombinant His-
EDIN-B protein was purified with Ni-NTA-Agarose (Qiagen, Hilden, Germany). 
YadA-mediated uptake in EDIN-B treated cells was evaluated by a double fluorescence 
staining method (see above). Efficiency of RhoA inactivation by EDIN-B was controlled by 
staining of F-actin with labeled phalloidin (see above). Cells with disrupted F-actin 
cytoskeleton were evaluated for YadA-E. coli (DH5A-pBR-A1) uptake. Endothelial cells 
(HUVEC) seeded on coverslips 24 hours were treated with EDIN-B (60 µg/ml in ECGM) for 
22 hours to inactivate RhoA. YadA-E. coli were added (at a ratio of 30:1), attachment was 
synchronized by centrifugation (1 min, 18x g), after 90 min cells were fixed with 4% 
paraformaldehyde and double fluorescence staining performed. External bacteria were stained 
with mouse anti-YadA primary antibody (mouse IgG, 9H11) and red-labeled anti-mouse 
secondary antibody (AlexaFluor 568, goat IgG, Molecular Probes/Invitrogen, Karlsruhe, 
Germany). After permeabilization internalized YadA-E. coli were stained with rabbit anti-
E. coli (Biodesign, Maine, USA) and mouse anti-YadA primary antibodies followed by blue 
anti-rabbit (MarinaBlue 365 IgG goat, Molecular Probes/Invitrogen, Karlsruhe, Germany) and 
anti-mouse (MarinaBlue 365 IgG goat, Molecular Probes/Invitrogen, Karlsruhe, Germany) 
secondary antibodies. F-actin staining was performed with green AlexaFluor 488-labeled 
phalloidin.  
Internalization was statistically evaluated for EDIN-B treated cells (showing RhoA inhibition 
by disruption of F-actin) and for untreated control cells. Internalization was normalized to 
control cells that was set to 100%. Data presented in the results are mean +/- standard 
deviation (+/-S.D) of three independent experiments. For each experiment at least 90 cells per 
condition were evaluated. 
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F. ABBREVIATIONS 
°C degree Celsius 
A adenine, alanine, ampere 
aa amino acid 
Ab antibody 
Amp ampicillin 
APS ammoniumpersulfate 
ATP adenosintriphosphate 
au arbitrary units 
BG biogroup 
BHI Brain-Heart-Infusion 
bp base pair 
BSA bovine serum albumin 
C cytosine 
cDNA complementary DNA 
CFU colony forming unit 
CHO chinese hamster ovarian tumor cells 
CIB calcium and integrin binding protein 
Cm chloramphenicol 
cm centimeter 
COL collagen 
CR complement receptor 
D aspartic acid 
Da dalton 
dd  double distilled 
DMEM Dulbecco’s Modified Eagle Medium 
DNA deoxyribonucleic acid 
dNTP  deoxynucleoside triphosphate (dATP, dCTP, 
dGTP, dTTP) 
DTT dithiothreitol 
ECGM endothelial cell growth medium 
ECM  extracellular matrix 
EDTA ethylendiamin-N,N,N',N'-tetra acetic acid 
ELISA  Enzyme Linked Immunoabsorbent Assay 
EtOH ethanol 
F-actin filamentous actin 
FAK  focal adhesion kinase 
FCS  fetal calf Serum 
FGM Fibroblast growth medium 
fig. Figure 
FN  fibronectin 
g Gram 
G Guanine 
G-actin globular actin 
GAP GTPase activating protein 
GDI Guanine nucleotide dissociation inhibitor 
GEF GTP exchange factor 
GFP green fluorescent protein 
GST Glutathion-S-Transferase 
h Hour 
H2O water 
H2Odd bidestilled water 
HPI high Pathogenicity island 
Ig immunoglobulin 
IM inner membrane 
IPTG 1-Isopropyl-β-D-1-thiogalaktoside 
Kan kanamycin 
kb kilo bases 
kDa kilo Dalton 
l liter 
L lysine 
LB Luria-Bertani 
LD50 lethal dosis 50 
LIM protein-protein interaction motive from genes 
lin-11, isl-1 and mec-3  
m milli 
M molar 
MCS multiple cloning site 
min minute 
n nano 
Nal nalidixic acid 
nm nanometer 
o/n over night 
OD optical density at 600nm 
OM  outer membrane 
PAGE poly-acrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PFA  paraformaldehyde 
PMN polymorphnuclear neutrophile granulocytes 
PMSF phenylmethanosulfonylfluoride 
PTP protein tyrosine phosphatase 
pYV Yersinia virulence plasmid 
RFP red fluorescent protein 
RNS ribonucleic acid 
rpm revolutions per minute 
RT room temperature 
S.D. standard deviation 
SDS sodiumdodecylsulfate 
Sm streptomycin 
SRF serum response factor 
T thymine 
T threonine 
Tab. table 
TAE Tris/Acetate/EDTA 
TE Tris/EDTA 
TEMED N,N,N',N'-tetramethylethylenediamine 
Tet tetracycline 
Tris Tris(hydroxymethyl)aminomethane 
TTS type III secretion 
U units, uracil 
UV ultra violet 
V Volt 
v/v volume/volume 
Vol. volume 
W  watt 
w/v weight/volume 
WASP Wiskott Aldrich syndrome protein 
WT wild type 
Yop Yersinia outer protein 
YpkA Yersinia protein kinase A 
µ micro 
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